BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-544. [PMID: 32123347 DOI: 10.1038/s41564-020-0695-z] [Cited by in Crossref: 2735] [Cited by in F6Publishing: 3121] [Article Influence: 1367.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu C, Ma M, Yi Y, Yi C, Dai H. Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019. Ann Med 2022;54:2391-401. [PMID: 36039499 DOI: 10.1080/07853890.2022.2114608] [Reference Citation Analysis]
2 Ghazal I, Rachadi A, Ez-Zahraouy H. Optimal allocation strategies for prioritized geographical vaccination for Covid-19. Physica A 2022;607:128166. [PMID: 36090308 DOI: 10.1016/j.physa.2022.128166] [Reference Citation Analysis]
3 Ji N, Zhang M, Ren L, Wang Y, Hu B, Xiang J, Gong Y, Wu C, Qu G, Ding W, Yin Z, Li S, Wang Z, Zhou L, Chen X, Ma Y, Tang J, Liu Y, Liu L, Huang M. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients. Emerg Microbes Infect 2022;11:1115-25. [PMID: 35343389 DOI: 10.1080/22221751.2022.2059400] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hang XM, Wang HY, Liu PF, Zhao KR, Wang L. Cas12a-assisted RTF-EXPAR for accurate, rapid and simple detection of SARS-CoV-2 RNA. Biosens Bioelectron 2022;216:114683. [PMID: 36088673 DOI: 10.1016/j.bios.2022.114683] [Reference Citation Analysis]
5 O'sullivan-murphy B, Driehuys B, Mammarappallil J. MR Imaging for the Evaluation of Diffuse Lung Disease. Radiologic Clinics of North America 2022;60:1021-32. [DOI: 10.1016/j.rcl.2022.06.007] [Reference Citation Analysis]
6 Liu P, Zheng Y. Temporal and spatial evolution of the distribution related to the number of COVID-19 pandemic. Physica A: Statistical Mechanics and its Applications 2022;603:127837. [DOI: 10.1016/j.physa.2022.127837] [Reference Citation Analysis]
7 Ruiz MJ, Siracusano G, Cottignies-calamarte A, Tudor D, Real F, Zhu A, Pastori C, Capron C, Rosenberg AR, Temperton N, Cantoni D, Liao H, Ternette N, Moine P, Godement M, Geri G, Chiche J, Annane D, Cramer Bordé E, Lopalco L, Bomsel M. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis. Front Immunol 2022;13:842468. [DOI: 10.3389/fimmu.2022.842468] [Reference Citation Analysis]
8 Naik NG, Lee SC, Veronese BHS, Ma Z, Toth Z. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway. Microbiol Spectr 2022;:e0232222. [PMID: 36173315 DOI: 10.1128/spectrum.02322-22] [Reference Citation Analysis]
9 Kashyap P, Thakur M, Singh N, Shikha D, Kumar S, Baniwal P, Yadav YS, Sharma M, Sridhar K, Inbaraj BS. In Silico Evaluation of Natural Flavonoids as a Potential Inhibitor of Coronavirus Disease. Molecules 2022;27:6374. [DOI: 10.3390/molecules27196374] [Reference Citation Analysis]
10 Inokuchi H. Discovery of a tRNA-like base sequence in the coronavirus genome and possible mechanism of action. Genes Genomics 2022. [PMID: 36166141 DOI: 10.1007/s13258-022-01299-w] [Reference Citation Analysis]
11 Chen Y, Zhao X, Zhou H, Zhu H, Jiang S, Wang P. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat Rev Immunol 2022. [PMID: 36168054 DOI: 10.1038/s41577-022-00784-3] [Reference Citation Analysis]
12 Tu B, Gao Y, An X, Wang H, Huang Y. Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharm Sin B 2022. [PMID: 36168329 DOI: 10.1016/j.apsb.2022.09.011] [Reference Citation Analysis]
13 Korkut S. Research of the Coronavirus Anxiety, Post-Traumatic Stress, Generalized Anxiety Disorder, Quality of Life, and Stress Coping Styles in COVID-19 Survivors. Psychol Rep 2022;:332941221129131. [PMID: 36134735 DOI: 10.1177/00332941221129131] [Reference Citation Analysis]
14 AlSahow A, AlQallaf A, AlYousef A, Bahbahani H, Bahbahani Y, AlHelal B, AlRajab H, AlMuhaiteeb A, Shalaby H, Elabbadi M, Elsebaei M, Abdallah E, Ayoub M, AbouTrabeh A, AlSarrajji M, AlAwadhi A, Kumar R. Impact of COVID-19 infection on the dialysis population prospective, observational, nationwide study. Int Urol Nephrol 2022. [PMID: 36136260 DOI: 10.1007/s11255-022-03368-1] [Reference Citation Analysis]
15 Saini J, Kaur P, Malik N, Lakhawat SS, Sharma PK. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era. Microbiol Res 2022;265:127206. [PMID: 36162150 DOI: 10.1016/j.micres.2022.127206] [Reference Citation Analysis]
16 Khan MM, Goh YW, Ahmad N, Siddique MM. Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2. Bioprocess Biosyst Eng 2022. [PMID: 36125525 DOI: 10.1007/s00449-022-02788-8] [Reference Citation Analysis]
17 Mohammadzadeh Hosseini Moghri SAH, Ranjbar M, Hassannia H, Khakdan F. In silico analysis of the conserved surface-exposed epitopes to design novel multiepitope peptide vaccine for all variants of the SARS-CoV-2. J Biomol Struct Dyn 2022;:1-13. [PMID: 36124826 DOI: 10.1080/07391102.2022.2123395] [Reference Citation Analysis]
18 Tyrkalska SD, Martínez-lópez A, Arroyo AB, Martínez-morcillo FJ, Candel S, García-moreno D, Mesa-del-castillo P, Cayuela ML, Mulero V. Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern. Sci Adv 2022;8:eabo0732. [DOI: 10.1126/sciadv.abo0732] [Reference Citation Analysis]
19 Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. [DOI: 10.1007/s00431-022-04600-x] [Reference Citation Analysis]
20 Zhang Y, Lu Y, Tang J, Sun Y, Zhao Z, Jian X, Gao X. Strategies for screening, occupational prevention, and management of COVID-19 in outpatient clinics in Shandong. Front Public Health 2022;10:911364. [DOI: 10.3389/fpubh.2022.911364] [Reference Citation Analysis]
21 Santos ES, Silva PC, Sousa PSA, Aquino CC, Pacheco G, Teixeira LFLS, Araujo AR, Sousa FBM, Barros RO, Ramos RM, Rocha JA, Nicolau LAD, Medeiros JVR. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches. Chem Biol Interact 2022;367:110161. [PMID: 36116513 DOI: 10.1016/j.cbi.2022.110161] [Reference Citation Analysis]
22 Tucciarone CM, Cecchinato M, Vianello L, Simi G, Borsato E, Silvestrin L, Giorato M, Salata C, Morandin M, Greggio E, Drigo M. Evaluation of UVC Excimer Lamp (222 nm) Efficacy for Coronavirus Inactivation in an Animal Model. Viruses 2022;14:2038. [DOI: 10.3390/v14092038] [Reference Citation Analysis]
23 Zhang H, Feng T. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach. Biochem Genet. [DOI: 10.1007/s10528-022-10280-x] [Reference Citation Analysis]
24 Paparella A, Purgatorio C, Chaves-lópez C, Rossi C, Serio A. The Multifaceted Relationship between the COVID-19 Pandemic and the Food System. Foods 2022;11:2816. [DOI: 10.3390/foods11182816] [Reference Citation Analysis]
25 Yamacli S, Avci M. Computation of the Binding Energies between Human ACE2 and Spike RBDs of the Original Strain, Delta and Omicron Variants of the SARS‐CoV‐2: A DFT Simulation Approach. Advcd Theory and Sims. [DOI: 10.1002/adts.202200337] [Reference Citation Analysis]
26 Darmawan KK, Karagiannis TC, Hughes JG, Small DM, Hung A. Molecular insights into the interaction of apo-lactoferrin with the receptor binding domain of the SARS-CoV-2 spike protein: a molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2121759] [Reference Citation Analysis]
27 Ostrycharz E, Hukowska-Szematowicz B. Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals. Int J Mol Sci 2022;23:10536. [PMID: 36142450 DOI: 10.3390/ijms231810536] [Reference Citation Analysis]
28 Luo J, Klett J, Gabert J, Lipp T, Karbach J, Jäger E, Borte S, Hoffmann R, Milkovska-Stamenova S. A Quantitative ELISA to Detect Anti-SARS-CoV-2 Spike IgG Antibodies in Infected Patients and Vaccinated Individuals. Microorganisms 2022;10:1812. [PMID: 36144414 DOI: 10.3390/microorganisms10091812] [Reference Citation Analysis]
29 Jitvaropas R, Mayuramart O, Sawaswong V, Kaewsapsak P, Payungporn S. Classification of salivary bacteriome in asymptomatic COVID-19 cases based on long-read nanopore sequencing. Exp Biol Med (Maywood) 2022;:15353702221118091. [PMID: 36082397 DOI: 10.1177/15353702221118091] [Reference Citation Analysis]
30 Tanimoto S, Itoh SG, Okumura H. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2. IJMS 2022;23:10358. [DOI: 10.3390/ijms231810358] [Reference Citation Analysis]
31 Blann AD, Heitmar R. SARS-CoV-2 and COVID-19: A Narrative Review. Br J Biomed Sci 2022;79:10426. [DOI: 10.3389/bjbs.2022.10426] [Reference Citation Analysis]
32 Hao Y, Yang B, Yang J, Shi X, Yang X, Zhang D, Zhao D, Yan W, Chen L, Zheng H, Zhang K, Liu X. ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity. IJMS 2022;23:10224. [DOI: 10.3390/ijms231810224] [Reference Citation Analysis]
33 Faridzadeh A, Mahmoudi M, Ghaffarpour S, Zamani MS, Hoseinzadeh A, Naghizadeh MM, Ghazanfari T. The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study. Front Genet 2022;13:955965. [DOI: 10.3389/fgene.2022.955965] [Reference Citation Analysis]
34 Gentile D, Coco A, Patamia V, Zagni C, Floresta G, Rescifina A. Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process. Int J Mol Sci 2022;23:10067. [PMID: 36077465 DOI: 10.3390/ijms231710067] [Reference Citation Analysis]
35 Ferreira GM, Claro IM, Grosche VR, Cândido D, José DP, Rocha EC, de Moura Coletti T, Manuli ER, Gaburo N, Faria NR, Sabino EC, de Jesus JG, Jardim ACG. Molecular characterization and sequecing analysis of SARS-CoV-2 genome in Minas Gerais, Brazil. Biologicals 2022. [DOI: 10.1016/j.biologicals.2022.08.001] [Reference Citation Analysis]
36 Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Reference Citation Analysis]
37 Latifi-pupovci H. Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies. Biomedicine & Pharmacotherapy 2022;153:113368. [DOI: 10.1016/j.biopha.2022.113368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Jug U, Naumoska K, Malovrh T. Japanese Knotweed Rhizome Bark Extract Inhibits Live SARS-CoV-2 In Vitro. Bioengineering 2022;9:429. [DOI: 10.3390/bioengineering9090429] [Reference Citation Analysis]
39 Ascencio-cabral A, Reyes-aldasoro CC. Comparison of Convolutional Neural Networks and Transformers for the Classification of Images of COVID-19, Pneumonia and Healthy Individuals as Observed with Computed Tomography. J Imaging 2022;8:237. [DOI: 10.3390/jimaging8090237] [Reference Citation Analysis]
40 Roy S, Tyagi M, Bansal V, Jain V. SVD-CLAHE boosting and balanced loss function for Covid-19 detection from an imbalanced Chest X-ray dataset. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.106092] [Reference Citation Analysis]
41 Gartland N, Fishwick D, Coleman A, Davies K, Hartwig A, Johnson S, van Tongeren M. Transmission and control of SARS-CoV-2 on ground public transport: A rapid review of the literature up to May 2021. J Transp Health 2022;26:101356. [PMID: 35261878 DOI: 10.1016/j.jth.2022.101356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zahangir MS, Rokonuzzaman M. Depression, anxiety and stress among people infected with COVID-19 in Dhaka and Chittagong cities. Heliyon 2022;8:e10415. [DOI: 10.1016/j.heliyon.2022.e10415] [Reference Citation Analysis]
43 Lee G, Park S, Song B, Kim D, Han H, Park J, Jo Y, Hwang M, Sim K, Kang S, Tark D. Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus 2. Journal of Hospital Infection 2022. [DOI: 10.1016/j.jhin.2022.09.011] [Reference Citation Analysis]
44 Craina M, Iacob D, Dima M, Bernad S, Silaghi C, Moza A, Pantea M, Gluhovschi A, Bernad E. Clinical, Laboratory, and Imaging Findings of Pregnant Women with Possible Vertical Transmission of SARS-CoV-2—Case Series. IJERPH 2022;19:10916. [DOI: 10.3390/ijerph191710916] [Reference Citation Analysis]
45 Manish M, Mishra S, Anand A, Subbarao N. Computational molecular interaction between SARS-CoV-2 main protease and theaflavin digallate using free energy perturbation and molecular dynamics. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.106125] [Reference Citation Analysis]
46 Bunaciu AA, Aboul-enein HY. DETERMINATION OF COVID-19 VIRUSES IN SALIVA USING FOURIER TRANSFORM INFRARED SPECTROSCOPY. Chinese Journal of Analytical Chemistry 2022. [DOI: 10.1016/j.cjac.2022.100178] [Reference Citation Analysis]
47 Ghasemi H, Darvishi N, Salari N, Hosseinian-Far A, Akbari H, Mohammadi M. Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies. Trop Med Health 2022;50:60. [PMID: 36042531 DOI: 10.1186/s41182-022-00456-x] [Reference Citation Analysis]
48 Kalva A, Brigis G, Kruks S, Smits D. Public-private partnership role during the pandemic: A case of COVID-19 testing in the Republic of Latvia 2020. International Journal of Healthcare Management. [DOI: 10.1080/20479700.2022.2112437] [Reference Citation Analysis]
49 Zhang X, Zhang H, Li T, Chen S, Luo F, Zhou J, Zheng P, Song S, Wu Y, Jin T, Tang N, Jin A, Yang C, Cheng G, Gong R, Chiu S, Huang A. A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery. Signal Transduct Target Ther 2022;7:301. [PMID: 36042204 DOI: 10.1038/s41392-022-01135-3] [Reference Citation Analysis]
50 Robles-Fernández ÁL, Santiago-Alarcon D, Lira-Noriega A. Wildlife susceptibility to infectious diseases at global scales. Proc Natl Acad Sci U S A 2022;119:e2122851119. [PMID: 35994656 DOI: 10.1073/pnas.2122851119] [Reference Citation Analysis]
51 Chen S, Guan F, Candotti F, Benlagha K, Camara NOS, Herrada AA, James LK, Lei J, Miller H, Kubo M, Ning Q, Liu C. The role of B cells in COVID-19 infection and vaccination. Front Immunol 2022;13:988536. [DOI: 10.3389/fimmu.2022.988536] [Reference Citation Analysis]
52 Arnold CE, Voegtly LJ, Stefanov EK, Lueder MR, Luquette AE, Miller RH, Miner HL, Bennett AJ, Glang L, Mcginnis TN, Reisinger KE, Dugan JW, Mangat MA, Silberger DJ, Pavlicek RL, Watters CM, Rice GK, Malagon F, Cer RZ, Eggan SM, Bishop-lilly KA. SARS-CoV-2 Infections in Vaccinated and Unvaccinated Populations in Camp Lemonnier, Djibouti, from April 2020 to January 2022. Viruses 2022;14:1918. [DOI: 10.3390/v14091918] [Reference Citation Analysis]
53 Faisal M, Mohammed M, Richardson D, Fiori M, Beatson K. Development and validation of automated computer-aided risk scores to predict in-hospital mortality for emergency medical admissions with COVID-19: a retrospective cohort development and validation study. BMJ Open 2022;12:e050274. [PMID: 36041761 DOI: 10.1136/bmjopen-2021-050274] [Reference Citation Analysis]
54 Madi N, Sadeq M, Essa S, Safar HA, Al-adwani A, Al-khabbaz M. Strain Variation Based on Spike Glycoprotein Gene of SARS-CoV-2 in Kuwait from 2020 to 2021. Pathogens 2022;11:985. [DOI: 10.3390/pathogens11090985] [Reference Citation Analysis]
55 Madi N, Safar HA, Mustafa AS, Chehadeh W, Asadzadeh M, Sadeq M, Alawadhi E, Al-muhaini A, Benthani FA. Molecular epidemiology and genetic characterization of SARS-CoV-2 in Kuwait: A descriptive study. Front Microbiol 2022;13:858770. [DOI: 10.3389/fmicb.2022.858770] [Reference Citation Analysis]
56 Vesuna F, Akhrymuk I, Smith A, Winnard PT, Lin S, Panny L, Scharpf R, Kehn-hall K, Raman V. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2. Front Microbiol 2022;13:959577. [DOI: 10.3389/fmicb.2022.959577] [Reference Citation Analysis]
57 Dhanasooraj D, Viswanathan P, Saphia S, Jose BP, Parambath FC, Sivadas S, Akash NP, Vimisha TV, Nair PR, Mohan A, Hafeez N, Poovullathi JK, Vadekkandiyil S, Govindan SKK, Khobragade R, Aravindan K, Radhakrishnan C. Genomic surveillance of SARS-CoV-2 by sequencing the RBD region using Sanger sequencing from North Kerala. Front Public Health 2022;10:974667. [DOI: 10.3389/fpubh.2022.974667] [Reference Citation Analysis]
58 Nguyen HL, Thai NQ, Li MS. Identifying inhibitors of NSP16-NSP10 of SARS-CoV-2 from large databases. J Biomol Struct Dyn 2022;:1-10. [PMID: 36002258 DOI: 10.1080/07391102.2022.2114941] [Reference Citation Analysis]
59 Martins M, do Nascimento GM, Nooruzzaman M, Yuan F, Chen C, Caserta LC, Miller AD, Whittaker GR, Fang Y, Diel DG. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection. J Virol 2022;:e0096122. [PMID: 36000850 DOI: 10.1128/jvi.00961-22] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Amendola A, Canuti M, Bianchi S, Kumar S, Fappani C, Gori M, Colzani D, Kosakovsky Pond SL, Miura S, Baggieri M, Marchi A, Borghi E, Zuccotti G, Raviglione MC, Magurano F, Tanzi E. Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy. Environ Res 2022;:113979. [PMID: 36029839 DOI: 10.1016/j.envres.2022.113979] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Liu S, Chang H, Liu J, Kuo H. How Did the COVID-19 Pandemic Affect Population Mobility in Taiwan? IJERPH 2022;19:10559. [DOI: 10.3390/ijerph191710559] [Reference Citation Analysis]
62 Di DS, Zhang JL, Wei MH, Zhou HL, Cui Y, Zhang RY, Tong YQ, Liu JA, Wang Q. An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study. BMC Health Serv Res 2022;22:1080. [PMID: 36002820 DOI: 10.1186/s12913-022-08446-9] [Reference Citation Analysis]
63 Huang C, Feng F, Shi Y, Li W, Wang Z, Zhu Y, Yuan S, Hu D, Dai J, Jiang Q, Zhang R, Liu C, Zhang P. Protein Kinase C Inhibitors Reduce SARS-CoV-2 Replication in Cultured Cells. Microbiol Spectr 2022;:e0105622. [PMID: 36000889 DOI: 10.1128/spectrum.01056-22] [Reference Citation Analysis]
64 Chakraborty S, Saha A, Saha C, Ghosh S, Mondal T. Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants. Biochem Biophys Res Commun 2022;627:168-75. [PMID: 36041326 DOI: 10.1016/j.bbrc.2022.08.050] [Reference Citation Analysis]
65 Simon P, Le Borgne P, Lefevbre F, Cipolat L, Remillon A, Dib C, Hoffmann M, Gardeur I, Sabah J, Kepka S, Bilbault P, Lavoignet CE, Abensur Vuillaume L; CREMS Network (Clinical Research in Emergency Medicine and Sepsis). Platelet-to-Lymphocyte Ratio (PLR) Is Not a Predicting Marker of Severity but of Mortality in COVID-19 Patients Admitted to the Emergency Department: A Retrospective Multicenter Study. J Clin Med 2022;11:4903. [PMID: 36013142 DOI: 10.3390/jcm11164903] [Reference Citation Analysis]
66 Maleki B, Hojati Z. A precise review on NAATs-based diagnostic assays for COVID-19: A motion in fast POC molecular tests. Eur J Clin Invest 2022;:e13853. [PMID: 35989561 DOI: 10.1111/eci.13853] [Reference Citation Analysis]
67 Suzuki H, Ro A, Takada A, Saito K, Hayashi K. Autopsy findings of post-COVID-19 vaccination deaths in Tokyo Metropolis, Japan, 2021. Leg Med (Tokyo) 2022;59:102134. [PMID: 36037554 DOI: 10.1016/j.legalmed.2022.102134] [Reference Citation Analysis]
68 Strub DJ, Talma M, Strub M, Rut W, Zmudzinski M, Brud W, Neyts J, Vangeel L, Zhang L, Sun X, Lv Z, Nayak D, Olsen SK, Hilgenfeld R, Jochmans D, Drąg M. Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-18676-w] [Reference Citation Analysis]
69 Islam MR, Rahman MM, Ahasan MT, Sarkar N, Akash S, Islam M, Islam F, Aktar MN, Saeed M, Harun-or-rashid M, Hosain MK, Rahaman MS, Afroz S, Bibi S, Rahman MH, Sweilam SH. The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance. Environ Sci Pollut Res. [DOI: 10.1007/s11356-022-22204-8] [Reference Citation Analysis]
70 Omidian N, Mohammadi P, Sadeghalvad M, Mohammadi-Motlagh HR. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated? Biomed Pharmacother 2022;154:113534. [PMID: 35994816 DOI: 10.1016/j.biopha.2022.113534] [Reference Citation Analysis]
71 Karasneh RA, Khassawneh BY, Al-azzam S, Al-mistarehi A, Lattyak WJ, Aldiab M, Kabbaha S, Hasan SS, Conway BR, Aldeyab MA, B. D. P. Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/9617319] [Reference Citation Analysis]
72 Mares-guia MAMM, Paiva AAP, Mello VM, Eller CM, Salvio AL, Nascimento FF, Silva ESRF, Campos VTMG, da Silva Mendes Y, Lemos ERS, Sousa IP, Horta MAP. Effectiveness of Household Disinfection Techniques to Remove SARS-CoV-2 from Cloth Masks. Pathogens 2022;11:916. [DOI: 10.3390/pathogens11080916] [Reference Citation Analysis]
73 Gentile P. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies. Int J Mol Sci 2022;23:9116. [PMID: 36012383 DOI: 10.3390/ijms23169116] [Reference Citation Analysis]
74 Santos LH, Kronenberger T, Almeida RG, Silva EB, Rocha REO, Oliveira JC, Barreto LV, Skinner D, Fajtová P, Giardini MA, Woodworth B, Bardine C, Lourenço AL, Craik CS, Poso A, Podust LM, McKerrow JH, Siqueira-Neto JL, O'Donoghue AJ, da Silva Júnior EN, Ferreira RS. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease Mpro and Papain-like Protease PLpro of SARS-CoV-2. J Chem Inf Model 2022. [PMID: 35960688 DOI: 10.1021/acs.jcim.2c00693] [Reference Citation Analysis]
75 Pham D, Maddocks S, Dwyer DE, Sintchenko V, Kok J, Rockett RJ. Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2. Viruses 2022;14:1760. [PMID: 36016382 DOI: 10.3390/v14081760] [Reference Citation Analysis]
76 Kumar D, Verma S, Mysorekar IU. COVID-19 and pregnancy: clinical outcomes; mechanisms, and vaccine efficacy. Transl Res 2022:S1931-5244(22)00180-3. [PMID: 35970470 DOI: 10.1016/j.trsl.2022.08.007] [Reference Citation Analysis]
77 Wyszyńska M, Czelakowska A, Rosak P, Białożyt-bujak E, Gruca O, Rosak-szyrocka J, Kasperski J, Skucha-nowak M. Changes in the Oral Cavity Mucosal Surface under the Influence of Wearing Protective Face Masks—Nitric Oxide Concentration Analysis—Preliminary Report. Coatings 2022;12:1164. [DOI: 10.3390/coatings12081164] [Reference Citation Analysis]
78 Rizzo F. Optical Immunoassays Methods in Protein Analysis: An Overview. Chemosensors 2022;10:326. [DOI: 10.3390/chemosensors10080326] [Reference Citation Analysis]
79 Haberland E, Haberland J, Richter S, Schmid M, Hromek J, Zimmermann H, Geng S, Winterer H, Schneider S, Kollum M, Amaral Mendes R. Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN). International Journal of Clinical Practice 2022;2022:1-8. [DOI: 10.1155/2022/8373697] [Reference Citation Analysis]
80 Arora S, Goyal A, Rawat DS, Samantha K. Giloy: a potential anti-COVID-19 herb with propitious pharmacological attributes: a short review. J Biomol Struct Dyn 2022;:1-8. [PMID: 35950530 DOI: 10.1080/07391102.2022.2110157] [Reference Citation Analysis]
81 Zreiq R, Kamel S, Boubaker S, Algahtani FD, Alzain MA, Alshammari F, Aldhmadi BK, Alshammari FS, J. Araúzo-bravo M. Predictability of COVID-19 Infections Based on Deep Learning and Historical Data. Applied Sciences 2022;12:8029. [DOI: 10.3390/app12168029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Amanati A, Hedayati SB, Ziyaeyan M, Honar A, Dashtianeh R, Rabiei N, Saki N, Karami L. A fatal SARS-coronavirus-2 induced bone marrow aplasia complicated with invasive fungal infection and severe neutropenic enterocolitis. BMC Infect Dis 2022;22:682. [PMID: 35945491 DOI: 10.1186/s12879-022-07599-6] [Reference Citation Analysis]
83 Chen X, Wang Z, Wang J, Yao Y, Wang Q, Huang J, Xiang X, Zhou Y, Xue Y, Li Y, Gao X, Wang L, Chu M, Wang Y. Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2. Front Pharmacol 2022;13:940628. [DOI: 10.3389/fphar.2022.940628] [Reference Citation Analysis]
84 Lorenzo-leal AC, Vimalanathan S, Bach H. Adherence of SARS-CoV-2 Delta variant to a surgical mask and N95 respirators. Future Science OA. [DOI: 10.2144/fsoa-2022-0025] [Reference Citation Analysis]
85 D’angelo G, Rampone S. Forecasting the spread of SARS-CoV-2 in the campania region using genetic programming. Soft Comput. [DOI: 10.1007/s00500-022-07385-1] [Reference Citation Analysis]
86 Prandi IG, Mavian C, Giombini E, Gruber CEM, Pietrucci D, Borocci S, Abid N, Beccari AR, Talarico C, Chillemi G. Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins. IJMS 2022;23:8680. [DOI: 10.3390/ijms23158680] [Reference Citation Analysis]
87 Gupta A, Sahu N, Singh AP, Singh VK, Singh SC, Upadhye VJ, Mathew AT, Kumar R, Sinha RP. Exploration of Novel Lichen Compounds as Inhibitors of SARS-CoV-2 Mpro: Ligand-Based Design, Molecular Dynamics, and ADMET Analyses. Appl Biochem Biotechnol 2022. [PMID: 35921031 DOI: 10.1007/s12010-022-04103-3] [Reference Citation Analysis]
88 Čerňan M, Szotkowski T, Minařík J, Kolář M, Sauer P, Látal V, Zapletalová J, Papajík T. Breakthrough COVID-19 in Vaccinated Patients with Haematologic Malignancies-The First Single-Centre Experience from the Czech Republic. Life (Basel) 2022;12:1184. [PMID: 36013363 DOI: 10.3390/life12081184] [Reference Citation Analysis]
89 Wang A, Tian Y, Liu H, Ding P, Chen Y, Liang C, Du Y, Jiang D, Zhu X, Yin J, Zhang G. Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein. Emerg Microbes Infect 2022;:1-38. [PMID: 35916768 DOI: 10.1080/22221751.2022.2109515] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 More-adate P, Lokhande KB, Swamy KV, Nagar S, Baheti A. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro. Computers in Biology and Medicine 2022;147:105679. [DOI: 10.1016/j.compbiomed.2022.105679] [Reference Citation Analysis]
91 Wozney AJ, Smith MA, Abdrabbo M, Birch CM, Cicigoi KA, Dolan CC, Gerzema AEL, Hansen A, Henseler EJ, LaBerge B, Leavens CM, Le CN, Lindquist AC, Ludwig RK, O'Reilly MG, Reynolds JH, Sherman BA, Sillman HW, Smith MA, Snortheim MJ, Svaren LM, Vanderpas EC, Voon A, Wackett MJ, Weiss MM, Hati S, Bhattacharyya S. Evolution of Stronger SARS-CoV-2 Variants as Revealed Through the Lens of Molecular Dynamics Simulations. Protein J 2022. [PMID: 35913554 DOI: 10.1007/s10930-022-10065-6] [Reference Citation Analysis]
92 Wang H, Pei R, Li X, Deng W, Xing S, Zhang Y, Zhang C, He S, Sun H, Xiao S, Xiong J, Zhang Y, Chen X, Wang Y, Guo Y, Zhang B, Shang L. The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate. European Journal of Medicinal Chemistry 2022;238:114458. [DOI: 10.1016/j.ejmech.2022.114458] [Reference Citation Analysis]
93 Zhu Y, Zhang X, Peng Z. Consequences of COVID-19 on the cardiovascular and renal systems. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.07.011] [Reference Citation Analysis]
94 Syed AUY, Ahmed MA, Aziz MS, Jouhar R, Aga N, Tovani-palone MR, Hussain Bokhari SA, Al Abdulsalam M, khan S, Marya A. Oral healthcare-seeking behavior during the COVID-19 lockdown period: A cross-sectional study from Eastern Saudi Arabia. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e10369] [Reference Citation Analysis]
95 Chamseddine E, Mansouri N, Soui M, Abed M. Handling class imbalance in COVID-19 chest X-ray images classification: Using SMOTE and weighted loss. Applied Soft Computing 2022. [DOI: 10.1016/j.asoc.2022.109588] [Reference Citation Analysis]
96 Yamacli S, Avci M. Density functional theory computation of the binding free energies between various mutations of SARS-CoV-2 RBD and human ACE2: molecular level roots of the contagiousness. Heliyon 2022;8:e10128. [PMID: 35971531 DOI: 10.1016/j.heliyon.2022.e10128] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Almendárez-Rodriguez C, Solis-Andrade KI, Govea-Alonso DO, Comas-Garcia M, Rosales-Mendoza S. Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus. Int J Biol Macromol 2022;213:1007-17. [PMID: 35690161 DOI: 10.1016/j.ijbiomac.2022.06.021] [Reference Citation Analysis]
98 Patil SS, Catanese HN, Brayton KA, Lofgren ET, Gebremedhin AH. Sequence Similarity Network Analysis Provides Insight into the Temporal and Geographical Distribution of Mutations in SARS-CoV-2 Spike Protein. Viruses 2022;14:1672. [PMID: 36016294 DOI: 10.3390/v14081672] [Reference Citation Analysis]
99 Tioni MF, Jordan R, Pena AS, Garg A, Wu D, Phan SI, Weiss CM, Cheng X, Greenhouse J, Orekov T, Valentin D, Kar S, Pessaint L, Andersen H, Stobart CC, Bloodworth MH, Stokes Peebles R, Liu Y, Xie X, Shi PY, Moore ML, Tang RS. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2. NPJ Vaccines 2022;7:85. [PMID: 35906244 DOI: 10.1038/s41541-022-00509-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Kayabolen A, Akcan U, Özturan D, Ulbegi-Polat H, Sahin GN, Pinarbasi-Degirmenci N, Bayraktar C, Soyler G, Sarayloo E, Nurtop E, Ozer B, Guney-Esken G, Barlas T, Yildirim IS, Dogan O, Karahuseyinoglu S, Lack NA, Kaya M, Albayrak C, Can F, Solaroglu I, Bagci-Onder T. Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo. Adv Sci (Weinh) 2022;:e2201294. [PMID: 35896894 DOI: 10.1002/advs.202201294] [Reference Citation Analysis]
101 Tan MI, Alfarafisa NM, Septiani P, Barlian A, Firmansyah M, Faizal A, Melani L, Nugrahapraja H. Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 2022;11:2319. [DOI: 10.3390/cells11152319] [Reference Citation Analysis]
102 Tsuchiya K, Yamamoto N, Hosaka Y, Wakita M, Hiki M, Matsushita Y, Mori H, Hori S, Misawa S, Miida T, Nojiri S, Takahashi K, Naito T, Tabe Y. Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity. Front Microbiol 2022;13:912061. [DOI: 10.3389/fmicb.2022.912061] [Reference Citation Analysis]
103 Biagioni S, Baldini F, Baroni M, Cerrai S, Melis F, Potente R, Scalese M, Molinaro S. Adolescents’ Psychoactive Substance Use During the First COVID-19 Lockdown: A Cross Sectional Study in Italy. Child Youth Care Forum. [DOI: 10.1007/s10566-022-09701-0] [Reference Citation Analysis]
104 de Oliveira JR, Antunes BS, do Nascimento GO, Kawall JCS, Oliveira JVB, Silva KGDS, Costa MAT, Oliveira CR. Antiviral activity of medicinal plant-derived products against SARS-CoV-2. Exp Biol Med (Maywood) 2022;:15353702221108915. [PMID: 35894129 DOI: 10.1177/15353702221108915] [Reference Citation Analysis]
105 Mohammed Hashim KK, Manoj E, Prathapachandra Kurup MR. Bis(thio)carbohydrazone Luminogens with AIEE and ACQ Features and Their In Silico Investigations with SARS‐CoV‐2. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201229] [Reference Citation Analysis]
106 Zou Z, Shan H, Sun D, Xia L, Shi Y, Wan J, Zhou A, Wu Y, Xu H, Lei H, Xu Z, Wu Y. Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease. Acta Biochim Biophys Sin (Shanghai) 2022. [PMID: 35866602 DOI: 10.3724/abbs.2022092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Csordas BG, de Sousa Palmeira PH, Peixoto RF, Comberlang FCQDDS, de Medeiros IA, Azevedo FLAA, Veras RC, Janebro DI, Amaral IPG, Barbosa-Filho JM, Keesen TSL. Is IFN expression by NK cells a hallmark of severe COVID-19? Cytokine 2022;157:155971. [PMID: 35908408 DOI: 10.1016/j.cyto.2022.155971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Yao Z, Zhao T, Su W, You S, Wang CH. Towards understanding respiratory particle transport and deposition in the human respiratory system: Effects of physiological conditions and particle properties. J Hazard Mater 2022;439:129669. [PMID: 35908402 DOI: 10.1016/j.jhazmat.2022.129669] [Reference Citation Analysis]
109 Torrens-mas M, Perelló-reus CM, Trias-ferrer N, Ibargüen-gonzález L, Crespí C, Galmes-panades AM, Navas-enamorado C, Sanchez-polo A, Piérola-lopetegui J, Masmiquel L, Crespi LS, Barcelo C, Gonzalez-freire M. GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Front Cell Infect Microbiol 2022;12:942951. [DOI: 10.3389/fcimb.2022.942951] [Reference Citation Analysis]
110 Hu R, Hotta M, Maruyama T, Fujisawa M, Sou K, Takeoka S. Temperature-Responsive Liposome-Linked Immunosorbent Assay for the Rapid Detection of SARS-CoV-2 Using Immunoliposomes. ACS Omega. [DOI: 10.1021/acsomega.2c03597] [Reference Citation Analysis]
111 Saha T, Quiñones-Mateu ME, Das SC. Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices. Int J Pharm 2022;624:122042. [PMID: 35868481 DOI: 10.1016/j.ijpharm.2022.122042] [Reference Citation Analysis]
112 Tiwari S, Adupa V, Das DS, Anki Reddy K, Bharat TV. Structural and Dynamic Insights into SARS-CoV-2 Spike-Protein-Montmorillonite Interactions. Langmuir 2022. [PMID: 35855632 DOI: 10.1021/acs.langmuir.2c00837] [Reference Citation Analysis]
113 Xia S, Wang L, Zhu Y, Lu L, Jiang S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduct Target Ther 2022;7:241. [PMID: 35853878 DOI: 10.1038/s41392-022-01105-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
114 Grewal S, Syed Gurcoo M, Sudhan Sharma S. Comparative analysis of specificity and sensitivity between Cobas 6800 system and SARS-CoV-2 rRT-PCR to detect COVID-19 infection in clinical samples. Arch Microbiol 2022;204:502. [PMID: 35852637 DOI: 10.1007/s00203-022-03118-y] [Reference Citation Analysis]
115 Soares R, Vieira CP, Vieira J. Predictive Models of within- and between-Species SARS-CoV-2 Transmissibility. Viruses 2022;14:1565. [DOI: 10.3390/v14071565] [Reference Citation Analysis]
116 Thaingtamtanha T, Baeurle SA. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2. J Mol Model 2022;28:224. [PMID: 35854129 DOI: 10.1007/s00894-022-05206-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Sharma R, Kumar P, Rauf A, Chaudhary A, Prajapati PK, Emran TB, Gonçalves Lima CM, Conte-junior CA. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication. Front Cell Infect Microbiol 2022;12:937481. [DOI: 10.3389/fcimb.2022.937481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Mustafa S, Alomair LA, Hussein M. In Silico Analysis Using SARS-CoV-2 Main Protease and a Set of Phytocompounds to Accelerate the Development of Therapeutic Components against COVID-19. Processes 2022;10:1397. [DOI: 10.3390/pr10071397] [Reference Citation Analysis]
119 Yip Y, Yip K, Tsui W. Psychological Experiences of Patients with Coronavirus Disease 2019 (COVID-19) during and after Hospitalization: A Descriptive Phenomenological Study. IJERPH 2022;19:8742. [DOI: 10.3390/ijerph19148742] [Reference Citation Analysis]
120 Seufert JD, Python A, Weisser C, Cisneros E, Kis‐katos K, Kneib T. Mapping ex ante risks of COVID‐19 in Indonesia using a Bayesian geostatistical model on airport network data. Royal Stats Society Series A. [DOI: 10.1111/rssa.12866] [Reference Citation Analysis]
121 Strömich L, Wu N, Barahona M, Yaliraki SN. Allosteric Hotspots in the Main Protease of SARS-CoV-2. J Mol Biol 2022;:167748. [PMID: 35843284 DOI: 10.1016/j.jmb.2022.167748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Temesgen Abebe H, Mitiku Ashebir M, Mohamedniguss Ebrahim M, Berhe Zelelow Y, Mulugeta Bezabih A, Redae Tefere G, Fseha Teklehaimanot B, Hintsa S, Leul Welderufael A. Epidemiological and Clinical Characteristics of COVID-19 Patients in Northern Ethiopia: A Retrospective Cohort Study. Infect Drug Resist 2022;15:3579-88. [PMID: 35837540 DOI: 10.2147/IDR.S345936] [Reference Citation Analysis]
123 Panagopoulos P, Petrakis V, Trypsianis G, Papazoglou D. Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story. J Chemother 2022;:1-4. [PMID: 35838194 DOI: 10.1080/1120009X.2022.2099693] [Reference Citation Analysis]
124 Vassilaki N, Papadimitriou K, Ioannidis A, Papandreou NC, Milona RS, Iconomidou VA, Chatzipanagiotou S. SARS-CoV-2 Amino Acid Mutations Detection in Greek Patients Infected in the First Wave of the Pandemic. Microorganisms 2022;10:1430. [PMID: 35889149 DOI: 10.3390/microorganisms10071430] [Reference Citation Analysis]
125 Niraula A, Baral N, Lamsal M, Bataju M, Thapa S. Potential role of biochemical markers in the prognosis of COVID-19 patients. SAGE Open Med 2022;10:20503121221108613. [PMID: 35832258 DOI: 10.1177/20503121221108613] [Reference Citation Analysis]
126 Patiti C, Sfragano PS, Laschi S, Pillozzi S, Boddi A, Crociani O, Bernini A, Palchetti I. Chip-Based and Wearable Tools for Isothermal Amplification and Electrochemical Analysis of Nucleic Acids. Chemosensors 2022;10:278. [DOI: 10.3390/chemosensors10070278] [Reference Citation Analysis]
127 Samy A, Maher MA, Abdelsalam NA, Badr E. SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis. Sci Rep 2022;12:11934. [PMID: 35831333 DOI: 10.1038/s41598-022-15898-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Yazdi AK, Pakarian P, Perveen S, Hajian T, Santhakumar V, Bolotokova A, Li F, Vedadi M. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis 2022. [PMID: 35822715 DOI: 10.1021/acsinfecdis.2c00165] [Reference Citation Analysis]
129 da Silva VH, Goes CP, Trevisoli PA, Lello R, Clemente LG, de Almeida TB, Petrini J, Coutinho LL. Simulation of group testing scenarios can boost COVID-19 screening power. Sci Rep 2022;12:11854. [PMID: 35831373 DOI: 10.1038/s41598-022-14626-8] [Reference Citation Analysis]
130 Pradhan A, Prabhu S, Chadaga K, Sengupta S, Nath G. Supervised Learning Models for the Preliminary Detection of COVID-19 in Patients Using Demographic and Epidemiological Parameters. Information 2022;13:330. [DOI: 10.3390/info13070330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Ganesh PS, Kim SY. A comparison of conventional and advanced electroanalytical methods to detect SARS-CoV-2 virus: A concise review. Chemosphere 2022;307:135645. [PMID: 35817176 DOI: 10.1016/j.chemosphere.2022.135645] [Reference Citation Analysis]
132 Bassett M, Salemi M, Rife Magalis B. Lessons Learned and Yet-to-Be Learned on the Importance of RNA Structure in SARS-CoV-2 Replication. Microbiol Mol Biol Rev. [DOI: 10.1128/mmbr.00057-21] [Reference Citation Analysis]
133 Morales-jadán D, Viteri-dávila C, Castro-rodriguez B, Vallejo-janeta AP, Rivera-olivero IA, Perez F, Garcia-bereguiain MA. Clinical Performance of Three Commercial SARS‐CoV‐2 Rapid Antigen Tests for Community-Dwelling Individuals in a Tropical Setting. Front Cell Infect Microbiol 2022;12:832235. [DOI: 10.3389/fcimb.2022.832235] [Reference Citation Analysis]
134 Hao M, Wang D, Xia Q, Kan S, Chang L, Liu H, Yang Z, Liu W. Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19. Front Immunol 2022;13:879792. [DOI: 10.3389/fimmu.2022.879792] [Reference Citation Analysis]
135 Asif M, Amir M, Hussain A, Achakzai NM, Natesan Pushparaj P, Rasool M. Role of tyrosine kinase inhibitor in chronic myeloid leukemia patients with SARS-CoV-2 infection: A narrative Review. Medicine (Baltimore) 2022;101:e29660. [PMID: 35777011 DOI: 10.1097/MD.0000000000029660] [Reference Citation Analysis]
136 Tian C, Zhao L, Qi G, Zhu J, Zhang S. One-pot and rapid detection of SARS-CoV-2 viral particles in environment using SERS aptasensor based on a locking amplifier. Sensors and Actuators B: Chemical 2022. [DOI: 10.1016/j.snb.2022.132445] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Nguyen TP, Do Q, Phan LT, Dinh DV, Khong H, Hoang LV, Nguyen TV, Pham HN, Chu MV, Nguyen TT, Pham QD, Le TM, Trang TN, Dinh TT, Vo TV, Vu TT, Nguyen QB, Phan VT, Nguyen LV, Nguyen GT, Tran PM, Nghiem TD, Tran TV, Nguyen TG, Tran TQ, Nguyen LT, Do AT, Nguyen DD, Ho SA, Nguyen VT, Pham DT, Tran HB, Vu ST, Hoang SX, Do TM, Nguyen XT, Le GQ, Tran T, Cao TM, Dao HM, Nguyen TT, Doan UY, Le VT, Tran LP, Nguyen NM, Nguyen NT, Pham HT, Nguyen QH, Nguyen HT, Nguyen HL, Tran VT, Tran MT, Nguyen TT, Ha PT, Huynh HT, Nguyen KD, Thuan UT, Doan CC, Do SM. Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial. The Lancet Regional Health - Western Pacific 2022;24:100474. [DOI: 10.1016/j.lanwpc.2022.100474] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Housawi AA, Qazi SJS, Jan AA, Osman RA, Alshamrani MM, AlFaadhel TA, AlHejaili FF, Al-Tawfiq JA, Wafa AA, Hamza AE, Hassan MA, Alharbi SA, Albasheer H, Almohmmdi MM, Alsisi SA, Mankowski M, Van de Klundert J, Alhelal AM, Sala FH, Kheyami A, Alhomayeed BA. Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah. Ann Saudi Med 2022;42:246-51. [PMID: 35933611 DOI: 10.5144/0256-4947.2022.229] [Reference Citation Analysis]
139 Yates EF, Zhang K, Naus A, Forbes C, Wu X, Dey T. A review on the biological, epidemiological, and statistical relevance of COVID-19 paired with air pollution. Environmental Advances 2022;8:100250. [DOI: 10.1016/j.envadv.2022.100250] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
140 Gupta R, Rathore B, Srivastava A, Biswas B. Decision-making framework for identifying regions vulnerable to transmission of COVID-19 pandemic. Comput Ind Eng 2022;169:108207. [PMID: 35529174 DOI: 10.1016/j.cie.2022.108207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Duan C, Ma R, Zeng X, Chen B, Hou D, Liu R, Li X, Liu L, Li T, Huang H. SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19. Front Immunol 2022;13:946731. [DOI: 10.3389/fimmu.2022.946731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Pitsillou E, Liang J, Hung A, Karagiannis TC. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling. Journal of Molecular Graphics and Modelling 2022;114:108193. [DOI: 10.1016/j.jmgm.2022.108193] [Reference Citation Analysis]
143 Yamazaki H, Yamamoto N, Sonoyama T, Maruoka H, Nasu S, Makino A, Tomonaga K, Shigemoto N, Ohge H, Fujiwara K, Shinohara S, Takeno S, Omori K, Naito Y. A Multicenter Study to Investigate the Positive Rate of SARS-CoV-2 in Middle Ear and Mastoid Specimens from Otologic Surgery Patients. Auris Nasus Larynx 2022. [DOI: 10.1016/j.anl.2022.07.007] [Reference Citation Analysis]
144 Rangel-Ramírez VV, Macías-Piña KA, Servin-Garrido RR, de Alba-Aguayo DR, Moreno-Fierros L, Rubio-Infante N. A systematic review and meta-analysis of the IgA seroprevalence in COVID-19 patients: Is there a role for IgA in COVID-19 diagnosis or severity? Microbiol Res 2022;263:127105. [PMID: 35816990 DOI: 10.1016/j.micres.2022.127105] [Reference Citation Analysis]
145 Farooq M, Khan AW, Ahmad B, Kim MS, Choi S. Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection. Front Pharmacol 2022;13:915565. [DOI: 10.3389/fphar.2022.915565] [Reference Citation Analysis]
146 Nguyen HL, Thai NQ, Nguyen PH, Li MS. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation. J Phys Chem B 2022;126:4669-78. [PMID: 35723978 DOI: 10.1021/acs.jpcb.2c01048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
147 Rovito R, Augello M, Ben-Haim A, Bono V, d'Arminio Monforte A, Marchetti G. Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors. Front Immunol 2022;13:912336. [PMID: 35757770 DOI: 10.3389/fimmu.2022.912336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Ventura-Santana E, Ninan JR, Snyder CM, Okeke EB. Neutrophil Extracellular Traps, Sepsis and COVID-19 - A Tripod Stand. Front Immunol 2022;13:902206. [PMID: 35757734 DOI: 10.3389/fimmu.2022.902206] [Reference Citation Analysis]
149 Bold D, Roman-Sosa G, Gaudreault NN, Zayat B, Pogranichniy RM, Richt JA. Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats. Front Vet Sci 2022;9:864884. [PMID: 35754530 DOI: 10.3389/fvets.2022.864884] [Reference Citation Analysis]
150 Rutherford C, Kafle P, Soos C, Epp T, Bradford L, Jenkins E. Investigating SARS-CoV-2 Susceptibility in Animal Species: A Scoping Review. Environ�Health�Insights 2022;16:117863022211077. [DOI: 10.1177/11786302221107786] [Reference Citation Analysis]
151 Singh E, Jha RK, Khan RJ, Kumar A, Jain M, Muthukumaran J, Singh AK. A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2. Comput Biol Chem 2022;99:107721. [PMID: 35835027 DOI: 10.1016/j.compbiolchem.2022.107721] [Reference Citation Analysis]
152 Patel KG, Hilton T, Choi RY, Abbey AM. Uveitis and Posterior Ophthalmic Manifestations Following the SARS-CoV-2 (COVID-19) Vaccine. Ocul Immunol Inflamm 2022;:1-7. [PMID: 35763603 DOI: 10.1080/09273948.2022.2079533] [Reference Citation Analysis]
153 Hardison RL, Nelson SW, Barriga D, Feliciano Ruiz N, Ghere JM, Fenton GA, Lindstrom DJ, James RR, Stewart MJ, Lee SD, Calfee MW, Ryan SP, Howard MW. Evaluation of surface disinfection methods to inactivate the beta coronavirus Murine Hepatitis Virus. J Occup Environ Hyg 2022;:1-14. [PMID: 35687041 DOI: 10.1080/15459624.2022.2088768] [Reference Citation Analysis]
154 Shi X, Jia M, Li J, Chen Q, Liu G, Liu Q. Users' Feedback on COVID-19 Lockdown Documentary: An Emotion Analysis and Topic Modeling Analysis. Front Psychol 2022;13:944049. [DOI: 10.3389/fpsyg.2022.944049] [Reference Citation Analysis]
155 Mansouritorghabeh H, Bagherimoghaddam A, Eslami S, Raouf-rahmati A, Hamer DH, Kiani B, Mohammadebrahimi S. Spatial epidemiology of COVID-19 infection through the first outbreak in the city of Mashhad, Iran. Spat Inf Res . [DOI: 10.1007/s41324-022-00454-5] [Reference Citation Analysis]
156 Moga E, Lynton-pons E, Domingo P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Front Immunol 2022;13:904686. [DOI: 10.3389/fimmu.2022.904686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Elijah IM, Amsalu E, Jian X, Cao M, Mibei EK, Kerosi DO, Mwatsahu FG, Wang W, Onyangore F, Wang Y. Characterization and Determinant Factors of Critical Illness and In-Hospital Mortality of COVID-19 Patients: A Retrospective Cohort of 1792 Patients in Kenya. Biosaf Health 2022. [PMID: 35782165 DOI: 10.1016/j.bsheal.2022.06.002] [Reference Citation Analysis]
158 Ebomah KE, Msolo L, Okoh AI. A Review on SARS-CoV-2 Genome in the Aquatic Environment of Africa: Prevalence, Persistence and the Future Prospects. Water 2022;14:2020. [DOI: 10.3390/w14132020] [Reference Citation Analysis]
159 Jin Y, Ouyang M, Yu T, Zhuang J, Wang W, Liu X, Duan F, Guo D, Peng X, Pan JA. Genome-Wide Analysis of the Indispensable Role of Non-structural Proteins in the Replication of SARS-CoV-2. Front Microbiol 2022;13:907422. [PMID: 35722274 DOI: 10.3389/fmicb.2022.907422] [Reference Citation Analysis]
160 Wakui N, Noguchi N, Ichikawa K, Togawa C, Matsuoka R, Yoshizawa Y, Shirozu S, Suzuki K, Ozawa M, Yanagiya T, Kikuchi M. Psychological and Physical Changes Caused by COVID-19 Pandemic in Elementary and Junior High School Teachers: A Cross-Sectional Study. IJERPH 2022;19:7568. [DOI: 10.3390/ijerph19137568] [Reference Citation Analysis]
161 Zhang G, Cui X, Zhang L, Liu G, Zhu X, Shangguan J, Zhang W, Zheng Y, Zhang H, Tang J, Zhang J. Uncovering the genetic links of SARS-CoV-2 infections on heart failure co-morbidity by a systems biology approach. ESC Heart Fail 2022. [PMID: 35727093 DOI: 10.1002/ehf2.14003] [Reference Citation Analysis]
162 Lin CH, Luo SC. Zwitterionic Conducting Polymers: From Molecular Design, Surface Modification, and Interfacial Phenomenon to Biomedical Applications. Langmuir 2022;38:7383-99. [PMID: 35675211 DOI: 10.1021/acs.langmuir.2c00448] [Reference Citation Analysis]
163 Köhnlein T, Wilkens M, Eydt K. [Impact of COVID-19 pandemic on information management and adherence to replacement therapy with AAT of patients with alpha-1 antitrypsin deficiency (AATM)]. Pneumologie 2022. [PMID: 35724679 DOI: 10.1055/a-1845-0160] [Reference Citation Analysis]
164 Ding J, Liu C, Wang Z, Guo H, Zhang K, Ma L, Wang B, Zhao H, Song M, Guan X. Characteristics and Prognosis of Antibody Non-responders With Coronavirus Disease 2019. Front Med 2022;9:813820. [DOI: 10.3389/fmed.2022.813820] [Reference Citation Analysis]
165 Melo MM, Neta MMR, Neto ARS, Carvalho ARB, Magalhães RLB, Valle ARMC, Ferreira JHL, Aliaga KMJ, Moura MEB, Freitas DRJ. Symptoms of COVID-19 in children. Braz J Med Biol Res 2022;55:e12038. [PMID: 35703681 DOI: 10.1590/1414-431X2022e12038] [Reference Citation Analysis]
166 Adams O, Andrée M, Hermsen D, Lübke N, Timm J, Schaal H, Müller L. Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts. J Virol Methods 2022;307:114569. [PMID: 35724697 DOI: 10.1016/j.jviromet.2022.114569] [Reference Citation Analysis]
167 Horton AL, Russell BS, Tambling RR, Britner PA, Hutchison M, Tomkunas AJ. Predictors of children's emotion regulation outcomes during COVID ‐19: Role of conflict within the family. Family Relations. [DOI: 10.1111/fare.12717] [Reference Citation Analysis]
168 Massi MN, Abidin RS, Farouk AE, Halik H, Soraya GV, Hidayah N, Sjahril R, Handayani I, Hakim MS, Gazali FM, Setiawaty V, Wibawa T. Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia. PeerJ 2022;10:e13522. [PMID: 35707124 DOI: 10.7717/peerj.13522] [Reference Citation Analysis]
169 Martins M, do Nascimento GM, Nooruzzaman M, Yuan F, Chen C, Caserta LC, Miller AD, Whittaker GR, Fang Y, Diel DG. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection. bioRxiv 2022:2022. [PMID: 35734088 DOI: 10.1101/2022.06.15.496220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Ebihara T, Matsumoto H, Matsubara T, Togami Y, Nakao S, Matsuura H, Onishi S, Kojima T, Sugihara F, Okuzaki D, Hirata H, Yamamura H, Ogura H. Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19. Front Immunol 2022;13:830061. [DOI: 10.3389/fimmu.2022.830061] [Reference Citation Analysis]
171 Pillaiyar T, Flury P, Krüger N, Su H, Schäkel L, Barbosa Da Silva E, Eppler O, Kronenberger T, Nie T, Luedtke S, Rocha C, Sylvester K, Petry MRI, McKerrow JH, Poso A, Pöhlmann S, Gütschow M, O'Donoghue AJ, Xu Y, Müller CE, Laufer SA. Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination. J Med Chem 2022. [PMID: 35709506 DOI: 10.1021/acs.jmedchem.2c00636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Molchanov VS, Shibaev AV, Karamov EV, Larichev VF, Kornilaeva GV, Fedyakina IT, Turgiev AS, Philippova OE, Khokhlov AR. Antiseptic Polymer-Surfactant Complexes with Long-Lasting Activity against SARS-CoV-2. Polymers (Basel) 2022;14:2444. [PMID: 35746017 DOI: 10.3390/polym14122444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Sarkar S, Runge B, Russell RW, Movellan KT, Calero D, Zeinalilathori S, Quinn CM, Lu M, Calero G, Gronenborn AM, Polenova T. Atomic-Resolution Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain. J Am Chem Soc 2022;144:10543-55. [PMID: 35638584 DOI: 10.1021/jacs.2c03320] [Reference Citation Analysis]
174 Chen CP, Huang KA, Shih SR, Lin YC, Cheng CY, Huang YC, Lin TY, Cheng SH. Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants. Microbiol Spectr 2022;:e0074322. [PMID: 35703556 DOI: 10.1128/spectrum.00743-22] [Reference Citation Analysis]
175 Miao X, Liu C, Liu M, Han X, Zhu L, Bai X. The role of pipe biofilms on dissemination of viral pathogens and virulence factor genes in a full-scale drinking water supply system. J Hazard Mater 2022;432:128694. [PMID: 35316639 DOI: 10.1016/j.jhazmat.2022.128694] [Reference Citation Analysis]
176 Icho S, Rujas E, Muthuraman K, Tam J, Liang H, Landreth S, Liao M, Falzarano D, Julien JP, Melnyk RA. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells. Antimicrob Agents Chemother 2022;:e0043922. [PMID: 35703551 DOI: 10.1128/aac.00439-22] [Reference Citation Analysis]
177 Sun C, Yuan RY, Xie C, Sun JF, Fang XY, Hu YS, Yu XH, Liu Z, Zeng MS, Kang YF. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines. J Virol 2022;:e0038322. [PMID: 35699445 DOI: 10.1128/jvi.00383-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Karamov EV, Larichev VF, Kornilaeva GV, Fedyakina IT, Turgiev AS, Shibaev AV, Molchanov VS, Philippova OE, Khokhlov AR. Cationic Surfactants as Disinfectants against SARS-CoV-2. Int J Mol Sci 2022;23:6645. [PMID: 35743090 DOI: 10.3390/ijms23126645] [Reference Citation Analysis]
179 Nguyen V, Zhang Y, Gao C, Cao X, Tian Y, Carver W, Kiaris H, Cui T, Tan W. The Spike Protein of SARS-CoV-2 Impairs Lipid Metabolism and Increases Susceptibility to Lipotoxicity: Implication for a Role of Nrf2. Cells 2022;11:1916. [PMID: 35741045 DOI: 10.3390/cells11121916] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Chen CC, Zhuang ZJ, Wu CW, Tan YL, Huang CH, Hsu CY, Tsai EM, Hsieh TH. Venetoclax Decreases the Expression of the Spike Protein through Amino Acids Q493 and S494 in SARS-CoV-2. Cells 2022;11:1924. [PMID: 35741053 DOI: 10.3390/cells11121924] [Reference Citation Analysis]
181 Das S, Roy A, Das R. New autopsy technique in COVID-19 positive dead bodies: opening the thoracic cavity with an outlook to reduce aerosol spread. J Clin Pathol 2022:jclinpath-2022-208173. [PMID: 35701143 DOI: 10.1136/jclinpath-2022-208173] [Reference Citation Analysis]
182 Meewan I, Kattoula J, Kattoula JY, Skinner D, Fajtová P, Giardini MA, Woodworth B, McKerrow JH, Lage de Siqueira-Neto J, O'Donoghue AJ, Abagyan R. Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L. Pharmaceuticals (Basel) 2022;15:744. [PMID: 35745663 DOI: 10.3390/ph15060744] [Reference Citation Analysis]
183 Puhl AC, Gomes GF, Damasceno S, Godoy AS, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha FQ, Alves-Filho JC, Cunha TM, Ekins S. Pyronaridine Protects against SARS-CoV-2 Infection in Mouse. ACS Infect Dis 2022;8:1147-60. [PMID: 35609344 DOI: 10.1021/acsinfecdis.2c00091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Hawsawi YM, Shams A, Theyab A, Siddiqui J, Barnawee M, Abdali WA, Marghalani NA, Alshelali NH, Al-sayed R, Alzahrani O, Alqahtani A, Alsulaiman AM. The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19. Front Cell Infect Microbiol 2022;12:869889. [DOI: 10.3389/fcimb.2022.869889] [Reference Citation Analysis]
185 Ghimire D, Han Y, Lu M. Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants. Viruses 2022;14:1255. [PMID: 35746726 DOI: 10.3390/v14061255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
186 Casati B, Verdi JP, Hempelmann A, Kittel M, Klaebisch AG, Meister B, Welker S, Asthana S, Di Giorgio S, Boskovic P, Man KH, Schopp M, Ginno PA, Radlwimmer B, Stebbins CE, Miethke T, Papavasiliou FN, Pecori R. Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO. Nat Commun 2022;13:3308. [PMID: 35676259 DOI: 10.1038/s41467-022-30862-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
187 Zhu Z, Shi J, Li L, Wang J, Zhao Y, Ma H. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. Front Immunol 2022;13:870216. [PMID: 35655782 DOI: 10.3389/fimmu.2022.870216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Kiriacos CJ, Khedr MR, Tadros M, Youness RA. Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha. Front Oncol 2022;12:837408. [PMID: 35664773 DOI: 10.3389/fonc.2022.837408] [Reference Citation Analysis]
189 Karwaciak I, Karaś K, Sałkowska A, Pastwińska J, Ratajewski M. Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes. Molecules 2022;27:3651. [PMID: 35744777 DOI: 10.3390/molecules27123651] [Reference Citation Analysis]
190 Kruchevsky D, Levanon S, Givon A, Bodas M, Ramon Y, Ullmann Y, Zeltzer AA; Israeli Trauma Group. Burns During COVID 19 Lockdown- A Multi-Center Retrospective Study in Israel. J Burn Care Res 2022:irac078. [PMID: 35666996 DOI: 10.1093/jbcr/irac078] [Reference Citation Analysis]
191 Saito Y, Matsui A, Michiyuki S, Morooka H, Ibi T, Yamauchi Y, Takahashi N, Shimizu Y, Ikeya T, Hoshi E, Sakao Y, Kawamura M. Loop-Mediated Isothermal Amplification as Point-of-Care Testing for EGFR-Mutated Lung Adenocarcinoma. Micromachines 2022;13:897. [DOI: 10.3390/mi13060897] [Reference Citation Analysis]
192 Baildya N, Ghosh NN, Chattopadhyay AP, Mandal V, Majumdar S, Ansary D, Sarkar MM. Inhibitory effect of compounds extracted from Monochoria hastata (L.) Solms on SARS-CoV-2 main protease: An insight from molecular docking and MD-simulation studies. J Mol Struct 2022;1257:132644. [PMID: 35185220 DOI: 10.1016/j.molstruc.2022.132644] [Reference Citation Analysis]
193 Volkov V. System analysis of the fast global coronavirus disease 2019 (COVID-19) spread. Can we avoid future pandemics under global climate change? Commun Integr Biol 2022;15:150-7. [PMID: 35656201 DOI: 10.1080/19420889.2022.2082735] [Reference Citation Analysis]
194 Gonçalves JJ, da Mata CPSM, Lourenço AA, Ribeiro ÁL, Ferreira GM, Fraga-silva TFDC, de Souza FM, Almeida VES, Batista IA, D`avila-mesquita C, Couto AES, Campos LCB, Paim AAO, Ferreira LL, de Melo Oliveira P, de Almeida Teixeira L, Priscila de Almeida Marques D, Retes de Moraes H, Pereira SH, Brito-de-sousa JP, Campi-azevedo AC, Peruhype-magalhães V, Araújo MSS, Teixeira-carvalho A, da Fonseca FG, Bonato VLD, Becari C, Ferro D, Menegueti MG, Mazzoni AAS, Auxiliadora-martins M, Coelho-dos-reis JG, Martins-filho OA. Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients. Front Immunol 2022;13:903903. [DOI: 10.3389/fimmu.2022.903903] [Reference Citation Analysis]
195 Neil JA, Griffith M, Godfrey DI, Purcell DFJ, Deliyannis G, Jackson D, Rockman S, Subbarao K, Nolan T. Nonhuman primate models for evaluation of SARS-CoV-2 vaccines. Expert Rev Vaccines 2022;:1-16. [PMID: 35652289 DOI: 10.1080/14760584.2022.2071264] [Reference Citation Analysis]
196 Shanmugaraj B, Khorattanakulchai N, Panapitakkul C, Malla A, Im-erbsin R, Inthawong M, Sunyakumthorn P, Hunsawong T, Klungthong C, Reed MC, Kemthong T, Suttisan N, Malaivijitnond S, Srimangkornkaew P, Klinkhamhom A, Manopwisedjaroen S, Thitithanyanont A, Taychakhoonavudh S, Phoolcharoen W. Preclinical Evaluation of a Plant-derived SARS-CoV-2 Subunit Vaccine: Protective Efficacy, Immunogenicity, Safety, and Toxicity. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.05.087] [Reference Citation Analysis]
197 Talap J, Shen M, Yu L, Zeng S, Cai S. RT-LAMP assay combining multi-fluorescent probes for SARS-CoV-2 RNA detection and variant differentiation. Talanta 2022;248:123644. [PMID: 35660994 DOI: 10.1016/j.talanta.2022.123644] [Reference Citation Analysis]
198 Suryavanshi H, Chaudhari RD, Patil V, Majumdar S, Debnath S, Biswas G. Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor. Daru 2022;30:139-52. [PMID: 35508799 DOI: 10.1007/s40199-022-00441-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Camblor DG, Miranda D, Albaiceta GM, Amado-rodríguez L, Cuesta-llavona E, Vázquez-coto D, Gómez de Oña J, García-lago C, Gómez J, Coto E. Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients. Human Immunology 2022. [DOI: 10.1016/j.humimm.2022.06.002] [Reference Citation Analysis]
200 Chen D, Zhao YG, Zhang H. Endomembrane remodeling in SARS-CoV-2 infection. Cell Insight 2022;1:100031. [DOI: 10.1016/j.cellin.2022.100031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Wester CT, Bovil T, Scheel-hincke LL, Ahrenfeldt LJ, Möller S, Andersen-ranberg K. Longitudinal changes in mental health following the COVID-19 lockdown: Results from the Survey of Health, Ageing and Retirement in Europe. Annals of Epidemiology 2022. [DOI: 10.1016/j.annepidem.2022.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Telek E, Ujfalusi Z, Kemenesi G, Zana B, Jakab F, Hild G, Lukács A, Hild G. A Possible Way to Relate the Effects of SARS-CoV-2-Induced Changes in Transferrin to Severe COVID-19-Associated Diseases. IJMS 2022;23:6189. [DOI: 10.3390/ijms23116189] [Reference Citation Analysis]
203 Jahan M, Nasif MAO, Rahmat R, Islam SRU, Munshi SU, Ahmed MS, Roux S. Genome Sequencing of Omicron Variants of SARS-CoV-2 Circulating in Bangladesh during the Third Wave of the COVID-19 Pandemic. Microbiol Resour Announc. [DOI: 10.1128/mra.00381-22] [Reference Citation Analysis]
204 Chen T, Hsu M, Lee M, Chou C. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses 2022;14:1188. [DOI: 10.3390/v14061188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
205 Zhang C, Yang M. Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules. IJMS 2022;23:6083. [DOI: 10.3390/ijms23116083] [Reference Citation Analysis]
206 Huang F, Chen L, Guo W, Zhou X, Feng K, Huang T, Cai Y. Identifying COVID-19 Severity-Related SARS-CoV-2 Mutation Using a Machine Learning Method. Life 2022;12:806. [DOI: 10.3390/life12060806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Liu P, Fang M, Luo Y, Zheng F, Jin Y, Cheng F, Zhu H, Jin X. Rare Variants in Inborn Errors of Immunity Genes Associated With Covid-19 Severity. Front Cell Infect Microbiol 2022;12:888582. [DOI: 10.3389/fcimb.2022.888582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Alghamdy Z, Alshahrani A, Memon I, Khan A, Khan MA, Alrayan Y, Alfawzan F, Zaidi SF. Awareness regarding COVID-19 and its effects on mental health among pre-professional health sciences students at King Saud bin Abdulaziz University for health sciences in Riyadh and Jeddah, Saudi Arabia. Environ Sci Pollut Res Int 2022. [PMID: 35624363 DOI: 10.1007/s11356-022-20934-3] [Reference Citation Analysis]
209 Zuzic L, Samsudin F, Shivgan AT, Raghuvamsi PV, Marzinek JK, Boags A, Pedebos C, Tulsian NK, Warwicker J, MacAry P, Crispin M, Khalid S, Anand GS, Bond PJ. Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein. Structure 2022:S0969-2126(22)00180-0. [PMID: 35660160 DOI: 10.1016/j.str.2022.05.006] [Reference Citation Analysis]
210 Alberto-Orlando S, Calderon JL, Leon-Sosa A, Patiño L, Zambrano-Alvarado MN, Pasquel-Villa LD, Rugel-Gonzalez DO, Flores D, Mera MD, Valencia P, Zuñiga-Velarde JJ, Tello-Cabrera C, Garcia-Bereguiain MA. SARS-CoV-2 transmission from infected owner to household dogs and cats is associated with food sharing. Int J Infect Dis 2022;122:295-9. [PMID: 35643308 DOI: 10.1016/j.ijid.2022.05.049] [Reference Citation Analysis]
211 Selvaraj S, Prasadh S, Fuloria S, Subramaniyan V, Sekar M, Ahmed AM, Bouallegue B, Hari Kumar D, Sharma VK, Maziz MNH, Sathasivam KV, Meenakshi DU, Fuloria NK. COVID-19 Biomedical Plastics Wastes—Challenges and Strategies for Curbing the Environmental Disaster. Sustainability 2022;14:6466. [DOI: 10.3390/su14116466] [Reference Citation Analysis]
212 Liu C, Piao H, Zhang T, Yang D, Li X, Tang X. Delayed Diagnosis and Treatment of Cancer Patients During the COVID-19 Pandemic in Henan, China: An Interrupted Time Series Analysis. Front Public Health 2022;10:881718. [DOI: 10.3389/fpubh.2022.881718] [Reference Citation Analysis]
213 Morrell ED, Bhatraju PK, Sathe NA, Lawson J, Mabrey L, Holton SE, Presnell SR, Wiedeman A, Acosta-Vega C, Mitchem MA, Liu T, Chai XY, Sahi S, Brager C, Orlov M, Sakr SS, Sader A, Lum DM, Koetje N, Garay A, Barnes E, Cromer G, Bray MK, Pipavath S, Fink SL, Evans L, Long SA, West TE, Wurfel MM, Mikacenic C. Chemokines, Soluble PD-L1, and Immune Cell Hyporesponsiveness are Distinct Features of SARS-CoV-2 Critical Illness. Am J Physiol Lung Cell Mol Physiol 2022. [PMID: 35608267 DOI: 10.1152/ajplung.00049.2022] [Reference Citation Analysis]
214 Ricardo S, Canão P, Martins D, Magalhães AC, Pereira M, Ribeiro-Junior U, de Mello ES, Alves VA, Pinto R, Leitão D, Alves G, Oliveira R, Wilton J, Costelha S, Meireles D, Cabanes D, David L, Schmitt F. Searching for SARS-CoV-2 in Cancer Tissues: Results of an Extensive Methodologic Approach based on ACE2 and Furin Expression. Cancers (Basel) 2022;14:2582. [PMID: 35681562 DOI: 10.3390/cancers14112582] [Reference Citation Analysis]
215 El‐hayek E, Kahwagi G, Issy N, Tawil C, Younis N, Abou‐khalil R, Matar M, Hallit S. ‎Factors associated with coronavirus disease 2019 infection severity among a sample of Lebanese adults: Data from a cross‐sectional study. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.654] [Reference Citation Analysis]
216 Wu J, Feng B, Gao LX, Zhang C, Li J, Xiang DJ, Zang Y, Wang WL. Synthesis and Biochemical Evaluation of 8H-Indeno[1,2-d]thiazole Derivatives as Novel SARS-CoV-2 3CL Protease Inhibitors. Molecules 2022;27:3359. [PMID: 35630836 DOI: 10.3390/molecules27103359] [Reference Citation Analysis]
217 Chen J, Lu Z, Yang X, Zhou Y, Gao J, Zhang S, Huang S, Cai J, Yu J, Zhao W, Zhang B. Severe Acute Respiratory Syndrome Coronavirus 2 ORF8 Protein Inhibits Type I Interferon Production by Targeting HSP90B1 Signaling. Front Cell Infect Microbiol 2022;12:899546. [DOI: 10.3389/fcimb.2022.899546] [Reference Citation Analysis]
218 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
219 Sheikhi F, Yousefian N, Tehranipoor P, Kowsari Z. Estimation of the basic reproduction number of Alpha and Delta variants of COVID-19 pandemic in Iran. PLoS One 2022;17:e0265489. [PMID: 35580114 DOI: 10.1371/journal.pone.0265489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Pritchard L, Brown CT, Harrington B, Heath LS, Pierce-ward NT, Vinatzer BA. Could a Focus on the “Why” of Taxonomy Help Taxonomy Better Respond to the Needs of Science and Society? Front Microbiol 2022;13:887310. [DOI: 10.3389/fmicb.2022.887310] [Reference Citation Analysis]
221 Lai X, Li S, Yan J, Liu L, Zhang A. Multiphase large-eddy simulations of human cough jet development and expiratory droplet dispersion. J Fluid Mech 2022;942. [DOI: 10.1017/jfm.2022.334] [Reference Citation Analysis]
222 Mahwish, Saeed F, Afzaal M, Hussain M, Imran M, Nawaz T, Siddeeg A. Dietary guidelines to boost immunity during pre and post covid-19 conditions. International Journal of Food Properties 2022;25:1246-65. [DOI: 10.1080/10942912.2022.2071287] [Reference Citation Analysis]
223 Bhosle SM, Tran JP, Yu S, Geiger J, Jackson JD, Crozier I, Crane A, Wada J, Warren TK, Kuhn JH, Worwa G. Duplex One-Step RT-qPCR Assays for Simultaneous Detection of Genomic and Subgenomic RNAs of SARS-CoV-2 Variants. Viruses 2022;14:1066. [DOI: 10.3390/v14051066] [Reference Citation Analysis]
224 Avetyan D, Hakobyan S, Nikoghosyan M, Ghukasyan L, Khachatryan G, Sirunyan T, Muradyan N, Zakharyan R, Chavushyan A, Hayrapetyan V, Hovhannisyan A, Mohamed Bakhash SA, Jerome KR, Roychoudhury P, Greninger AL, Niazyan L, Davidyants M, Melik-andreasyan G, Sargsyan S, Nersisyan L, Arakelyan A. Molecular Analysis of SARS-CoV-2 Lineages in Armenia. Viruses 2022;14:1074. [DOI: 10.3390/v14051074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Lu Q, Yu S, Meng X, Shi M, Huang S, Li J, Zhang J, Liang Y, Ji M, Zhao Y, Fan H. MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome. Int J Mol Sci 2022;23:5545. [PMID: 35628354 DOI: 10.3390/ijms23105545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Liu LT, Tsai JJ, Chang K, Chen CH, Lin PC, Tsai CY, Tsai YY, Hsu MC, Chuang WL, Chang JM, Hwang SJ, Chong IW. Identification and Analysis of SARS-CoV-2 Alpha Variants in the Largest Taiwan COVID-19 Outbreak in 2021. Front Med (Lausanne) 2022;9:869818. [PMID: 35547225 DOI: 10.3389/fmed.2022.869818] [Reference Citation Analysis]
227 Li J, Jia H, Tian M, Wu N, Yang X, Qi J, Ren W, Li F, Bian H. SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms. Front Cell Infect Microbiol 2022;12:869832. [DOI: 10.3389/fcimb.2022.869832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Chu K, Zhou Z, Wang Q, Ye S, Guo L, Qiu Y, Zhang Y, Ge X. Characterization of Deltacoronavirus in Black-Headed Gulls (Chroicocephalus ridibundus) in South China Indicating Frequent Interspecies Transmission of the Virus in Birds. Front Microbiol 2022;13:895741. [DOI: 10.3389/fmicb.2022.895741] [Reference Citation Analysis]
229 Chatterjee B, Thakur SS. Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics. Front Immunol 2022;13:830990. [DOI: 10.3389/fimmu.2022.830990] [Reference Citation Analysis]
230 Malla TR, Brewitz L, Muntean DG, Aslam H, Owen CD, Salah E, Tumber A, Lukacik P, Strain-Damerell C, Mikolajek H, Walsh MA, Schofield CJ. Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine. J Med Chem 2022. [PMID: 35549342 DOI: 10.1021/acs.jmedchem.1c02214] [Reference Citation Analysis]
231 Sagulkoo P, Suratanee A, Plaimas K. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 2022;12:690. [DOI: 10.3390/biom12050690] [Reference Citation Analysis]
232 Willette AA, Willette SA, Wang Q, Pappas C, Klinedinst BS, Le S, Larsen B, Pollpeter A, Li T, Mochel JP, Allenspach K, Brenner N, Waterboer T. Using machine learning to predict COVID-19 infection and severity risk among 4510 aged adults: a UK Biobank cohort study. Sci Rep 2022;12:7736. [PMID: 35545624 DOI: 10.1038/s41598-022-07307-z] [Reference Citation Analysis]
233 Ichikawa T, Torii S, Suzuki H, Takada A, Suzuki S, Nakajima M, Tampo A, Kakinoki Y. Mutations in the non-structural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in COVID-19 patients. Int J Infect Dis 2022:S1201-9712(22)00275-2. [PMID: 35562044 DOI: 10.1016/j.ijid.2022.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
234 Lüscher B, Verheirstraeten M, Krieg S, Korn P. Intracellular mono-ADP-ribosyltransferases at the host-virus interphase. Cell Mol Life Sci 2022;79:288. [PMID: 35536484 DOI: 10.1007/s00018-022-04290-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Vollenberg R, Tepasse PR, Fobker M, Hüsing-Kabar A. Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients. Nutrients 2022;14:2007. [PMID: 35631143 DOI: 10.3390/nu14102007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Huang SC, Pak TK, Graber CP, Searby CC, Liu G, Marcy J, Yaszemski AK, Bedell K, Bui E, Perlman S, Zhang Q, Wang K, Sheffield VC, Carter CS. An open source and convenient method for the wide-spread testing of COVID-19 using deep throat sputum samples. PeerJ 2022;10:e13277. [DOI: 10.7717/peerj.13277] [Reference Citation Analysis]
237 Li H, Zhang G, Cao Y. Forest Area, CO2 Emission, and COVID-19 Case-Fatality Rate: A Worldwide Ecological Study Using Spatial Regression Analysis. Forests 2022;13:736. [DOI: 10.3390/f13050736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Elfiky AA. Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective. Future Microbiol 2022. [PMID: 35510477 DOI: 10.2217/fmb-2022-0083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Kumari R, Kumar V, Dhankhar P, Dalal V. Promising antivirals for PLpro of SARS-CoV-2 using virtual screening, molecular docking, dynamics, and MMPBSA. J Biomol Struct Dyn 2022;:1-17. [PMID: 35510600 DOI: 10.1080/07391102.2022.2071340] [Reference Citation Analysis]
240 Qu N, Hui Z, Shen Z, Kan C, Hou N, Sun X, Han F. Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development. Front Endocrinol 2022;13:873027. [DOI: 10.3389/fendo.2022.873027] [Reference Citation Analysis]
241 Aher SB, Nandi S, Ramesh G, Raj D, Patel L, Tiwari R. Effects of COVID-19 lockdown on ambient air pollution in Madhya Pradesh, India. International Journal of Environmental Studies 2022;79:401-16. [DOI: 10.1080/00207233.2021.1929412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Rahman MM, Islam MR, Shohag S, Hossain ME, Shah M, Shuvo SK, Khan H, Chowdhury MAR, Bulbul IJ, Hossain MS, Sultana S, Ahmed M, Akhtar MF, Saleem A, Rahman MH. Multifaceted role of natural sources for COVID-19 pandemic as marine drugs. Environ Sci Pollut Res Int 2022. [PMID: 35507224 DOI: 10.1007/s11356-022-20328-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
243 Peinado B, Martínez-García L, Martínez F, Nozal L, Sánchez MB. Improved methods for the detection and quantification of SARS-CoV-2 RNA in wastewater. Sci Rep 2022;12:7201. [PMID: 35504966 DOI: 10.1038/s41598-022-11187-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
244 Deval J, Gurard-Levin ZA. Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex. Molecules 2022;27:2918. [PMID: 35566268 DOI: 10.3390/molecules27092918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
245 Hanani A, Badrasawi M, Zidan S, Hunjul M. Effect of cognitive behavioral therapy program on mental health status among medical student in Palestine during COVID pandemic. BMC Psychiatry 2022;22:310. [PMID: 35501772 DOI: 10.1186/s12888-022-03915-1] [Reference Citation Analysis]
246 Prince T, Dong X, Penrice-randal R, Randle N, Hartley C, Goldswain H, Jones B, Semple MG, Baillie JK, Openshaw PJM, Turtle L, Hughes GL, Anderson ER, Patterson EI, Druce J, Screaton G, Carroll MW, Stewart JP, Hiscox JA, Lee B. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages. mSphere. [DOI: 10.1128/msphere.00913-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Otal Y, Avcıoglu G, Haydar FG. A new biomarker in severe pneumonia associated with coronavirus disease 2019: hypoalbuminemia. A prospective study. Sao Paulo Med J 2022:S1516-31802022005009201. [PMID: 35507997 DOI: 10.1590/1516-3180.2021.0066.R2.16082021] [Reference Citation Analysis]
248 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Sadeghalvad M, Mansourabadi AH, Noori M, Nejadghaderi SA, Masoomikarimi M, Alimohammadi M, Rezaei N. Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies. Reviews in Medical Virology. [DOI: 10.1002/rmv.2359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
250 Thadathil DA, Varghese A, Ahamed CVS, Krishnakumar K, Varma SS, Lankalapalli RS, Radhakrishnan KV. Enzyme based bioelectrocatalysis over laccase immobilized poly-thiophene supported carbon fiber paper for the oxidation of D-ribofuranose to D-ribonolactone. Molecular Catalysis 2022;524:112314. [DOI: 10.1016/j.mcat.2022.112314] [Reference Citation Analysis]
251 Lyra e Silva NM, Barros-aragão FG, De Felice FG, Ferreira ST. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology 2022;209:109023. [DOI: 10.1016/j.neuropharm.2022.109023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
252 Cucchi EW, Kopec SE, Lilly CM. COVID-19 and the transformation of ICU Telemedicine. Clinics in Chest Medicine 2022. [DOI: 10.1016/j.ccm.2022.05.007] [Reference Citation Analysis]
253 Yemata GA, Tesfaw A, Mihret G, Tiruneh M, Walle Z, Molla E, Sisay E, Admassu FT, Habtie E, Desalagn T, Shimels H, Teshome F. Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study. JMDH 2022;Volume 15:1187-201. [DOI: 10.2147/jmdh.s361061] [Reference Citation Analysis]
254 Kuzmin A, Orekhov P, Astashkin R, Gordeliy V, Gushchin I. Structure and dynamics of the SARS-CoV-2 envelope protein monomer. Proteins 2022;90:1102-14. [PMID: 35119706 DOI: 10.1002/prot.26317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
255 Duabie B, Alfattani A, Althawadi S, Taha A, Javaid HA, Mobarak O, Albanyan E. Epidemiological characteristics, clinical course, and laboratory investigation of pediatric COVID-19 patients in a Tertiary Care Center in Saudi Arabia. International Journal of Pediatrics and Adolescent Medicine 2022. [DOI: 10.1016/j.ijpam.2022.05.001] [Reference Citation Analysis]
256 Li B, Cai W. A novel CO2-based demand-controlled ventilation strategy to limit the spread of COVID-19 in the indoor environment. Building and Environment 2022. [DOI: 10.1016/j.buildenv.2022.109232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Leong J, Shi D, Tan JPK, Yang C, Yang S, Wang Y, Ngow YS, Kng J, Balakrishnan N, Peng SQ, Yeow CS, Periaswamy B, Venkataraman S, Kwa AL, Liu X, Yao H, Yang YY. Potent Antiviral and Antimicrobial Polymers as Safe and Effective Disinfectants for the Prevention of Infections. Adv Healthc Mater 2022;11:e2101898. [PMID: 34694749 DOI: 10.1002/adhm.202101898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Treviño S, Cortezano-esteban S, Hernández-fragoso H, Díaz A, Vázquez-roque R, Enrique Sarmiento-ortega V, Moroni-gonzález D, Pelayo R, Brambila E. Clinical monitored in subjects metabolically healthy and unhealthy before and during a SARS-CoV-2 infection– A cross-sectional study in Mexican population. Cytokine 2022;153:155868. [DOI: 10.1016/j.cyto.2022.155868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Alshammary AF, Alsughayyir JM, Alharbi KK, Al-sulaiman AM, Alshammary HF, Alshammary HF. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med 2022;9:852749. [DOI: 10.3389/fmed.2022.852749] [Reference Citation Analysis]
260 Santa Maria F, Huang YS, Vanlandingham DL, Bringmann P. Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies. Pathogens 2022;11:521. [DOI: 10.3390/pathogens11050521] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Majeed M, Nagabhushanam K, Prakasan P, Mundkur L. Can Selenium Reduce the Susceptibility and Severity of SARS-CoV-2?-A Comprehensive Review. Int J Mol Sci 2022;23:4809. [PMID: 35563199 DOI: 10.3390/ijms23094809] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
262 Jamiruddin MR, Meghla BA, Islam DZ, Tisha TA, Khandker SS, Khondoker MU, Haq MA, Adnan N, Haque M. Microfluidics Technology in SARS-CoV-2 Diagnosis and Beyond: A Systematic Review. Life 2022;12:649. [DOI: 10.3390/life12050649] [Reference Citation Analysis]
263 Zhang M, Gong Y, Jiao S. Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent. Future Virology. [DOI: 10.2217/fvl-2021-0100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Vollenberg R, Tepasse P, Lorentzen E, Nowacki TM. Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study. JPM 2022;12:694. [DOI: 10.3390/jpm12050694] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Mohamed FF, Anhlan D, Schöfbänker M, Schreiber A, Classen N, Hensel A, Hempel G, Scholz W, Kühn J, Hrincius ER, Ludwig S. Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2. Pharmaceuticals 2022;15:530. [DOI: 10.3390/ph15050530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
266 Wu CC, Chiang YH, Chiang HY. A Label-Free Electrochemical Impedimetric Immunosensor with Biotinylated-Antibody for SARS-CoV-2 Nucleoprotein Detection in Saliva. Biosensors (Basel) 2022;12:265. [PMID: 35624566 DOI: 10.3390/bios12050265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
267 Hussein MAA, Hussein HAM, Thabet AA, Selim KM, Dawood MA, El-adly AM, Wardany AA, Sobhy A, Magdeldin S, Osama A, Anwar AM, Abdel-wahab M, Askar H, Bakhiet EK, Sultan S, Ezzat AA, Abdel Raouf U, Afifi MM. Human Wharton’s Jelly Mesenchymal Stem Cells Secretome Inhibits Human SARS-CoV-2 and Avian Infectious Bronchitis Coronaviruses. Cells 2022;11:1408. [DOI: 10.3390/cells11091408] [Reference Citation Analysis]
268 Demirci A, Hızlı F, Başar H. COVID-19 effect on perioperative findings of flexible/semi-rigid ureterorenoscopic lithotripsy: A match-pair analysis. Urologia 2022;:3915603221093719. [PMID: 35445621 DOI: 10.1177/03915603221093719] [Reference Citation Analysis]
269 Greasley SE, Noell S, Plotnikova O, Ferre R, Liu W, Bolanos B, Fennell K, Nicki J, Craig T, Zhu Y, Stewart AE, Steppan CM. Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants. J Biol Chem 2022;:101972. [PMID: 35461811 DOI: 10.1016/j.jbc.2022.101972] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 17.0] [Reference Citation Analysis]
270 Yajima S, Koto A, Koda M, Sakamoto H, Takamura E, Suye SI. Photo-Cross-Linked Probe-Modified Magnetic Particles for the Selective and Reliable Recovery of Nucleic Acids. ACS Omega 2022;7:12701-6. [PMID: 35474845 DOI: 10.1021/acsomega.1c07012] [Reference Citation Analysis]
271 Bagwe PV, Bagwe PV, Ponugoti SS, Joshi SV. Peptide-Based Vaccines and Therapeutics for COVID-19. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10397-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
272 Garanina E, Hamza S, Stott-marshall RJ, Martynova E, Markelova M, Davidyuk Y, Shakirova V, Kaushal N, Baranwal M, Khaertynova IM, Rizvanov A, Foster TL, Khaiboullina S. Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients. Front Microbiol 2022;13:842232. [DOI: 10.3389/fmicb.2022.842232] [Reference Citation Analysis]
273 Maçin G, Maçin S, Arslan PDU. EVALUATION OF COMPUTED TOMOGRAPHY AND PCR RESULTS OF PATIENTS ADMITTED TO PANDEMIC HOSPITAL IN TERMS OF COVID-19. Journal of Contemporary Medicine. [DOI: 10.16899/jcm.1066691] [Reference Citation Analysis]
274 Cabanillas-Bernal O, Cervantes-Luevano K, Flores-Acosta GI, Bernáldez-Sarabia J, Licea-Navarro AF. COVID-19 Neutralizing Antibodies in Breast Milk of Mothers Vaccinated with Three Different Vaccines in Mexico. Vaccines (Basel) 2022;10:629. [PMID: 35455378 DOI: 10.3390/vaccines10040629] [Reference Citation Analysis]
275 Ahan RE, Hanifehnezhad A, Kehribar EŞ, Oguzoglu TC, Földes K, Özçelik CE, Filazi N, Öztop S, Palaz F, Önder S, Bozkurt EU, Ergünay K, Özkul A, Şeker UÖŞ. A Highly Potent SARS-CoV-2 Blocking Lectin Protein. ACS Infect Dis 2022. [PMID: 35426678 DOI: 10.1021/acsinfecdis.2c00006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
276 Chen PH, Huang CC, Wu CC, Chen PH, Tripathi A, Wang YL. Saliva-based COVID-19 detection: A rapid antigen test of SARS-CoV-2 nucleocapsid protein using an electrical-double-layer gated field-effect transistor-based biosensing system. Sens Actuators B Chem 2022;357:131415. [PMID: 35043033 DOI: 10.1016/j.snb.2022.131415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
277 Ghosh D, Ghosh Dastidar D, Roy K, Ghosh A, Mukhopadhyay D, Sikdar N, Biswas NK, Chakrabarti G, Das A. Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis. Sci Rep 2022;12:6241. [PMID: 35422113 DOI: 10.1038/s41598-022-09845-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Pang W, Yang F, Zhao Y, Dai E, Feng J, Huang Y, Guo Y, Zhou S, Huang M, Zheng W, Ma J, Li H, Li Q, Hou L, Zhang S, Wang H, Liu Q, Zhang B, Zhang J. Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial. J Evid Based Med 2022;15:30-8. [PMID: 35416437 DOI: 10.1111/jebm.12465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
279 Fatema KN, Sagadevan S, Cho JY, Jang WK, Oh W. Graphene-based nanocomposite using new modeling molecular dynamic simulations for proposed neutralizing mechanism and real-time sensing of COVID-19. Nanotechnology Reviews 2022;11:1555-69. [DOI: 10.1515/ntrev-2022-0093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Ebner B, Volz Y, Mumm JN, Stief CG, Magistro G. The COVID-19 pandemic - what have urologists learned? Nat Rev Urol 2022. [PMID: 35418709 DOI: 10.1038/s41585-022-00586-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
281 Militello KT, Nedelkovska H. An undergraduate laboratory to detect viruses in human DNA samples using qPCR. Biochem Mol Biol Educ 2022. [PMID: 35412013 DOI: 10.1002/bmb.21620] [Reference Citation Analysis]
282 Kasis A, Timotheou S, Monshizadeh N, Polycarpou M. Optimal intervention strategies to mitigate the COVID-19 pandemic effects. Sci Rep 2022;12:6124. [PMID: 35414076 DOI: 10.1038/s41598-022-09857-8] [Reference Citation Analysis]
283 Girdhar D, Manocha E. A Comprehensive Review on the Management of COVID-19-Associated Mucormycosis (CAM): The New Basics. BioMed 2022;2:181-98. [DOI: 10.3390/biomed2020017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
284 Ghosh R, Badavath VN, Chowdhuri S, Sen A. Identification of Alkaloids from Terminalia chebula as Potent SARS‐ CoV‐2 Main Protease Inhibitors: An In Silico Perspective. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202200055] [Reference Citation Analysis]
285 Zhao M, Xu Y, Zhang D, Li G, Gao H, Zeng X, Tie Y, Wu Y, Dai E, Feng Z. Establishment and evaluation of a quadruple quantitative real-time PCR assay for simultaneous detection of human coronavirus subtypes. Virol J 2022;19. [DOI: 10.1186/s12985-022-01793-3] [Reference Citation Analysis]
286 Martynova E, Hamza S, Markelova M, Garanina E, Davidyuk Y, Shakirova V, Kaushal N, Baranwal M, Stott-Marshall RJ, Foster TL, Rizvanov A, Khaiboullina S. Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19. Front Immunol 2022;13:830715. [PMID: 35386707 DOI: 10.3389/fimmu.2022.830715] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Ping YH, Yeh H, Chu LW, Lin ZH, Hsu YC, Lin LC, Hsu CH, Fu SL, Lin TY. The Traditional Chinese Medicine Formula Jing Guan Fang for Preventing SARS-CoV-2 Infection: From Clinical Observation to Basic Research. Front Pharmacol 2022;13:744439. [PMID: 35387343 DOI: 10.3389/fphar.2022.744439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
288 Zhang Q, Guo H, Wang J, Zhang Y, Deng P, Li F. Structural Genomic Analysis of SARS-CoV-2 and Other Coronaviruses. Front Genet 2022;13:801902. [DOI: 10.3389/fgene.2022.801902] [Reference Citation Analysis]
289 Mcmillan CLD, Azuar A, Choo JJY, Modhiran N, Amarilla AA, Isaacs A, Honeyman KE, Cheung STM, Liang B, Wurm MJ, Pino P, Kint J, Fernando GJP, Landsberg MJ, Khromykh AA, Hobson-peters J, Watterson D, Young PR, Muller DA. Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern. Vaccines 2022;10:578. [DOI: 10.3390/vaccines10040578] [Reference Citation Analysis]
290 Li Y, Liu Q, Zeng Z, Luo Y. Using an Unsupervised Clustering Model to Detect the Early Spread of SARS-CoV-2 Worldwide. Genes 2022;13:648. [DOI: 10.3390/genes13040648] [Reference Citation Analysis]
291 Chen J, Li Z, Guo J, Xu S, Zhou J, Chen Q, Tong X, Wang D, Peng G, Fang L, Xiao S. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog. J Virol 2022;:e0003722. [PMID: 35389264 DOI: 10.1128/jvi.00037-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
292 Veisi A, Delavari H. A novel fractional-order feedback management of COVID-19 prevalence. Journal of Statistics and Management Systems. [DOI: 10.1080/09720510.2021.1970951] [Reference Citation Analysis]
293 Jemioło P, Storman D, Orzechowski P. Artificial Intelligence for COVID-19 Detection in Medical Imaging—Diagnostic Measures and Wasting—A Systematic Umbrella Review. JCM 2022;11:2054. [DOI: 10.3390/jcm11072054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
294 Muhammad U, Hoque MZ, Oussalah M, Keskinarkaus A, Seppänen T, Sarder P. SAM: Self-augmentation mechanism for COVID-19 detection using chest X-ray images. Knowl Based Syst 2022;:108207. [PMID: 35068707 DOI: 10.1016/j.knosys.2022.108207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
295 Strobelt R, Adler J, Paran N, Yahalom-Ronen Y, Melamed S, Politi B, Shulman Z, Schmiedel D, Shaul Y. Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism. Sci Rep 2022;12:5758. [PMID: 35388061 DOI: 10.1038/s41598-022-09664-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
296 Au GG, Marsh GA, McAuley AJ, Lowther S, Trinidad L, Edwards S, Todd S, Barr J, Bruce MP, Poole TB, Brown S, Layton R, Riddell S, Rowe B, Soldani E, Suen WW, Bergfeld J, Bingham J, Payne J, Durr PA, Drew TW, Vasan SS. Characterisation and natural progression of SARS-CoV-2 infection in ferrets. Sci Rep 2022;12:5680. [PMID: 35383204 DOI: 10.1038/s41598-022-08431-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
297 Abbas G, Irfan A, Ahmed I, Al-Zeidaneen FK, Muthu S, Fuhr O, Thomas R. Synthesis and investigation of anti-COVID19 ability of ferrocene Schiff base derivatives by quantum chemical and molecular docking. J Mol Struct 2022;1253:132242. [PMID: 34975177 DOI: 10.1016/j.molstruc.2021.132242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
298 Cattaneo AM. Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus. Future Virology. [DOI: 10.2217/fvl-2021-0233] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Nga NTT, Latinne A, Thuy HB, Long NV, Ngoc PTB, Anh NTL, Thai NV, Phuong TQ, Thai HV, Hai LK, Long PT, Phuong NT, Hung VV, Quang LTV, Lan NT, Hoa NT, Johnson CK, Mazet JAK, Roberton SI, Walzer C, Olson SH, Fine AE. Evidence of SARS-CoV-2 Related Coronaviruses Circulating in Sunda pangolins (Manis javanica) Confiscated From the Illegal Wildlife Trade in Viet Nam. Front Public Health 2022;10:826116. [PMID: 35356028 DOI: 10.3389/fpubh.2022.826116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
300 Panahi Y, Dadkhah M, Talei S, Gharari Z, Asghariazar V, Abdolmaleki A, Matin S, Molaei S. Can anti-parasitic drugs help control COVID-19? Future Virol 2022. [PMID: 35359702 DOI: 10.2217/fvl-2021-0160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
301 Van Honacker E, Coorevits L, Boelens J, Verhasselt B, Van Braeckel E, Bauters F, De Bus L, Schelstraete P, Willems J, Vandendriessche S, Padalko E. Sensitivity and specificity of 14 SARS-CoV-2 serological assays and their diagnostic potential in RT-PCR negative COVID-19 infections. Acta Clin Belg 2022;77:315-20. [PMID: 33350362 DOI: 10.1080/17843286.2020.1861885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
302 Bandaru R, Rout SR, Kamble O, Samal SK, Gorain B, Sahebkar A, Ahmed FJ, Kesharwani P, Dandela R. Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment. Process Biochemistry 2022. [DOI: 10.1016/j.procbio.2022.04.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Hayashi H, Sun J, Yanagida Y, Otera T, Kubota-koketsu R, Shioda T, Ono C, Matsuura Y, Arase H, Yoshida S, Nakamaru R, Ju N, Ide R, Tenma A, Kawabata S, Ehara T, Sakaguchi M, Tomioka H, Shimamura M, Okamoto S, Amaishi Y, Chono H, Mineno J, Komatsuno T, Saito Y, Rakugi H, Morishita R, Nakagami H. Preclinical study of a DNA vaccine targeting SARS-CoV-2. Current Research in Translational Medicine 2022. [DOI: 10.1016/j.retram.2022.103348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
304 Yoon J, Conley BM, Shin M, Choi JH, Bektas CK, Choi JW, Lee KB. Ultrasensitive Electrochemical Detection of Mutated Viral RNAs with Single-Nucleotide Resolution Using a Nanoporous Electrode Array (NPEA). ACS Nano 2022. [PMID: 35362957 DOI: 10.1021/acsnano.1c10824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
305 Fenaux H, Limam L, Soutiere M, Veillet F, Escuret V, Roque-afonso A. Performance of the QIAprep&amp Viral RNA UM Kit assay (Qiagen), an automatable method for RT-qPCR detection of SARS-CoV-2 without RNA extraction. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115700] [Reference Citation Analysis]
306 Martins AS, Siqueira MAMTD, Flores GL, Coelho WN, Carvajal E, Aguiar-oliveira MDL. Condições socioeconômicas e impactos da pandemia da Covid-19 na região da Sub-Bacia do Canal do Cunha, Rio de Janeiro. Saúde debate 2022;46:290-303. [DOI: 10.1590/0103-1104202213303] [Reference Citation Analysis]
307 Zhang J, Ejikemeuwa A, Gerzanich V, Nasr M, Tang Q, Simard JM, Zhao RY. Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19. Front Microbiol 2022;13:854567. [PMID: 35356515 DOI: 10.3389/fmicb.2022.854567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
308 Drain P, Sulaiman R, Hoppers M, Lindner NM, Lawson V, Ellis JE. Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children. Am J Clin Pathol 2022;157:602-7. [PMID: 34668536 DOI: 10.1093/ajcp/aqab173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
309 Cacciabue M, Aguilera P, Gismondi MI, Taboga O. Covidex: An ultrafast and accurate tool for SARS-CoV-2 subtyping. Infect Genet Evol 2022;99:105261. [PMID: 35231666 DOI: 10.1016/j.meegid.2022.105261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
310 El-hefnawy SM, Eid HA, Mostafa RG, Soliman SS, Omar TA, Azmy RM. COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101612] [Reference Citation Analysis]
311 Freire-Paspuel B, Morales-Jadan D, Zambrano-Mila M, Perez F, Garcia-Bereguiain MA. Analytical sensitivity and clinical performance of "COVID-19 RT-PCR Real TM FAST (CY5) (ATGen, Uruguay) and "ECUGEN SARS-CoV-2 RT-qPCR" (UDLA-STARNEWCORP, Ecuador)": High quality-low cost local SARS-CoV-2 tests for South America. PLoS Negl Trop Dis 2022;16:e0010082. [PMID: 35417456 DOI: 10.1371/journal.pntd.0010082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Firoz A, Talwar P. COVID-19 and Retinal Degenerative Diseases: Promising link “Kaempferol”. Current Opinion in Pharmacology 2022. [DOI: 10.1016/j.coph.2022.102231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Xiang R, Yu Z, Wang Y, Wang L, Huo S, Li Y, Liang R, Hao Q, Ying T, Gao Y, Yu F, Jiang S. Recent advances in developing small-molecule inhibitors against SARS-CoV-2. Acta Pharm Sin B 2022;12:1591-623. [PMID: 34249607 DOI: 10.1016/j.apsb.2021.06.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 18.0] [Reference Citation Analysis]
314 Kellner MJ, Ross JJ, Schnabl J, Dekens MPS, Matl M, Heinen R, Grishkovskaya I, Bauer B, Stadlmann J, Menéndez-arias L, Straw AD, Fritsche-polanz R, Traugott M, Seitz T, Zoufaly A, Födinger M, Wenisch C, Zuber J, Vienna Covid-19 Detection Initiative (VCDI), Pauli A, Brennecke J. A Rapid, Highly Sensitive and Open-Access SARS-CoV-2 Detection Assay for Laboratory and Home Testing. Front Mol Biosci 2022;9:801309. [DOI: 10.3389/fmolb.2022.801309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
315 Vacaflores Salinas A, Ashavaid T, Payne DA, Linder MW, Baluchova K, Pan S, Huggett J, Ahmad-nejad P. Molecular Diagnostics of SARS-CoV-2: Findings of an International Survey. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.04.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Yi Y. Potential benefits of ginseng against COVID-19 by targeting inflammasomes. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
317 Ji X, Huang J, Teng L, Li S, Li X, Cai W, Chen Z, Lai Y. Advances in particulate matter filtration: Materials, performance, and application. Green Energy & Environment 2022. [DOI: 10.1016/j.gee.2022.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
318 Shah R, Shah J, Kunyiha N, Ali S, Sayed S, Surani S, Saleh M. Demographic, Clinical, and Co-Morbidity Characteristics of COVID-19 Patients: A Retrospective Cohort from a Tertiary Hospital in Kenya. IJGM 2022;Volume 15:4237-46. [DOI: 10.2147/ijgm.s361176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Aileni M, Rohela GK, Jogam P, Soujanya S, Zhang B. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms. Cells 2022;11:1182. [DOI: 10.3390/cells11071182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
320 De R, Dutta S. Role of the Microbiome in the Pathogenesis of COVID-19. Front Cell Infect Microbiol 2022;12:736397. [DOI: 10.3389/fcimb.2022.736397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
321 Kocakoglu S, Cadirci D, Kivanc Terzi N, Ayazoz Y. Anxiety Status and Associated Factors of Health Personnel Working in a Tertiary Hospital in Turkey in the COVID-19 Pandemic. Euras J Fam Med 2022;11:8-18. [DOI: 10.33880/ejfm.2022110102] [Reference Citation Analysis]
322 Eleje GU, Ugwu EO, Enebe JT, Okoro CC, Okpala BC, Ezeora NC, Iloghalu EI, Anikwe CC, Okafor CG, Agu PU, Igbodike EP, Ake ID, Ekwuazi KE, Onwuegbuna AA, Umeononihu OS, Anaedu OP, Ikwuka DC, Nwaolisa HI, Njoku CC, Nwankwo CP, Emeka EA, Eleje LI, Adinnu KM, Okoye CO, Ugwu AO, Nwachukwu EO, Mba SG, Ezenkwele EP, Okoye UE, Ofiaeli CI, Ikpeze GC, Onah LN, Ikpeze OZ, Ejikeme TB, Udigwe GO, Ikechebelu JI. Cesarean section rate and outcomes during and before the first wave of COVID-19 pandemic. SAGE Open Med 2022;10:20503121221085453. [PMID: 35342633 DOI: 10.1177/20503121221085453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Barmania F, Mellet J, Ryder MA, Ford G, Herd CL, Tamuhla T, Hendricks C, Giles R, Kalua T, Joubert F, Tiffin N, Pepper MS. Coronavirus Host Genetics South Africa (COHG-SA) database-a variant database for gene regions associated with SARS-CoV-2 outcomes. Eur J Hum Genet 2022. [PMID: 35351987 DOI: 10.1038/s41431-022-01089-8] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
324 Li H, Wen K. Research on Design of Emergency Science Popularization Information Visualization for Public Health Events-Taking “COVID-19”as an Example. Sustainability 2022;14:4022. [DOI: 10.3390/su14074022] [Reference Citation Analysis]
325 Ferreira LLC, Abreu MP, Costa CB, Leda PO, Behrens MD, Dos Santos EP. Curcumin and Its Analogs as a Therapeutic Strategy in Infections Caused by RNA Genome Viruses. Food Environ Virol 2022. [PMID: 35352306 DOI: 10.1007/s12560-022-09514-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
326 Nikolaidis M, Papakyriakou A, Chlichlia K, Markoulatos P, Oliver SG, Amoutzias GD. Comparative Analysis of SARS-CoV-2 Variants of Concern, Including Omicron, Highlights Their Common and Distinctive Amino Acid Substitution Patterns, Especially at the Spike ORF. Viruses 2022;14:707. [DOI: 10.3390/v14040707] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
327 Liu MQ, Jiang RD, Guo J, Chen Y, Yang DS, Wang X, Lin HF, Li A, Li B, Hu B, Wang ZJ, Yang XL, Shi ZL. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice. J Virol 2022;:e0016922. [PMID: 35343762 DOI: 10.1128/jvi.00169-22] [Reference Citation Analysis]
328 Mallis P, Chatzistamatiou T, Dimou Z, Sarri EF, Georgiou E, Salagianni M, Triantafyllia V, Andreakos E, Stavropoulos-Giokas C, Michalopoulos E. Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results. World J Biol Chem 2022; 13(2): 47-65 [DOI: 10.4331/wjbc.v13.i2.47] [Reference Citation Analysis]
329 Alratrout H, Debroux E. Acute right-sided ischemic colitis in a COVID-19 patient: a case report and review of the literature. J Med Case Rep 2022;16:135. [PMID: 35337362 DOI: 10.1186/s13256-022-03276-z] [Reference Citation Analysis]
330 Jiang J, Wang YE, Palazzo AF, Shen Q. Roles of Nucleoporin RanBP2/Nup358 in Acute Necrotizing Encephalopathy Type 1 (ANE1) and Viral Infection. Int J Mol Sci 2022;23:3548. [PMID: 35408907 DOI: 10.3390/ijms23073548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
331 Kiely P, Hoad VC, Seed CR, Gosbell IB. Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review. Transfus Med Hemother. [DOI: 10.1159/000522264] [Reference Citation Analysis]
332 Vindeirinho JM, Pinho E, Azevedo NF, Almeida C. SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond. Front Cell Infect Microbiol 2022;12:799678. [DOI: 10.3389/fcimb.2022.799678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
333 Yanchao L, Sibin Z, Gareev I, Huan X, Junfei Z, Chunyang L, Beylerli O, Sufianov A, Chao Y, Yuyan G, Xun X, Ahmad A, Peng L, Guang Y. Bioinformatics analysis of potential therapeutic targets for COVID-19 infection in patients with carotid atherosclerosis. J Infect Public Health 2022;15:437-47. [PMID: 35344771 DOI: 10.1016/j.jiph.2022.03.004] [Reference Citation Analysis]
334 Paz M, Aldunate F, Arce R, Ferreiro I, Cristina J. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern. Virus Res 2022;:198753. [PMID: 35331836 DOI: 10.1016/j.virusres.2022.198753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
335 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
336 Chen L, Pang P, Qi H, Yan K, Ren Y, Ma M, Cao R, Li H, Hu C, Li Y, Xia J, Lai D, Dong Y, Jiang H, Zhang H, Shan H, Tao S, Liu S. Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19. Front Immunol 2022;13:770982. [DOI: 10.3389/fimmu.2022.770982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
337 Kovalenko AO, Ryabchevskaya EM, Evtushenko EA, Manukhova TI, Kondakova OA, Ivanov PA, Arkhipenko MV, Gushchin VA, Nikitin NA, Karpova OV. Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant. Front Microbiol 2022;13:845316. [PMID: 35295298 DOI: 10.3389/fmicb.2022.845316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
338 Tsutsumi-Arai C, Iwamiya Y, Hoshino R, Terada-Ito C, Sejima S, Akutsu-Suyama K, Shibayama M, Hiroi Z, Tokuyama-Toda R, Iwamiya R, Ijichi K, Chiba T, Satomura K. Surface Functionalization of Non-Woven Fabrics Using a Novel Silica-Resin Coating Technology: Antiviral Treatment of Non-Woven Fabric Filters in Surgical Masks. Int J Environ Res Public Health 2022;19:3639. [PMID: 35329324 DOI: 10.3390/ijerph19063639] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Chouikha A, Fares W, Laamari A, Haddad-boubaker S, Belaiba Z, Ghedira K, Kammoun Rebai W, Ayouni K, Khedhiri M, Ben Halima S, Krichen H, Touzi H, Ben Dhifallah I, Guerfali FZ, Atri C, Azouz S, Khamessi O, Ardhaoui M, Safer M, Ben Alaya N, Guizani I, Kefi R, Gdoura M, Triki H. Molecular Epidemiology of SARS-CoV-2 in Tunisia (North Africa) through Several Successive Waves of COVID-19. Viruses 2022;14:624. [DOI: 10.3390/v14030624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
340 Neculicioiu VS, Colosi IA, Costache C, Sevastre-Berghian A, Clichici S. Time to Sleep?-A Review of the Impact of the COVID-19 Pandemic on Sleep and Mental Health. Int J Environ Res Public Health 2022;19:3497. [PMID: 35329184 DOI: 10.3390/ijerph19063497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
341 Yang B, Yu Z, Cai Y. The impact of vaccination on the spread of COVID-19: Studying by a mathematical model. Physica A 2022;590:126717. [PMID: 34924686 DOI: 10.1016/j.physa.2021.126717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
342 Takamatsu A, Oshiro S, Mizutani N, Tada T, Tabe Y, Miida T, Kirikae T, Tagashira Y. Correlation of COVID-19 Severity and Immunoglobulin Presence Against Spike and Nucleocapsid Proteins in SARS-CoV-2. Viral Immunol 2022. [PMID: 35290756 DOI: 10.1089/vim.2021.0168] [Reference Citation Analysis]
343 Costantini VP, Nguyen K, Lyski Z, Novosad S, Bardossy AC, Lyons AK, Gable P, Kutty PK, Lutgring JD, Brunton A, Thornburg NJ, Brown AC, McDonald LC, Messer W, Vinjé J. Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG. J Immunol 2022;208:1500-8. [PMID: 35228262 DOI: 10.4049/jimmunol.2100934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
344 Sheng Y, Vinjamuri A, Alvarez MRS, Xie Y, Mcgrath M, Chen S, Barboza M, Frieman M, Lebrilla CB. Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites. Front Mol Biosci 2022;9:799703. [DOI: 10.3389/fmolb.2022.799703] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
345 Souza PFN, Mesquita FP, Amaral JL, Landim PGC, Lima KRP, Costa MB, Farias IR, Belém MO, Pinto YO, Moreira HHT, Magalhaes ICL, Castelo-Branco DSCM, Montenegro RC, de Andrade CR. The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape. Int J Biol Macromol 2022:S0141-8130(22)00528-1. [PMID: 35300999 DOI: 10.1016/j.ijbiomac.2022.03.058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
346 Abdou M, Hassan MM, Hassanein SA, Elsebaie EH, Shamma RA. Presentations, Complications, and Challenges Encountered During Management of Type 1 Diabetes in Egyptian Children During COVID-19 Pandemic: A Single-Center Experience. Front Endocrinol 2022;13:814991. [DOI: 10.3389/fendo.2022.814991] [Reference Citation Analysis]
347 Kumar S, Saxena SK, Maurya VK, Tripathi AK. Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19. Front Immunol 2021;12:804808. [PMID: 35250966 DOI: 10.3389/fimmu.2021.804808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
348 Fenaux H, Ghelfenstein-Ferreira T, Salmona M, Mahjoub N, Feghoul L, Maylin S, Chaix ML, Minier M, Gabassi A, Goff JL, Delaugerre C. Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests. J Clin Virol Plus 2021;1:100021. [PMID: 35262008 DOI: 10.1016/j.jcvp.2021.100021] [Reference Citation Analysis]
349 Chadda KR, Blakey EE, Huang CL-, Jeevaratnam K. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed? Front Cardiovasc Med 2022;9:860198. [DOI: 10.3389/fcvm.2022.860198] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
350 Fenton C, Keam SJ. Emerging small molecule antivirals may fit neatly into COVID-19 treatment. Drugs Ther Perspect 2022;38:112-26. [PMID: 35250258 DOI: 10.1007/s40267-022-00897-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
351 Oliveira F, Dos Santos LMC, da Silva ES, de Alencar Pereira Rodrigues L, Freitas Neves PR, Fernandes Moreira GA, Lobato GM, Nascimento C, Gerhardt M, Bandeira Santos AA, Brêda Mascarenhas LA, Souza Machado BA. Disinfecting Efficacy of an Ozonated Water Spray Chamber: Scientific Evidence of the Total and Partial Biocidal Effect on Personal Protective Equipment and in Vitro Analysis of a Viral Experimental Model. Ozone: Science & Engineering. [DOI: 10.1080/01919512.2022.2040353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
352 Touati R, Elngar AA. Intelligent system based comparative analysis study of SARS-CoV-2 spike protein and antigenic proteins in different types of vaccines. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00216-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Jiménez-Rodríguez MG, Silva-Lance F, Parra-Arroyo L, Medina-Salazar DA, Martínez-Ruíz M, Melchor-Martinez EM, Martínez-Prado MA, Iqbal HMN, Parra-Saldívar R, Barceló D, Sosa-Hernández JE. Biosensors for the detection of disease outbreaks through Wastewater-based Epidemiology. Trends Analyt Chem 2022;:116585. [PMID: 35281332 DOI: 10.1016/j.trac.2022.116585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Yang B, Yu Z, Cai Y. A spread model of COVID-19 with some strict anti-epidemic measures. Nonlinear Dyn. [DOI: 10.1007/s11071-022-07244-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 Kałucka S, Kusideł E, Głowacka A, Oczoś P, Grzegorczyk-karolak I. Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers. Vaccines 2022;10:401. [DOI: 10.3390/vaccines10030401] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
356 Dai Z, Xu X, Wang Y, Li M, Zhou K, Zhang L, Tan Y. Surface plasmon resonance biosensor with laser heterodyne feedback for highly-sensitive and rapid detection of COVID-19 spike antigen. Biosens Bioelectron 2022;206:114163. [PMID: 35272216 DOI: 10.1016/j.bios.2022.114163] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
357 Carossino M, Kenney D, O'Connell AK, Montanaro P, Tseng AE, Gertje HP, Grosz KA, Ericsson M, Huber BR, Kurnick SA, Subramaniam S, Kirkland TA, Walker JR, Francis KP, Klose AD, Paragas N, Bosmann M, Saeed M, Balasuriya UBR, Douam F, Crossland NA. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses 2022;14:535. [PMID: 35336942 DOI: 10.3390/v14030535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
358 Suri A, Singh NK, Perumal V. Association of inflammatory biomarker abnormalities with mortality in COVID-19: a meta-analysis. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00733-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
359 Sun H, Wang A, Wang L, Wang B, Tian G, Yang J, Liao M. Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework. Front Microbiol 2022;13:781770. [DOI: 10.3389/fmicb.2022.781770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
360 Mohammed KS, de Laurent ZR, Omuoyo DO, Lewa C, Gicheru E, Cheruiyot R, Bartilol B, Mutua S, Musyoki J, Gumba H, Mwacharo J, Riako D, Mwangi SJ, Gichuki BM, Nyamako L, Karani A, Karanja H, Mugo D, Gitonga JN, Njuguna S, Gumbi W, Tawa B, Tendwa M, Cheruiyot W, Sein Y, Nyambu JK, Patta SO, Thani TS, Maitha EK, Kitole B, Mwakinangu MS, Muslih BS, Otieno JO, Nyiro JU, Kiyuka P, Ndwiga L, Wamae K, Kimani D, Makale J, Morobe JM, Osoti V, Lambisia AW, Odundo C, Mwarumba S, Mutunga M, Bejon P, Tsofa B, Agoti CN, Ochola-oyier LI. An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams. Wellcome Open Res 2020;5:162. [DOI: 10.12688/wellcomeopenres.16063.2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Mariottini A, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C, Barilaro A, Massacesi L, Repice AM. Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis. J Neurol 2022. [PMID: 35239006 DOI: 10.1007/s00415-022-11003-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
362 Xie LM, Huang YF, Liu YL, Liang JQ, Deng W, Lin GL, Luo HM, Guo XG. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2. Biochem Genet 2022. [PMID: 35235083 DOI: 10.1007/s10528-022-10206-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Kim YI, Casel MAB, Choi YK. Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models. J Microbiol 2022;60:255-67. [PMID: 35235177 DOI: 10.1007/s12275-022-2033-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
364 Geromichalou EG, Trafalis DT, Dalezis P, Malis G, Psomas G, Geromichalos GD. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111805] [Reference Citation Analysis]
365 Hemmati SA, Tabein S. Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease. Computers in Biology and Medicine 2022;142:105228. [DOI: 10.1016/j.compbiomed.2022.105228] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Tuzer C, Karadag P, Yegit O, Eyice D, Oztop N, Can A, Demir S, Coskun R, Erdogdu Unal D, Olgac M, Buyukozturk S, Colakoglu B, Gelincik A. Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19. Allergy Asthma Proc 2022;43:106-15. [PMID: 35317887 DOI: 10.2500/aap.2022.43.210116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
367 Poston D, Weisblum Y, Hobbs A, Bieniasz PD. VPS29 Exerts Opposing Effects on Endocytic Viral Entry. mBio 2022;:e0300221. [PMID: 35229640 DOI: 10.1128/mbio.03002-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
368 Örs ED, Alkan ŞB, Öksüz A. Possible Effect of Astaxanthin on Obesity-related Increased COVID-19 Infection Morbidity and Mortality. CNF 2022;18:265-73. [DOI: 10.2174/1573401317666211011105732] [Reference Citation Analysis]
369 Alkady W, Elbahnasy K, Leiva V, Gad W. Classifying COVID-19 based on amino acids encoding with machine learning algorithms. Chemometrics and Intelligent Laboratory Systems 2022. [DOI: 10.1016/j.chemolab.2022.104535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
370 Pozdnyakova V, Weber B, Cheng S, Ebinger JE. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.006] [Reference Citation Analysis]
371 Chai C, Ng D, Chua WJ, Tung Y, Sindeh W, Ibrahim MA, Badlishah Sham SF, Tan S. Knowledge, Attitude, and Practices Among the General Population During the Later Stage of the COVID-19 Pandemic in Malaysia: A Cross-Sectional Study. RMHP 2022;Volume 15:389-401. [DOI: 10.2147/rmhp.s349798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
372 de Lima Gianfelice PR, Sovek Oyarzabal R, Cunha A, Vicensi Grzybowski JM, da Conceição Batista F, E. N. Macau E. The starting dates of COVID-19 multiple waves. Chaos 2022;32:031101. [DOI: 10.1063/5.0079904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
373 Yamani AH, Alraddadi BM, Almaghrabi RS, Amer AA, Mehdawi FS, Al-Hamzi MA, Aldajani MS, Alattas MS, Elsaed Ramadan AM, Wali GY, Alshukairi AN, Al Mutair A. Early use of tocilizumab in solid organ transplant recipients with COVID-19: A retrospective cohort study in Saudi Arabia. Immun Inflamm Dis 2022;10:e587. [PMID: 35029324 DOI: 10.1002/iid3.587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
374 Martins M, Boggiatto PM, Buckley A, Cassmann ED, Falkenberg S, Caserta LC, Fernandes MHV, Kanipe C, Lager K, Palmer MV, Diel DG. From Deer-to-Deer: SARS-CoV-2 is efficiently transmitted and presents broad tissue tropism and replication sites in white-tailed deer. PLoS Pathog 2022;18:e1010197. [PMID: 35312736 DOI: 10.1371/journal.ppat.1010197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
375 Pecora A, Malacari DA, Mozgovoj MV, Díaz MDLÁ, Peralta AV, Cacciabue M, Puebla AF, Carusso C, Mundo SL, Gonzalez Lopez Ledesma MM, Gamarnik AV, Rinaldi O, Vidal O, Mas J, Dus Santos MJ. Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires. Front Vet Sci 2022;9:790058. [DOI: 10.3389/fvets.2022.790058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
376 Fu L, Yao M, Liu X, Zheng D. Using bioinformatics and systems biology to discover common pathogenetic processes between sarcoidosis and COVID-19. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101597] [Reference Citation Analysis]
377 Sur UK, Santra C. Spectroscopy: a versatile sensing tool for cost-effective and rapid detection of novel coronavirus (COVID-19). emergent mater . [DOI: 10.1007/s42247-022-00358-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Silva LM, Riani LR, Silvério MS, Pereira-júnior ODS, Pittella F. Comparison of Rapid Nucleic Acid Extraction Methods for SARS-CoV-2 Detection by RT-qPCR. Diagnostics 2022;12:601. [DOI: 10.3390/diagnostics12030601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Kehinde IA, Egbeyemi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. J Biomol Struct Dyn 2022;:1-10. [PMID: 35220925 DOI: 10.1080/07391102.2022.2043938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
380 Ito GNW, Rodrigues VAC, Hümmelgen J, Meschino GSPG, Abou-Rejaile GM, Brenny ID, de Castro Júnior CR, Artigas RC, Munhoz JPS, Cardoso GC, Picheth GF. COVID-19 pathophysiology and ultrasound imaging: A multiorgan review. J Clin Ultrasound 2022. [PMID: 35218034 DOI: 10.1002/jcu.23160] [Reference Citation Analysis]
381 Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP). Viruses 2022;14:481. [DOI: 10.3390/v14030481] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
382 Zuhour M, Ismayilzade M, Dadacı M, Ince B. The Impact of Wearing a Face Mask during the COVID-19 Pandemic on Temporomandibular Joint: A Radiological and Questionnaire Assessment. Indian J Plast Surg. [DOI: 10.1055/s-0042-1743131] [Reference Citation Analysis]
383 Ren C, Gao Y, Zhang C, Zhou C, Hong Y, Qu M, Zhao Z, Du Y, Yang L, Liu B, Wang S, Han M, Shen Y, Liu Y. Respiratory Mucosal Immunity: Kinetics of Secretory Immunoglobulin A in Sputum and Throat Swabs From COVID-19 Patients and Vaccine Recipients. Front Microbiol 2022;13:782421. [DOI: 10.3389/fmicb.2022.782421] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Chen L, Ji Y, Wang Q, Fu M. Effects of traditional Chinese exercise on the treatment of COVID-19: A protocol for systematic review. Medicine (Baltimore) 2022;101:e28948. [PMID: 35212304 DOI: 10.1097/MD.0000000000028948] [Reference Citation Analysis]
385 Maffetone PB, Laursen PB. Rethinking COVID-19 and Beyond: Prevention, Remedies, and Recovery. Front Public Health 2022;10:748498. [DOI: 10.3389/fpubh.2022.748498] [Reference Citation Analysis]
386 Yue K, Yao B, Shi Y, Yang Y, Qian Z, Ci Y, Shi L. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity. Biochem Biophys Res Commun 2022;601:129-36. [PMID: 35245742 DOI: 10.1016/j.bbrc.2022.02.068] [Reference Citation Analysis]
387 Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, Manyane T, Komane L, Venter M, Jassat W, Goga A, Feucht U. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health 2022;6:294-302. [PMID: 35189083 DOI: 10.1016/S2352-4642(22)00027-X] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
388 Kupcewicz E, Mikla M, Kadučáková H, Grochans E, Valcarcel MDR, Cybulska AM. Correlation between Positive Orientation and Control of Anger, Anxiety and Depression in Nursing Students in Poland, Spain and Slovakia during the COVID-19 Pandemic. Int J Environ Res Public Health 2022;19:2482. [PMID: 35206674 DOI: 10.3390/ijerph19042482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
389 Ramírez-Rendon D, Passari AK, Ruiz-Villafán B, Rodríguez-Sanoja R, Sánchez S, Demain AL. Impact of novel microbial secondary metabolites on the pharma industry. Appl Microbiol Biotechnol 2022. [PMID: 35188588 DOI: 10.1007/s00253-022-11821-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
390 Armeanu DS, Gherghina SC, Andrei JV, Joldes CC. Modeling the impact of the COVID ‐19 outbreak on environment, health sector and energy market. Sustainable Development. [DOI: 10.1002/sd.2299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Premeaux TA, Yeung ST, Bukhari Z, Bowler S, Alpan O, Gupta R, Ndhlovu LC. Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. Front Immunol 2022;13:842740. [DOI: 10.3389/fimmu.2022.842740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
392 Rivera-olivero IA, Henríquez-trujillo AR, Kyriakidis NC, Ortiz-prado E, Laglaguano JC, Vallejo-janeta AP, Lozada T, Garcia-bereguiain MA; UDLA COVID-19 team. Diagnostic Performance of Seven Commercial COVID-19 Serology Tests Available in South America. Front Cell Infect Microbiol 2022;12:787987. [DOI: 10.3389/fcimb.2022.787987] [Reference Citation Analysis]
393 Simões RSQ, Rodríguez-Lázaro D. Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants. Int J Environ Res Public Health 2022;19:2392. [PMID: 35206580 DOI: 10.3390/ijerph19042392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
394 AlMalki FA, Albukhaty S, Alyamani AA, Khalaf MN, Thomas S. The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment. Environ Sci Pollut Res Int 2022. [PMID: 35175517 DOI: 10.1007/s11356-022-18868-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
395 Arora S, Grover V, Saluja P, Algarni YA, Saquib SA, Asif SM, Batra K, Alshahrani MY, Das G, Jain R, Ohri A. Literature Review of Omicron: A Grim Reality Amidst COVID-19. Microorganisms 2022;10:451. [DOI: 10.3390/microorganisms10020451] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
396 Zhang Y, Zheng L, Yang Y, Qu Y, Li YQ, Zhao M, Mu Y, Li W. Structural and energetic features of the dimerization of the main proteinase of SARS-CoV-2 using molecular dynamic simulations. Phys Chem Chem Phys 2022;24:4324-33. [PMID: 35107451 DOI: 10.1039/d1cp04630f] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Aukema W, Malhotra BR, Goddek S, Kämmerer U, Borger P, Mckernan K, Klement RJ. Bayes Lines Tool (BLT): a SQL-script for analyzing diagnostic test results with an application to SARS-CoV-2-testing. F1000Res 2021;10:369. [DOI: 10.12688/f1000research.51061.3] [Reference Citation Analysis]
398 Teimury A, Khameneh MT, Khaledi EM. Major coagulation disorders and parameters in COVID-19 patients. Eur J Med Res 2022;27:25. [PMID: 35168674 DOI: 10.1186/s40001-022-00655-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
399 Sulbaran G, Maisonnasse P, Amen A, Effantin G, Guilligay D, Dereuddre-Bosquet N, Burger JA, Poniman M, Grobben M, Buisson M, Dergan Dylon S, Naninck T, Lemaître J, Gros W, Gallouët AS, Marlin R, Bouillier C, Contreras V, Relouzat F, Fenel D, Thepaut M, Bally I, Thielens N, Fieschi F, Schoehn G, van der Werf S, van Gils MJ, Sanders RW, Poignard P, Le Grand R, Weissenhorn W. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection. Cell Rep Med 2022;3:100528. [PMID: 35233549 DOI: 10.1016/j.xcrm.2022.100528] [Reference Citation Analysis]
400 Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:107602962110566. [DOI: 10.1177/10760296211056648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
401 Zhang J, Li Q, Cruz Cosme RS, Gerzanich V, Tang Q, Simard JM, Zhao RY. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets. mBio 2022;:e0016922. [PMID: 35164548 DOI: 10.1128/mbio.00169-22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
402 Byadi S, Oblak D, Kassmi Y, Sadik K, Hachim ME, Podlipnik Č, Aboulmouhajir A. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2. J Biomol Struct Dyn 2022;:1-11. [PMID: 35168469 DOI: 10.1080/07391102.2022.2040594] [Reference Citation Analysis]
403 Rossetti GG, Ossorio MA, Rempel S, Kratzel A, Dionellis VS, Barriot S, Tropia L, Gorgulla C, Arthanari H, Thiel V, Mohr P, Gamboni R, Halazonetis TD. Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits. Sci Rep 2022;12:2505. [PMID: 35169179 DOI: 10.1038/s41598-022-06306-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
404 Langaliya A, Patel D, Shah A, Kumbhar A, Shah J, Shah S, Bhatt I, Dayala D, Gill RS, Patel S, Patel Y, Shah M, Shah M, Patel R, Agarwal A, Panchal D, Vachhani V. Endodontic Emergencies Encountered in a Tertiary Dental Hospital during the Periods of Prelockdown, Lockdown, and Sequential Unlock Phases of the First Wave of COVID-19 in Ahmedabad City, India. Int J Dent 2022;2022:5856267. [PMID: 35154323 DOI: 10.1155/2022/5856267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
405 Wijayanti N, Gazali FM, Supriyati E, Hakim MS, Arguni E, Daniwijaya MEW, Nuryastuti T, Nuhamunada M, Nabilla R, Haryana SM, Wibawa T. Evolutionary dynamics of SARS-CoV-2 circulating in Yogyakarta and Central Java, Indonesia: sequence analysis covering furin cleavage site (FCS) region of the spike protein. Int Microbiol 2022. [PMID: 35165816 DOI: 10.1007/s10123-022-00239-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
406 Afrasiabi A, Alinejad-rokny H, Khosh A, Rahnama M, Lovell N, Xu Z, Ebrahimi D. The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06046-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Ko K, Takahashi K, Nagashima S, E B, Ouoba S, Hussain MRA, Akita T, Sugiyama A, Sakaguchi T, Tahara H, Ohge H, Ohdan H, Kubo T, Ishikawa N, Takafuta T, Fujii Y, Mimori M, Okada F, Kishita E, Ariyoshi K, Kuwabara M, Tanaka J. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan. Sci Rep 2022;12:2419. [PMID: 35165301 DOI: 10.1038/s41598-022-04952-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
408 Najafi N, Soleimanjahi H, Shahali S, Pourkarim MR, Thijssen M, Fotouhi F, Bamdad T, Azadmanesh K, Nasiri Z, Afzali N, Jabbari MR, Yari A, Karimi H, Karbalaei Niya MH. Genomic and serological assessment of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in child labor. Pathogens and Global Health. [DOI: 10.1080/20477724.2022.2038052] [Reference Citation Analysis]
409 Galkin SO, Anisenko AN, Shadrina OA, Gottikh MB. Genetic Engineering Systems to Study Human Viral Pathogens from the Coronaviridae Family. Mol Biol 2022;56:72-89. [DOI: 10.1134/s0026893322010022] [Reference Citation Analysis]
410 Alali AH, Smaisem MS, Alsheikh AM, Alshareef AA, Smaisem FS, Alnahar BW, Hassouneh AK, Al-Tawfiq JA, Memish ZA. Myocardial injuries among patients with COVID-19: a systematic review. Infez Med 2021;29:345-54. [PMID: 35146339 DOI: 10.53854/liim-2903-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
411 Lyngse FP, Kirkeby C, Halasa T, Andreasen V, Skov RL, Møller FT, Krause TG, Mølbak K. Nationwide study on SARS-CoV-2 transmission within households from lockdown to reopening, Denmark, 27 February 2020 to 1 August 2020. Euro Surveill 2022;27. [PMID: 35144726 DOI: 10.2807/1560-7917.ES.2022.27.6.2001800] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
412 Kichatova VS, Asadi Mobarkhan FA, Potemkin IA, Zlobin SP, Perfilieva OM, Valuev-elliston VT, Ivanov AV, Solonin SA, Godkov MA, Belikova MG, Mikhailov MI, Kyuregyan KK. Assessment of Diagnostic Specificity of Anti-SARS-CoV-2 Antibody Tests and Their Application for Monitoring of Seroconversion and Stability of Antiviral Antibody Response in Healthcare Workers in Moscow. Microorganisms 2022;10:429. [DOI: 10.3390/microorganisms10020429] [Reference Citation Analysis]
413 da Silva Torres MK, Bichara CDA, de Almeida MDNDS, Vallinoto MC, Queiroz MAF, Vallinoto IMVC, dos Santos EJM, de Carvalho CAM, Vallinoto ACR. The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic. Front Microbiol 2022;13:789882. [DOI: 10.3389/fmicb.2022.789882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
414 Ebihara T, Matsumoto H, Matsubara T, Togami Y, Nakao S, Matsuura H, Kojima T, Sugihara F, Okuzaki D, Hirata H, Yamamura H, Ogura H. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis. Front Immunol 2021;12:798338. [PMID: 35095877 DOI: 10.3389/fimmu.2021.798338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
415 Sisay A, Abera A, Dufera B, Endrias T, Tasew G, Tesfaye A, Hartnack S, Beyene D, Desta AF. Diagnostic accuracy of three commercially available one step RT-PCR assays for the detection of SARS-CoV-2 in resource limited settings. PLoS One 2022;17:e0262178. [PMID: 35051204 DOI: 10.1371/journal.pone.0262178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
416 Montaño MA, Bemer MJ, Heller KB, Meisner A, Marfatia Z, Rechkina EA, Padgett LR, Ahls CL, Rains D, Hao L, Hsiang TY, Cangelosi GA, Greninger AL, Cantera JL, Golden A, Peck RB, Boyle DS, Gale M Jr, Drain PK. Performance of anterior nares and tongue swabs for nucleic acid, Nucleocapsid, and Spike antigen testing for detecting SARS-CoV-2 against nasopharyngeal PCR and viral culture. Int J Infect Dis 2022;117:287-94. [PMID: 35149246 DOI: 10.1016/j.ijid.2022.02.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Alnima T, Mulder MMG, van Bussel BCT, Ten Cate H. COVID-19 Coagulopathy: From Pathogenesis to Treatment. Acta Haematol 2022;145:282-96. [PMID: 35499460 DOI: 10.1159/000522498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
418 Zhou Y, Draghici A, Abbas J, Mubeen R, Boatca ME, Salam MA. Social Media Efficacy in Crisis Management: Effectiveness of Non-pharmaceutical Interventions to Manage COVID-19 Challenges. Front Psychiatry 2022;12:626134. [DOI: 10.3389/fpsyt.2021.626134] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 38.0] [Reference Citation Analysis]
419 Fridman SE, Di Giampietro P, Sensoli A, Beleffi M, Bucce C, Salvatore V, Giostra F, Gianstefani A. Prediction of Conventional Oxygen Therapy Failure in COVID-19 Patients With Acute Respiratory Failure by Assessing Serum Lactate Concentration, PaO2/FiO2 Ratio, and Body Temperature. Cureus. [DOI: 10.7759/cureus.21987] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
420 Odun-ayo F, Reddy L. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics. Gastroenterology Insights 2022;13:35-59. [DOI: 10.3390/gastroent13010006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
421 Pan Z, Feng Y, Wang Z, Lei Z, Han Q, Zhang J. MERS-CoV nsp1 impairs the cellular metabolic processes by selectively downregulating mRNAs in a novel granules. Virulence 2022;13:355-69. [DOI: 10.1080/21505594.2022.2032928] [Reference Citation Analysis]
422 Himmel M, Frey S. SARS-CoV-2: International Investigation Under the WHO or BWC. Front Public Health 2022;9:636679. [DOI: 10.3389/fpubh.2021.636679] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Festa J, Singh H, Hussain A, Da Boit M. Elderberries as a potential supplement to improve vascular function in a SARS-CoV-2 environment. J Food Biochem 2022;:e14091. [PMID: 35118699 DOI: 10.1111/jfbc.14091] [Reference Citation Analysis]
424 Vanmechelen B, Logist AS, Wawina-Bokalanga T, Verlinden J, Martí-Carreras J, Geenen C, Slechten B, Cuypers L, André E, Baele G, Maes P. Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe. Microbiol Resour Announc 2022;:e0116121. [PMID: 35112910 DOI: 10.1128/mra.01161-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
425 Barroso R, Vieira-pires A, Antunes A, Fidalgo-carvalho I. Susceptibility of Pets to SARS-CoV-2 Infection: Lessons from a Seroepidemiologic Survey of Cats and Dogs in Portugal. Microorganisms 2022;10:345. [DOI: 10.3390/microorganisms10020345] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
426 Lin L, Wang Y, Li Q, Hu M, Shi Y. Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence. Cell Death Differ 2022;29:263-5. [PMID: 35039647 DOI: 10.1038/s41418-021-00909-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Brierley L, Nanni F, Polka JK, Dey G, Pálfy M, Fraser N, Coates JA. Tracking changes between preprint posting and journal publication during a pandemic. PLoS Biol 2022;20:e3001285. [PMID: 35104285 DOI: 10.1371/journal.pbio.3001285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
428 Anjos D, Fiaccadori FS, Servian CDP, da Fonseca SG, Guilarde AO, Borges MASB, Franco FC, Ribeiro BM, Souza M. SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients. Journal of Clinical Virology Plus 2022;2:100059. [DOI: 10.1016/j.jcvp.2021.100059] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
429 Brindha S, Kuroda Y. A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein. Int J Mol Sci 2022;23:1703. [PMID: 35163624 DOI: 10.3390/ijms23031703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
430 Liang JJ, Pitsillou E, Ververis K, Guallar V, Hung A, Karagiannis TC. Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition. Chemical Physics Letters 2022;788:139294. [DOI: 10.1016/j.cplett.2021.139294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
431 Yin J, Norvihoho LK, Zhou Z, Chen B, Wu W. Investigation on the evaporation and dispersion of human respiratory droplets with COVID-19 virus. International Journal of Multiphase Flow 2022;147:103904. [DOI: 10.1016/j.ijmultiphaseflow.2021.103904] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Laza R, Lazureanu VE, Musta VF, Nicolescu ND, Vernic C, Tudor A, Critu R, Vilceanu L, Paczeyka R, Bica Profir V, Marinescu AR, Mocanu A, Cut TG, Lighezan DF, Baditoiu LM. COVID-19 Independent Risk Factors for Unfavorable Disease Progression: A Cross-Sectional Study from Romania. IJGM 2022;Volume 15:2025-36. [DOI: 10.2147/ijgm.s350920] [Reference Citation Analysis]
433 Alenzi KA, Albalawi WF, Alanazi TS, Alanazi NS, Alsuhaibani DS, Almuwallad N, Alshammari TM. Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.02.015] [Reference Citation Analysis]
434 Jung E, Lee G. Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
435 Gao S, Huang T, Song L, Xu S, Cheng Y, Cherukupalli S, Kang D, Zhao T, Sun L, Zhang J, Zhan P, Liu X. Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors. Acta Pharm Sin B 2022;12:581-99. [PMID: 34485029 DOI: 10.1016/j.apsb.2021.08.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
436 Liu S, Ng JK, Moon EH, Morgan D, Woodhouse N, Agrawal D, Chan L, Chhabra R. Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak. Ophthalmol Eye Dis 2022;14:251584142110708. [DOI: 10.1177/25158414211070881] [Reference Citation Analysis]
437 Feizollahi P, matin S, Roghani SA, Mostafaei S, Safarzadeh E, Taghadosi M. Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19. Inflammopharmacol. [DOI: 10.1007/s10787-021-00908-6] [Reference Citation Analysis]
438 Baysson H, Pennachio F, Wisniak A, Zabella ME, Pullen N, Collombet P, Lorthe E, Joost S, Balavoine JF, Bachmann D, Azman A, Pittet D, Chappuis F, Kherad O, Kaiser L, Guessous I, Stringhini S; Specchio-COVID19 study group. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland. BMJ Open 2022;12:e055515. [PMID: 35105645 DOI: 10.1136/bmjopen-2021-055515] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
439 Chandra R, Jain A, Singh Chauhan D. Deep learning via LSTM models for COVID-19 infection forecasting in India. PLoS One 2022;17:e0262708. [PMID: 35089976 DOI: 10.1371/journal.pone.0262708] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
440 Murae M, Shimizu Y, Yamamoto Y, Kobayashi A, Houri M, Inoue T, Irie T, Gemba R, Kondo Y, Nakano Y, Miyazaki S, Yamada D, Saitoh A, Ishii I, Onodera T, Takahashi Y, Wakita T, Fukasawa M, Noguchi K. The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione. Biochem Biophys Res Commun 2022;597:30-6. [PMID: 35123263 DOI: 10.1016/j.bbrc.2022.01.106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
441 Yang S, Dong Q, Li S, Cheng Z, Kang X, Ren D, Xu C, Zhou X, Liang P, Sun L, Zhao J, Jiao Y, Han T, Liu Y, Qian Y, Liu Y, Huang X, Qu J. Persistence of SARS-CoV-2 RNA in wastewater after the end of the COVID-19 epidemics. J Hazard Mater 2022;429:128358. [PMID: 35123131 DOI: 10.1016/j.jhazmat.2022.128358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
442 Mohammed SA, Shaaban EIA. Efficacious nanomedicine track toward combating COVID-19. Nanotechnology Reviews 2022;11:680-98. [DOI: 10.1515/ntrev-2022-0036] [Reference Citation Analysis]
443 Ostrycharz E, Hukowska-szematowicz B. New Insights into the Role of the Complement System in Human Viral Diseases. Biomolecules 2022;12:226. [DOI: 10.3390/biom12020226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
444 Escobedo RA, Kaushal D, Singh DK. Insights Into the Changing Landscape of Coronavirus Disease 2019. Front Cell Infect Microbiol 2021;11:761521. [PMID: 35083164 DOI: 10.3389/fcimb.2021.761521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
445 Puerta-Guardo H. Editorial: From Pathogenic Infections to Inflammation and Disease - the Tumultuous Road of the 'Cytokine Storm'. Front Cell Infect Microbiol 2021;11:827151. [PMID: 35083169 DOI: 10.3389/fcimb.2021.827151] [Reference Citation Analysis]
446 Jeon DY, Jang C. Detection of anti-SARS-CoV-2 antibody for the diagnosis of past-COVID-19 infection cases using a liquid-crystal-based immunosensor. Liquid Crystals. [DOI: 10.1080/02678292.2022.2028315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
447 Sudhakar M, Winfred SB, Meiyazhagan G, Venkatachalam DP. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem 2022. [PMID: 35084674 DOI: 10.1007/s11010-022-04356-w] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
448 Ibrahim MAA, Abdelrahman AHM, Jaragh-alhadad LA, Atia MAM, Alzahrani OR, Ahmed MN, Moustafa MS, Soliman MES, Shawky AM, Paré PW, Hegazy MF, Sidhom PA. Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study. Pharmaceuticals 2022;15:153. [DOI: 10.3390/ph15020153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
449 Kim Y, Jang G, Lee D, Kim N, Seon JW, Kim YH, Lee C. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry. Arch Virol 2022. [PMID: 35079901 DOI: 10.1007/s00705-021-05343-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
450 Wandtke T, Wędrowska E, Szczur M, Przybylski G, Libura M, Kopiński P. Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2. Int J Mol Sci 2022;23:1412. [PMID: 35163338 DOI: 10.3390/ijms23031412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
451 Bai Y, Wang Q, Liu M, Bian L, Liu J, Gao F, Mao Q, Wang Z, Wu X, Xu M, Liang Z. The next major emergent infectious disease: reflections on vaccine emergency development strategies. Expert Rev Vaccines 2022;:1-11. [PMID: 35080441 DOI: 10.1080/14760584.2022.2027240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
452 Hyun YS, Lee YH, Jo HA, Baek IC, Kim SM, Sohn HJ, Kim TG. Comprehensive Analysis of CD4+ T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II. Front Immunol 2021;12:774491. [PMID: 35069546 DOI: 10.3389/fimmu.2021.774491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
453 Liu LT, Tsai JJ, Chen CH, Lin PC, Tsai CY, Tsai YY, Hsu MC, Chuang WL, Chang JM, Hwang SJ, Chong IW. Isolation and Identification of a Rare Spike Gene Double-Deletion SARS-CoV-2 Variant From the Patient With High Cycle Threshold Value. Front Med (Lausanne) 2021;8:822633. [PMID: 35071285 DOI: 10.3389/fmed.2021.822633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
454 Pan R, Kindler E, Cao L, Zhou Y, Zhang Z, Liu Q, Ebert N, Züst R, Sun Y, Gorbalenya AE, Perlman S, Thiel V, Chen Y, Guo D. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition. mBio 2022;:e0366221. [PMID: 35073761 DOI: 10.1128/mbio.03662-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
455 Kuchipudi SV, Surendran-nair M, Ruden RM, Yon M, Nissly RH, Vandegrift KJ, Nelli RK, Li L, Jayarao BM, Maranas CD, Levine N, Willgert K, Conlan AJK, Olsen RJ, Davis JJ, Musser JM, Hudson PJ, Kapur V. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer. Proc Natl Acad Sci USA 2022;119:e2121644119. [DOI: 10.1073/pnas.2121644119] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 54.0] [Reference Citation Analysis]
456 Zhao LP, Roychoudhury P, Gilbert P, Schiffer J, Lybrand TP, Payne TH, Randhawa A, Thiebaud S, Mills M, Greninger A, Pyo CW, Wang R, Li R, Thomas A, Norris B, Nelson WC, Jerome KR, Geraghty DE. Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk. Sci Rep 2022;12:1206. [PMID: 35075180 DOI: 10.1038/s41598-021-04376-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
457 Mantzourani C, Vasilakaki S, Gerogianni V, Kokotos G. The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. Expert Opinion on Drug Discovery. [DOI: 10.1080/17460441.2022.2029843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Ngo ST, Nguyen TH, Tung NT, Mai BK. Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro. RSC Adv 2022;12:3729-37. [PMID: 35425393 DOI: 10.1039/d1ra08752e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
459 Hatami P, Nicknam Asl H, Aryanian Z. Cutaneous Manifestations of COVID-19 in Children: Practical Points for Clinicians. J Skin Stem Cell 2022;8. [DOI: 10.5812/jssc.122260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
460 Lee JY, Shin YS, Jeon S, Lee SI, Cho J, Myung S, Jang MS, Kim S, Song JH, Kim HR, Park CM. Synthesis and biological evaluation of 2‐benzylaminoquinazolin ‐4( 3 H )‐one derivatives as a potential treatment for SARS‐CoV ‐2. Bulletin Korean Chem Soc. [DOI: 10.1002/bkcs.12470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Hussain S, Afzal F, Afzal D, Thapa DK, Ali H. The Study about Relationship of Direct Form of Topological Indices via M-Polynomial and Computational Analysis of Dexamethasone. Journal of Chemistry 2022;2022:1-10. [DOI: 10.1155/2022/4912143] [Reference Citation Analysis]
462 Perbolianachis P, Ferla D, Arce R, Ferreiro I, Costábile A, Paz M, Simón D, Moreno P, Cristina J. Phylogenetic analysis of SARS-CoV-2 viruses circulating in the South American region: genetic relations and vaccine strain match. Virus Res 2022;:198688. [PMID: 35074431 DOI: 10.1016/j.virusres.2022.198688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
463 Dasovich M, Zhuo J, Goodman JA, Thomas A, McPherson RL, Jayabalan AK, Busa VF, Cheng SJ, Murphy BA, Redinger KR, Alhammad YMO, Fehr AR, Tsukamoto T, Slusher BS, Bosch J, Wei H, Leung AKL. High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain. ACS Chem Biol 2022;17:17-23. [PMID: 34904435 DOI: 10.1021/acschembio.1c00721] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
464 Cui Q, Garcia G Jr, Zhang M, Wang C, Li H, Zhou T, Sun G, Arumugaswami V, Shi Y. Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection. iScience 2022;25:103684. [PMID: 34977495 DOI: 10.1016/j.isci.2021.103684] [Reference Citation Analysis]
465 Yerukala Sathipati S, Shukla SK, Ho SY. Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2. iScience 2022;25:103560. [PMID: 34877480 DOI: 10.1016/j.isci.2021.103560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
466 Jia M, Taylor TM, Senger SM, Ovissipour R, Bertke AS. SARS-CoV-2 Remains Infectious on Refrigerated Deli Food, Meats, and Fresh Produce for up to 21 Days. Foods 2022;11:286. [DOI: 10.3390/foods11030286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
467 Song Y, Deng Y, Wang H, Bei Z, Gu H, Zhao H, Wang H, Zhang D, Xu L, Wang B, Li Y, Wang H. Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro. Molecules 2022;27:712. [PMID: 35163977 DOI: 10.3390/molecules27030712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Jin Y, Hou C, Li Y, Zheng K, Wang C. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2. Front Immunol 2022;12:821538. [DOI: 10.3389/fimmu.2021.821538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
469 Sun C, Nie Y, Cui X, Zhang F, Liu Y. Neonatal acute ethanol intoxication during the epidemic of COVID-19: a case report. BMC Pediatr 2022;22. [DOI: 10.1186/s12887-022-03128-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Barreto-vieira DF, da Silva MAN, de Almeida ALT, Rasinhas ADC, Monteiro ME, Miranda MD, Motta FC, Siqueira MM, Girard-dias W, Archanjo BS, Bozza PT, L. Souza TM, Gomes Dias SS, Soares VC, Barth OM. SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System. Viruses 2022;14:201. [DOI: 10.3390/v14020201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
471 Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J. Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Front Pharmacol 2022;12:784335. [DOI: 10.3389/fphar.2021.784335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Liang S, Liu X, Zhang S, Li M, Zhang Q, Chen J. Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations. Phys Chem Chem Phys 2022;24:1743-59. [PMID: 34985081 DOI: 10.1039/d1cp04361g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
473 Sanchez JN, Reyes GA, Martínez-López B, Johnson CK. Impact of social distancing on early SARS-CoV-2 transmission in the United States. Zoonoses Public Health 2022. [PMID: 35048530 DOI: 10.1111/zph.12909] [Reference Citation Analysis]
474 Liu X, Guo L, Xu T, Lu X, Ma M, Sheng W, Wu Y, Peng H, Cao L, Zheng F, Huang S, Yang Z, Du J, Shi M, Guo D. A comprehensive evolutionary and epidemiological characterization of insertion and deletion mutations in SARS-CoV-2 genomes. Virus Evol 2021;7:veab104. [PMID: 35039785 DOI: 10.1093/ve/veab104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
475 Fahnøe U, Pham LV, Fernandez-antunez C, Costa R, Rivera-rangel LR, Galli A, Feng S, Mikkelsen LS, Gottwein JM, Scheel TKH, Ramirez S, Bukh J. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication. Viruses 2022;14:172. [DOI: 10.3390/v14020172] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
476 Malik P, Jain S, Jain P, Kumawat J, Dwivedi J, Kishore D. A comprehensive update on the structure and synthesis of potential drug targets for combating the coronavirus pandemic caused by SARS-CoV-2. Arch Pharm (Weinheim) 2022;:e2100382. [PMID: 35040187 DOI: 10.1002/ardp.202100382] [Reference Citation Analysis]
477 Jeong BS, Cha JS, Hwang I, Kim U, Adolf-Bryfogle J, Coventry B, Cho HS, Kim KD, Oh BH. Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants. MAbs 2022;14:2021601. [PMID: 35030983 DOI: 10.1080/19420862.2021.2021601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
478 Kumar S, Bansal K. Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study. Virus Res 2022;308:198642. [PMID: 34822953 DOI: 10.1016/j.virusres.2021.198642] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
479 Jukič M, Kores K, Janežič D, Bren U. Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints. Front Chem 2021;9:757826. [PMID: 35028304 DOI: 10.3389/fchem.2021.757826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
480 Khadka B, Gupta RS. Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses. PeerJ 2021;9:e12434. [PMID: 35028194 DOI: 10.7717/peerj.12434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
481 Sulimov A, Kutov D, Ilin I, Sulimov V. Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations. Nanomaterials (Basel) 2022;12:274. [PMID: 35055291 DOI: 10.3390/nano12020274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
482 Vollenberg R, Tepasse P, Kühn JE, Hennies M, Strauss M, Rennebaum F, Schomacher T, Boeckel G, Lorentzen E, Bokemeyer A, Nowacki TM. Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2. Biomedicines 2022;10:171. [DOI: 10.3390/biomedicines10010171] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
483 Gopalakrishnan A, Hussaindeen JR, Sivaraman V, Swaminathan M, Wong YL, Armitage JA, Gentle A, Backhouse S. Prevalence of myopia among urban and suburban school children in Tamil Nadu, South India: findings from the Sankara Nethralaya Tamil Nadu Essilor Myopia (STEM) Study. Ophthalmic Physiol Opt 2022. [PMID: 35019150 DOI: 10.1111/opo.12943] [Reference Citation Analysis]
484 Jiang Y, Rubin L, Peng T, Liu L, Xing X, Lazarovici P, Zheng W. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy. Int J Biol Sci 2022;18:459-72. [PMID: 35002503 DOI: 10.7150/ijbs.59272] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 20.0] [Reference Citation Analysis]
485 Teima AAA, Amer AA, Mohammed LI, Kasemy ZA, Aloshari SH, Ahmed MM, Abuamer A, Shabaan A, Elzohry HA, Abdelwahab SF, Abdallah HM, Abdelmageed SM, Sakr MA, Abdel-Samiee M. A cross-sectional study of gastrointestinal manifestations in COVID-19 Egyptian patients. Ann Med Surg (Lond) 2022;:103234. [PMID: 35035951 DOI: 10.1016/j.amsu.2021.103234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
486 Li J, Du P, Yang L, Zhang J, Song C, Chen D, Song Y, Ding N, Hua M, Han K, Song R, Xie W, Chen Z, Wang X, Liu J, Xu Y, Gao G, Wang Q, Pu L, Di L, Li J, Yue J, Han J, Zhao X, Yan Y, Yu F, Wu AR, Zhang F, Gao YQ, Huang Y, Wang J, Zeng H, Chen C. Two-step fitness selection for intra-host variations in SARS-CoV-2. Cell Rep 2022;38:110205. [PMID: 34982968 DOI: 10.1016/j.celrep.2021.110205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
487 Qi X, Wang J, Liu J, Amporfro DA, Wang K, Liu H, Shah S, Wu Q, Hao Y. Factors associated with peritraumatic stress symptoms among the frontline healthcare workers during the outbreak of COVID-19 in China. BMJ Open 2022;12:e047753. [DOI: 10.1136/bmjopen-2020-047753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
488 Nudelman G, Kamble SV, Otto K. Using Protection Motivation Theory to Predict Adherence to COVID-19 Behavioral Guidelines. Behav Med 2022;:1-10. [PMID: 35000566 DOI: 10.1080/08964289.2021.2021383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
489 Saegerman C, Diep AN, Renault V, Donneau A, Stamatakis L, Coppieters W, Michel F, Breuer C, Dandoy M, Ek O, Gourzones C, Schyns J, Goffin E, Minner F, Durkin K, Artesi M, Bours V, Bureau F, Gillet L. A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers. Commun Med 2022;2. [DOI: 10.1038/s43856-021-00067-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
490 Deshpande PS, Abraham IE, Pitamberwale A, Dhote RH. Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies. Viral Immunol 2022. [PMID: 35007431 DOI: 10.1089/vim.2020.0313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Benahmed AG, Gasmi A, Anzar W, Arshad M, Bjørklund G. Improving safety in dental practices during the COVID-19 pandemic. Health Technol (Berl) 2022;:1-10. [PMID: 35036281 DOI: 10.1007/s12553-021-00627-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
492 Rashid TU, Sharmeen S, Biswas S. Effectiveness of N95 Masks against SARS-CoV-2: Performance Efficiency, Concerns, and Future Directions. ACS Chem Health Saf . [DOI: 10.1021/acs.chas.1c00016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
493 Talukder ME, Alam F, Pervez MN, Jiangming W, Hassan F, Stylios GK, Naddeo V, Song H. New generation washable PES membrane face mask for virus filtration. Nanocomposites 2022;8:13-23. [DOI: 10.1080/20550324.2021.2008209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
494 Abdelhakam DA, Badr FM, Abd El Monem Teama M, Bahig Elmihi NM, El-Mohamdy MA. Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19. Biomed Rep 2022;16:13. [PMID: 34987797 DOI: 10.3892/br.2021.1496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
495 Huang KA, Zhou D, Tan TK, Chen C, Duyvesteyn HME, Zhao Y, Ginn HM, Qin L, Rijal P, Schimanski L, Donat R, Harding A, Gilbert-Jaramillo J, James W, Tree JA, Buttigieg K, Carroll M, Charlton S, Lien CE, Lin MY, Chen CP, Cheng SH, Chen X, Lin TY, Fry EE, Ren J, Ma C, Townsend AR, Stuart DI. Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2. Theranostics 2022;12:1-17. [PMID: 34987630 DOI: 10.7150/thno.65563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Sattur SS, Sattur IS. COVID-19 Infection: Impact on Hair. Indian J Plast Surg 2021;54:521-6. [PMID: 34984095 DOI: 10.1055/s-0041-1740289] [Reference Citation Analysis]
497 Feng T, Nie C, Peng P, Lu H, Wang T, Li P, Huang W. Nanoagent-based theranostic strategies against human coronaviruses. Nano Res 2022;:1-15. [PMID: 35003529 DOI: 10.1007/s12274-021-3949-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 García-escobar A, Vera-vera S, Jurado-román A, Jiménez-valero S, Galeote G, Moreno R. Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19. Biomolecules 2022;12:76. [DOI: 10.3390/biom12010076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
499 Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM, Al-Hemaid F. Artesunate induces substantial topological alterations in the SARS-CoV-2 Nsp1 protein structure. J King Saud Univ Sci 2022;:101810. [PMID: 35002180 DOI: 10.1016/j.jksus.2021.101810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
500 Zhao X, Chen D, Li X, Griffith L, Chang J, An P, Guo JT. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development. J Mol Biol 2022;:167438. [PMID: 34990653 DOI: 10.1016/j.jmb.2021.167438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
501 Amoutzias GD, Nikolaidis M, Tryfonopoulou E, Chlichlia K, Markoulatos P, Oliver SG. The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2. Viruses 2022;14:78. [PMID: 35062282 DOI: 10.3390/v14010078] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
502 Zhang J, Qiao Y, Zhang Y; Faculty of Science, Beijing University of Technology, Beijing 100124, China. . MBE 2022;19:4911-32. [DOI: 10.3934/mbe.2022230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Jackson WM, Price JC, Eisler L, Sun LS, Lee JJ. COVID-19 in Pediatric Patients: A Systematic Review. J Neurosurg Anesthesiol 2022;34:141-7. [PMID: 34870638 DOI: 10.1097/ANA.0000000000000803] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
504 Kim YI, Park IJ. Surgical safety in the COVID-19 era: present and future considerations. Ann Surg Treat Res 2022;102:295. [DOI: 10.4174/astr.2022.102.6.295] [Reference Citation Analysis]
505 Yin J, Li C, Ye C, Ruan Z, Liang Y, Li Y, Wu J, Luo Z. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
506 Suminda GGD, Bhandari S, Won Y, Goutam U, Kanth Pulicherla K, Son Y, Ghosh M. High-throughput sequencing technologies in the detection of livestock pathogens, diagnosis, and zoonotic surveillance. Computational and Structural Biotechnology Journal 2022;20:5378-92. [DOI: 10.1016/j.csbj.2022.09.028] [Reference Citation Analysis]
507 Shankaranarayanan A, Wei H. . MBE 2022;19:11324-44. [DOI: 10.3934/mbe.2022527] [Reference Citation Analysis]
508 Kumar S, Choudhary M. Structure-based design and synthesis of copper( ii ) complexes as antivirus drug candidates targeting SARS CoV-2 and HIV. New J Chem 2022;46:7128-43. [DOI: 10.1039/d2nj00703g] [Reference Citation Analysis]
509 Ji W, Li Y, Peng H, Zhao R, Zhang X. Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases. Adv Drug Deliv Rev 2022;180:114029. [PMID: 34752841 DOI: 10.1016/j.addr.2021.114029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
510 Kokkotis G, Kitsou K, Xynogalas I, Spoulou V, Magiorkinis G, Trontzas I, Trontzas P, Poulakou G, Syrigos K, Bamias G. Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments. Aliment Pharmacol Ther 2022;55:154-67. [PMID: 34881430 DOI: 10.1111/apt.16717] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
511 Xie S, Liu M, Jiang R, Lin H, Zhang W, Li B, Su J, Ke F, Zhang Q, Shi Z, Yang X. Fish ACE2 is not susceptible to SARS-CoV-2. Virologica Sinica 2022. [DOI: 10.1016/j.virs.2022.01.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 Sanna V, Satta S, Hsiai T, Sechi M. Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
513 Lee J, Hong SW, Kim K. Mental Health of Adolescents and Subjective Economic Deterioration Caused by COVID-19 in Korea. J Korean Med Sci 2022;37:e268. [DOI: 10.3346/jkms.2022.37.e268] [Reference Citation Analysis]
514 邓 淑. Characteristics of Spatial and Temporal Distribution and Influencing Factors of COVID-19—A Case Study of Shijiazhuang City. AAM 2022;11:2747-63. [DOI: 10.12677/aam.2022.115291] [Reference Citation Analysis]
515 Agathokleous E, Barceló D, Iavicoli I, Tsatsakis A, Calabrese EJ. Disinfectant-induced hormesis: An unknown environmental threat of the application of disinfectants to prevent SARS-CoV-2 infection during the COVID-19 pandemic? Environ Pollut 2022;292:118429. [PMID: 34743965 DOI: 10.1016/j.envpol.2021.118429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
516 Wei J, Hui A. Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine. Life (Basel) 2022;12:57. [PMID: 35054450 DOI: 10.3390/life12010057] [Reference Citation Analysis]
517 Srivastav AK, Jaiswal J, Kumar U. In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2. J Biomol Struct Dyn 2021;:1-12. [PMID: 34971338 DOI: 10.1080/07391102.2021.2023048] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
518 Rainey A, Pierce A, Deng X, Actis LA, Smith P, Kiss AJ, Wilson TJ. Validation and deployment of a direct saliva real-time RT-PCR test on pooled samples for COVID-19 surveillance testing. PLoS One 2021;16:e0261956. [PMID: 34969053 DOI: 10.1371/journal.pone.0261956] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
519 Urushadze L, Babuadze G, Shi M, Escobar LE, Mauldin MR, Natradeze I, Machablishvili A, Kutateladze T, Imnadze P, Nakazawa Y, Velasco-Villa A. A Cross Sectional Sampling Reveals Novel Coronaviruses in Bat Populations of Georgia. Viruses 2021;14:72. [PMID: 35062276 DOI: 10.3390/v14010072] [Reference Citation Analysis]
520 Pourkarim F, Pourtaghi-Anvarian S, Rezaee H. Molnupiravir: A new candidate for COVID-19 treatment. Pharmacol Res Perspect 2022;10:e00909. [PMID: 34968008 DOI: 10.1002/prp2.909] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
521 Polat O, Berber M. The Status of Healthcare Professionals’ Having COVID-19 Vaccine and Evaluation of Its Side Effects: A Pandemic Hospital Experience. Euras J Fam Med 2021;10:203-10. [DOI: 10.33880/ejfm.2021100406] [Reference Citation Analysis]
522 Shapiro JT, Mollerup S, Jensen RH, Olofsson JK, Nguyen ND, Hansen TA, Vinner L, Monadjem A, McCleery RA, Hansen AJ. Metagenomic Analysis Reveals Previously Undescribed Bat Coronavirus Strains in Eswatini. Ecohealth 2021. [PMID: 34970712 DOI: 10.1007/s10393-021-01567-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
523 Ebenezer O, Bodede O, Awolade P, Jordaan MA, Ogunsakin RE, Shapi M. Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis. Acta Pharmaceutica 2022;72:199-224. [DOI: 10.2478/acph-2022-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Tapia-Conyer R, Valdez-Vázquez RR, Lomelín-Gascón J, Saucedo-Martínez R, Martinez-Juarez LA, Gallardo-Rincón H. Rapid establishment of a dedicated COVID-19 hospital in Mexico city during a public health crisis. Hosp Pract (1995) 2021;:1-5. [PMID: 34894978 DOI: 10.1080/21548331.2021.2017644] [Reference Citation Analysis]
525 Parra-martos L, Cobacho-salmoral O, Martínez-urbano J. COVID-19 en el paciente en diálisis. Una revisión sistemática. Enferm Nefrol 2021;24:351-63. [DOI: 10.37551/s2254-28842021030] [Reference Citation Analysis]
526 de Sousa AR, Teixeira JRB, Palma EMS, Moreira WC, Santos MB, de Carvalho HEF, Almeida ÉS, Florencio RMS, de Queiroz AM, Merces MCD, Mota TN, Araújo IFM, Silva JCD, Dos Santos SD, Camargo ELS, Lourenção LG, da Silva RAR, Carvalho ESS, Lua I, Barros S, de Araújo TM, Oliveira MAF, Pereira Á, Abreu W, da Cruz Sequeira CA. Psychological Distress in Men during the COVID-19 Pandemic in Brazil: The Role of the Sociodemographic Variables, Uncertainty, and Social Support. Int J Environ Res Public Health 2021;19:350. [PMID: 35010610 DOI: 10.3390/ijerph19010350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
527 Xu S, Wang Y, Wang Y, Zhang C, Hong Q, Gu C, Xu R, Wang T, Yang Y, Zang J, Zhou Y, Li Z, Liu Q, Zhou B, Bai L, Zhu Y, Deng Q, Wang H, Lavillette D, Wong G, Xie Y, Cong Y, Huang Z. Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein. Emerg Microbes Infect 2021;:1-51. [PMID: 34964428 DOI: 10.1080/22221751.2021.2024455] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
528 Ghasemitarei M, Privat-Maldonado A, Yusupov M, Rahnama S, Bogaerts A, Ejtehadi MR. Effect of Cysteine Oxidation in SARS-CoV-2 Receptor-Binding Domain on Its Interaction with Two Cell Receptors: Insights from Atomistic Simulations. J Chem Inf Model 2021. [PMID: 34965734 DOI: 10.1021/acs.jcim.1c00853] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
529 Johansson AM, Malhotra U, Kim YG, Gomez R, Krist MP, Wald A, Koelle DM, Kwok WW, Sant AJ. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals. PLoS Pathog 2021;17:e1010203. [DOI: 10.1371/journal.ppat.1010203] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
530 Zandi M. Diagnosis of COVID-19: hemagglutinin-esterase gene is used for molecular assays? Expert Rev Mol Diagn 2021;:1. [PMID: 34913783 DOI: 10.1080/14737159.2022.2020104] [Reference Citation Analysis]
531 Svobodova M, Skouridou V, Jauset-Rubio M, Viéitez I, Fernández-Villar A, Cabrera Alvargonzalez JJ, Poveda E, Bofill CB, Sans T, Bashammakh A, Alyoubi AO, O'Sullivan CK. Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen. ACS Omega 2021;6:35657-66. [PMID: 34957366 DOI: 10.1021/acsomega.1c05521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
532 Vijayan P P, P G C, Abraham P, George JS, Maria HJ, T S, Thomas S. Nanocoatings: Universal antiviral surface solution against COVID-19. Prog Org Coat 2022;163:106670. [PMID: 34955586 DOI: 10.1016/j.porgcoat.2021.106670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
533 Liu J, Li S, Zhou H, Hu C, Yue Z, Lv G. Clinical Characteristics and Laboratory Testing of Patients With COVID19: A Retrospective Analysis. acupunct electrother res 2021;47:81-90. [DOI: 10.3727/036012921x16287835103471] [Reference Citation Analysis]
534 Bautista-Becerril B, Pérez-Dimas G, Sommerhalder-Nava PC, Hanono A, Martínez-Cisneros JA, Zarate-Maldonado B, Muñoz-Soria E, Aquino-Gálvez A, Castillejos-López M, Juárez-Cisneros A, Lopez-Gonzalez JS, Camarena A. miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19. Viruses 2021;14:41. [PMID: 35062245 DOI: 10.3390/v14010041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
535 Marimuthu P, Gorle S, Karnati KR. Mechanistic Insights into SARS-CoV-2 Main Protease Inhibition Reveals Hotspot Residues. J Chem Inf Model 2021;61:6053-65. [PMID: 34842417 DOI: 10.1021/acs.jcim.1c00928] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
536 Gresh J, Kisner H, DuChateau B. Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19. Diagn Progn Res 2021;5:24. [PMID: 34952653 DOI: 10.1186/s41512-021-00113-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
537 Singh V, Singh V, Estrada E. Construction and stochastic scale-free modelling of empirical, global, index-case SARS-CoV-2 transmission network. Journal of Complex Networks 2022;10:cnab047. [DOI: 10.1093/comnet/cnab047] [Reference Citation Analysis]
538 Zeng H, Wang S, Chen L, Shen Z. Biologics for Psoriasis During the COVID-19 Pandemic. Front Med (Lausanne) 2021;8:759568. [PMID: 34938746 DOI: 10.3389/fmed.2021.759568] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
539 Hamdan M, Badrasawi M, Zidan S, Sayarah A, Zahra LA, Dana S, Almasry T. Risk factors associated with hospitalization owing to COVID-19: a cross-sectional study in Palestine. J Int Med Res 2021;49:3000605211064405. [PMID: 34939466 DOI: 10.1177/03000605211064405] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
540 Li F, Wang G, Zhang W, Zhang C. Efficacy and safety of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis caused by novel coronavirus disease: A protocol for Bayesian network meta-analysis. Medicine (Baltimore) 2021;100:e28282. [PMID: 34941111 DOI: 10.1097/MD.0000000000028282] [Reference Citation Analysis]
541 Picardi E, Mansi L, Pesole G. Detection of A-to-I RNA Editing in SARS-COV-2. Genes (Basel) 2021;13:41. [PMID: 35052382 DOI: 10.3390/genes13010041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
542 de Souza GAP, Le Bideau M, Boschi C, Ferreira L, Wurtz N, Devaux C, Colson P, La Scola B. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells. Viruses 2021;14:23. [PMID: 35062227 DOI: 10.3390/v14010023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
543 Ramezankhani R, Solhi R, Chai YC, Vosough M, Verfaillie C. Organoid and microfluidics-based platforms for drug screening in COVID-19. Drug Discov Today 2021:S1359-6446(21)00565-1. [PMID: 34954328 DOI: 10.1016/j.drudis.2021.12.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
544 Forinová M, Pilipenco A, Víšová I, Lynn NS Jr, Dostálek J, Mašková H, Hönig V, Palus M, Selinger M, Kočová P, Dyčka F, Štěrba J, Houska M, Vrabcová M, Horák P, Anthi J, Tung CP, Yu CM, Chen CY, Huang YC, Tsai PH, Lin SY, Hsu HJ, Yang AS, Dejneka A, Vaisocherová-Lísalová H. Functionalized Terpolymer-Brush-Based Biointerface with Improved Antifouling Properties for Ultra-Sensitive Direct Detection of Virus in Crude Clinical Samples. ACS Appl Mater Interfaces 2021;13:60612-24. [PMID: 34902239 DOI: 10.1021/acsami.1c16930] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
545 Ozger ZB, Cihan P. A novel ensemble fuzzy classification model in SARS-CoV-2 B-cell epitope identification for development of protein-based vaccine. Appl Soft Comput 2022;116:108280. [PMID: 34931117 DOI: 10.1016/j.asoc.2021.108280] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Gao Y, Chen J, Chen G, Fan C, Liu X. Recent Progress in the Transfer of Graphene Films and Nanostructures. Small Methods 2021;5:e2100771. [PMID: 34928026 DOI: 10.1002/smtd.202100771] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
547 Melton A, Doyle-Meyers LA, Blair RV, Midkiff C, Melton HJ, Russell-Lodrigue K, Aye PP, Schiro F, Fahlberg M, Szeltner D, Spencer S, Beddingfield BJ, Goff K, Golden N, Penney T, Picou B, Hensley K, Chandler KE, Plante JA, Plante KS, Weaver SC, Roy CJ, Hoxie JA, Gao H, Montefiori DC, Mankowski JL, Bohm RP, Rappaport J, Maness NJ. The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease. PLoS Pathog 2021;17:e1010162. [PMID: 34929014 DOI: 10.1371/journal.ppat.1010162] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
548 Konka A, Lejawa M, Gaździcka J, Bochenek A, Fronczek M, Strzelczyk JK. RT-PCR Detection of SARS-CoV-2 among Individuals from the Upper Silesian Region-Analysis of 108,516 Tests. Diagnostics (Basel) 2021;12:7. [PMID: 35054172 DOI: 10.3390/diagnostics12010007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
549 Cutrupi F, Cadonna M, Manara S, Foladori P. Surveillance of SARS-CoV-2 in extensive monitoring of municipal wastewater: key issues to yield reliable results. Water Sci Technol 2021;84:3508-14. [PMID: 34928822 DOI: 10.2166/wst.2021.469] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
550 Montenegro-Landívar MF, Tapia-Quirós P, Vecino X, Reig M, Valderrama C, Granados M, Cortina JL, Saurina J. Polyphenols and their potential role to fight viral diseases: An overview. Sci Total Environ 2021;801:149719. [PMID: 34438146 DOI: 10.1016/j.scitotenv.2021.149719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
551 Hu Q, Liu Y, Chen C, Sun Z, Wang Y, Xiang M, Guan H, Xia L. Reversible Bronchiectasis in COVID-19 Survivors With Acute Respiratory Distress Syndrome: Pseudobronchiectasis. Front Med (Lausanne) 2021;8:739857. [PMID: 34917630 DOI: 10.3389/fmed.2021.739857] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
552 Wu X, Chen Q, Li J, Liu Z. Diagnostic techniques for COVID-19: A mini-review. J Virol Methods 2021;:114437. [PMID: 34933045 DOI: 10.1016/j.jviromet.2021.114437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
553 Wu K, Choi A, Koch M, Elbashir S, Ma L, Lee D, Woods A, Henry C, Palandjian C, Hill A, Jani H, Quinones J, Nunna N, O'Connell S, McDermott AB, Falcone S, Narayanan E, Colpitts T, Bennett H, Corbett KS, Seder R, Graham BS, Stewart-Jones GBE, Carfi A, Edwards DK. Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice. Vaccine 2021;39:7394-400. [PMID: 34815117 DOI: 10.1016/j.vaccine.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
554 Xia Y, Qi W, Li X, Yang Y, Cao J. Clinical efficacy and safety of Qingshu Yiqi decoction as a complementary and alternative therapy for COVID-19 with Delta variant: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e28184. [PMID: 34918673 DOI: 10.1097/MD.0000000000028184] [Reference Citation Analysis]
555 Papadopoli R, De Sarro C, Palleria C, Gallelli L, Pileggi C, De Sarro G. Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population. Vaccines (Basel) 2021;9:1494. [PMID: 34960240 DOI: 10.3390/vaccines9121494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
556 Hubacek JA. Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression. Physiol Res 2021;70:S125-34. [PMID: 34913347 DOI: 10.33549/physiolres.934730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
557 Mabrey FL, Morrell ED, Bhatraju PK, Sathe NA, Sakr SS, Sahi SK, West TE, Mikacenic C, Wurfel MM. Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019. Crit Care Explor 2021;3:e0591. [PMID: 34909698 DOI: 10.1097/CCE.0000000000000591] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
558 Walker AP, Fan H, Keown JR, Knight ML, Grimes JM, Fodor E. The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme. Nucleic Acids Res 2021;49:13019-30. [PMID: 34850141 DOI: 10.1093/nar/gkab1160] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
559 Gocer S, Turk C, Ozguven SV, Doganay M. Coronavirus disease 2019 vaccine: An overview of the progression and current use. North Clin Istanb 2021;8:529-36. [PMID: 34909595 DOI: 10.14744/nci.2021.99075] [Reference Citation Analysis]
560 Kantarcioglu B, Patel K, Lewis J, Iqbal O, Siddiqui F, Jabeen N, Laddu AR, Carter CA, Fareed J. Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey. Clin Appl Thromb Hemost 2021;27:10760296211066942. [PMID: 34905980 DOI: 10.1177/10760296211066942] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
561 Zöllkau J, Hagenbeck C, Hecher K, Pecks U, Schlembach D, Simon A, Schlösser R, Schleußner E. [Recommendations for SARS-CoV-2/COVID-19 during Pregnancy, Birth and Childbed - Update November 2021 (Long Version)]. Z Geburtshilfe Neonatol 2021. [PMID: 34918334 DOI: 10.1055/a-1688-9398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Peng XL, Cheng JS, Gong HL, Yuan MD, Zhao XH, Li Z, Wei DX. Advances in the design and development of SARS-CoV-2 vaccines. Mil Med Res 2021;8:67. [PMID: 34911569 DOI: 10.1186/s40779-021-00360-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
563 Sessa F, Salerno M, Esposito M, Di Nunno N, Zamboni P, Pomara C. Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med 2021;10:5876. [PMID: 34945172 DOI: 10.3390/jcm10245876] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
564 San Onofre N, Soler C, Merino-Torres JF, Soriano JM. "Five Keys to Safer Food" and COVID-19. Nutrients 2021;13:4491. [PMID: 34960042 DOI: 10.3390/nu13124491] [Reference Citation Analysis]
565 Jia L, Chen Z, Zhang Y, Ma L, Wang L, Hu X, Liu H, Chen J, Liu D, Guan W. Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Microbiol 2021;12:768740. [PMID: 34899651 DOI: 10.3389/fmicb.2021.768740] [Reference Citation Analysis]
566 Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, Zhang C, Zhao E, Rustgi VK. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations . World J Gastroenterol 2021; 27(46): 7969-7981 [DOI: 10.3748/wjg.v27.i46.7969] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
567 Riaz M, Akhtar MN, Jinghong S, Gul H. Meteorological Factors and the COVID-19 Pandemic: The Backdrop of Pakistan. Front Psychol 2021;12:764016. [PMID: 34899508 DOI: 10.3389/fpsyg.2021.764016] [Reference Citation Analysis]
568 Li T, Hu Y, Xia L, Wen L, Ren W, Xia W, Wang J, Cai W, Chen L. Psychological experience of patients with confirmed COVID-19 at the initial stage of pandemic in Wuhan, China: a qualitative study. BMC Public Health 2021;21:2257. [PMID: 34895189 DOI: 10.1186/s12889-021-12277-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
569 Alwahaibi N, Al Maskari M, Al Dhahli B, Al Issaei H, Al-Jaaidi Shadia Al Bahlani S. One-year Review of COVID-19 in the Arab World. Qatar Med J 2021;2021:66. [PMID: 34888202 DOI: 10.5339/qmj.2021.66] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
570 Sharma A, Oda G, Icardi M, Mole L, Holodniy M. Implementation of large-scale laboratory-based detection of COVID-19 in the Veterans Health Administration, March 2020 - February 2021. Diagn Microbiol Infect Dis 2021;102:115617. [PMID: 35007825 DOI: 10.1016/j.diagmicrobio.2021.115617] [Reference Citation Analysis]
571 Chen Y, Huang S, Zhou L, Wang X, Yang H, Li W. Coronavirus Disease 2019 (COVID-19): Emerging detection technologies and auxiliary analysis. J Clin Lab Anal 2021;:e24152. [PMID: 34894011 DOI: 10.1002/jcla.24152] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
572 Srinivasan K, Rao M. Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review. Ther Adv Infect Dis 2021;8:20499361211063016. [PMID: 34881025 DOI: 10.1177/20499361211063016] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
573 Serebrennikova KV, Byzova NA, Zherdev AV, Khlebtsov NG, Khlebtsov BN, Biketov SF, Dzantiev BB. Lateral Flow Immunoassay of SARS-CoV-2 Antigen with SERS-Based Registration: Development and Comparison with Traditional Immunoassays. Biosensors (Basel) 2021;11:510. [PMID: 34940267 DOI: 10.3390/bios11120510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
574 Fadli A, Kusuma WA, Annisa, Batubara I, Heryanto R. Screening of Potential Indonesia Herbal Compounds Based on Multi-Label Classification for 2019 Coronavirus Disease. BDCC 2021;5:75. [DOI: 10.3390/bdcc5040075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
575 Raza S, Mukhtar N, Nawaz M, Ali MA, Shabbir MAB, Ashraf MA, Ali Z, Saleem MR, Latif R, Yaqub T. A Cross-Sectional Survey of Knowledge, Attitude, and Practices of University Students in Pakistan Regarding COVID-19. Front Public Health 2021;9:697686. [PMID: 34869139 DOI: 10.3389/fpubh.2021.697686] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
576 Yan P, Li M, Li J, Lu Z, Hui X, Bai Y, Xun Y, Lao Y, Wang S, Yang K. Bibliometric Analysis and Systematic Review of Global Coronavirus Research Trends Before COVID-19: Prospects and Implications for COVID-19 Research. Front Med (Lausanne) 2021;8:729138. [PMID: 34869424 DOI: 10.3389/fmed.2021.729138] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
577 Aiewsakun P, Nilplub P, Wongtrakoongate P, Hongeng S, Thitithanyanont A. SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity. Microb Genom 2021;7. [PMID: 34870573 DOI: 10.1099/mgen.0.000734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
578 Ogando NS, El Kazzi P, Zevenhoven-Dobbe JC, Bontes BW, Decombe A, Posthuma CC, Thiel V, Canard B, Ferron F, Decroly E, Snijder EJ. Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication. Proc Natl Acad Sci U S A 2021;118:e2108709118. [PMID: 34845015 DOI: 10.1073/pnas.2108709118] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
579 Zhou Y, Liao X, Song X, He M, Xiao F, Jin X, Xie X, Zhang Z, Wang B, Zhou C, Kang Y, Zhang W. Severe Adaptive Immune Suppression May Be Why Patients With Severe COVID-19 Cannot Be Discharged From the ICU Even After Negative Viral Tests. Front Immunol 2021;12:755579. [PMID: 34867988 DOI: 10.3389/fimmu.2021.755579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
580 Alves PA, de Oliveira EG, Franco-Luiz APM, Almeida LT, Gonçalves AB, Borges IA, Rocha FS, Rocha RP, Bezerra MF, Miranda P, Capanema FD, Martins HR, Weber G, Teixeira SMR, Wallau GL, do Monte-Neto RL. Optimization and Clinical Validation of Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification, a Fast, Highly Sensitive and Specific COVID-19 Molecular Diagnostic Tool That Is Robust to Detect SARS-CoV-2 Variants of Concern. Front Microbiol 2021;12:713713. [PMID: 34867841 DOI: 10.3389/fmicb.2021.713713] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
581 Karuna S, Li SS, Grant S, Walsh SR, Frank I, Casapia M, Trahey M, Hyrien O, Fisher L, Miner MD, Randhawa AK, Polakowski L, Kublin JG, Corey L, Montefiori D; HVTN 405/HPTN 1901 Study Team. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLoS Med 2021;18:e1003868. [PMID: 34871308 DOI: 10.1371/journal.pmed.1003868] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
582 Gorbalenya AE, Lauber C. Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification. Curr Opin Virol 2021;52:48-56. [PMID: 34883443 DOI: 10.1016/j.coviro.2021.11.003] [Reference Citation Analysis]
583 Hebbani AV, Pulakuntla S, Pannuru P, Aramgam S, Badri KR, Reddy VD. COVID-19: comprehensive review on mutations and current vaccines. Arch Microbiol 2022;204. [DOI: 10.1007/s00203-021-02606-x] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
584 Omar AZ, Mosa TM, El-Sadany SK, Hamed EA, El-Atawy M. Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study. J Mol Struct 2021;1245:131020. [PMID: 34248201 DOI: 10.1016/j.molstruc.2021.131020] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
585 Yu W, Wu X, Zhao Y, Chen C, Yang Z, Zhang X, Ren J, Wang Y, Wu C, Li C, Chen R, Wang X, Zheng W, Liao H, Yuan X. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design. Molecules 2021;26:7385. [PMID: 34885967 DOI: 10.3390/molecules26237385] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
586 Reshad RAI, Riana SH, Chowdhury MA, Moin AT, Miah F, Sarkar B, Jewel NA. Diabetes in COVID-19 patients: challenges and possible management strategies. Egypt J Bronchol 2021;15. [DOI: 10.1186/s43168-021-00099-2] [Reference Citation Analysis]
587 Cory TJ, Emmons RS, Yarbro JR, Davis KL, Pence BD. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1. Front Immunol 2021;12:733921. [PMID: 34858397 DOI: 10.3389/fimmu.2021.733921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
588 Abayomi A, Osibogun A, Ezechi O, Wright K, Ola B, Ojo O, Kuyinu Y, Zamba E, Abdur-Razzaq H, Erinoso OA, Anya SE. A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial. Trials 2021;22:869. [PMID: 34863267 DOI: 10.1186/s13063-021-05675-x] [Reference Citation Analysis]
589 Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G. Coronavirus Disease 2019: Clinics, Treatment, and Prevention. Front Microbiol 2021;12:761887. [PMID: 34858373 DOI: 10.3389/fmicb.2021.761887] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
590 Ahmadi E, Zabihi MR, Hosseinzadeh R, Mohamed Khosroshahi L, Noorbakhsh F. SARS-CoV-2 spike protein displays sequence similarities with paramyxovirus surface proteins; a bioinformatics study. PLoS One 2021;16:e0260360. [PMID: 34855795 DOI: 10.1371/journal.pone.0260360] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
591 Mak GCK, Ng AYY, Lam ETK, Chan RCW, Tsang DNC. Assessment of SARS-CoV-2 viral loads in combined nasal-and-throat swabs collected from COVID-19 individuals under the Universal Community Testing Programme in Hong Kong. J Virol Methods 2022;300:114396. [PMID: 34856306 DOI: 10.1016/j.jviromet.2021.114396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
592 Hussain S, Madi EN, Khan H, Etemad S, Rezapour S, Sitthiwirattham T, Patanarapeelert N. Investigation of the Stochastic Modeling of COVID-19 with Environmental Noise from the Analytical and Numerical Point of View. Mathematics 2021;9:3122. [DOI: 10.3390/math9233122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
593 Khan W, Khan AA, Khan J, Khatoon N, Arshad S, Los Ríos Escalante P. Death caused by covid-19 in top ten countries in Asia affected by covid-19 pandemic with special reference to Pakistan. Braz J Biol 2021;83:e248281. [PMID: 34852158 DOI: 10.1590/1519-6984.248281] [Reference Citation Analysis]
594 [DOI: 10.1109/icicyta53712.2021.9689122] [Reference Citation Analysis]
595 Chen Z, Du R, Galvan Achi JM, Rong L, Cui Q. SARS-CoV-2 cell entry and targeted antiviral development. Acta Pharm Sin B 2021;11:3879-88. [PMID: 34002130 DOI: 10.1016/j.apsb.2021.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
596 Ferreira G, Santander A, Savio F, Guirado M, Sobrevia L, Nicolson GL. SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases. Biochim Biophys Acta Mol Basis Dis 2021;1867:166264. [PMID: 34481867 DOI: 10.1016/j.bbadis.2021.166264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
597 Farah EM, Amine S, Allali K. Dynamics of a time-delayed two-strain epidemic model with general incidence rates. Chaos, Solitons & Fractals 2021;153:111527. [DOI: 10.1016/j.chaos.2021.111527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
598 Xie F, Su P, Pan T, Zhou X, Li H, Huang H, Wang A, Wang F, Huang J, Yan H, Zeng L, Zhang L, Zhou F. Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy. Adv Mater 2021;33:e2103471. [PMID: 34665481 DOI: 10.1002/adma.202103471] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
599 Lin Q, Wu J, Liu L, Wu W, Fang X, Kong J. Sandwich/competitive immuno-sensors on micro-interface for SARS-CoV-2 neutralizing antibodies. Anal Chim Acta 2021;1187:339144. [PMID: 34753584 DOI: 10.1016/j.aca.2021.339144] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
600 Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ 2021;808:152072. [PMID: 34863742 DOI: 10.1016/j.scitotenv.2021.152072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
601 Genecand C, Mongin D, Koegler F, Lebowitz D, Regard S, Falcone JL, Nehme M, Braillard O, Grira M, Joubert D, Chopard P, Delaporte E, Stirnemann J, Guessous I, Tardin A, Courvoisier DS. Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS). BMJ Open 2021;11:e048946. [PMID: 34848509 DOI: 10.1136/bmjopen-2021-048946] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
602 Blanco OR, Dorta D, Hernández CA, Abreu D, Domínguez AG, Luna Y, Valdivia O, Pérez-Bernal M, Tamayo C, Lemos G, Pasarón IM, Pérez JJ, Benítez L, Bequet-Romero M, Fragas A, Cabrera Y, Pérez ER. Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials. J Immunol Methods 2022;500:113195. [PMID: 34843713 DOI: 10.1016/j.jim.2021.113195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
603 Pokhrel S, Bouback TA, Samad A, Nur SM, Alam R, Abdullah-Al-Mamun M, Nain Z, Imon RR, Talukder MEK, Tareq MMI, Hossen MS, Karpiński TM, Ahammad F, Qadri I, Rahman MS. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2. Int J Biol Macromol 2021;191:1114-25. [PMID: 34592225 DOI: 10.1016/j.ijbiomac.2021.09.146] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
604 Razali R, Asis H, Budiman C. Structure-Function Characteristics of SARS-CoV-2 Proteases and Their Potential Inhibitors from Microbial Sources. Microorganisms 2021;9:2481. [PMID: 34946083 DOI: 10.3390/microorganisms9122481] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
605 Chakraborty J, Maity A, Sarkar H. A systematic drug repurposing approach to identify promising inhibitors from FDA-approved drugs against Nsp4 protein of SARS-CoV-2. J Biomol Struct Dyn 2021;:1-10. [PMID: 34844509 DOI: 10.1080/07391102.2021.2009033] [Reference Citation Analysis]
606 Stefanelli P, Fazio C, Vacca P, Neri A, Ambrosio L, Rezza G. Did social distancing measures deployed for SARS-CoV-2/COVID-19 control have an impact on invasive meningococcal disease? Pathog Glob Health 2021;:1-3. [PMID: 34844520 DOI: 10.1080/20477724.2021.1995657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
607 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
608 Safari I, Elahi E. Evolution of the SARS-CoV-2 genome and emergence of variants of concern. Arch Virol 2021. [PMID: 34846601 DOI: 10.1007/s00705-021-05295-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
609 Komiazyk M, Walory J, Kozinska A, Wasko I, Baraniak A. Impact of the Nucleic Acid Extraction Method and the RT-qPCR Assay on SARS-CoV-2 Detection in Low-Viral Samples. Diagnostics (Basel) 2021;11:2247. [PMID: 34943484 DOI: 10.3390/diagnostics11122247] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
610 Jung AS, Haldane V, Neill R, Wu S, Jamieson M, Verma M, Tan M, De Foo C, Abdalla SM, Shrestha P, Chua AQ, Bristol N, Singh S, Bartos M, Mabuchi S, Bonk M, McNab C, Werner GK, Panjabi R, Nordström A, Legido-Quigley H. National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic. BMJ 2021;375:e068954. [PMID: 34840138 DOI: 10.1136/bmj-2021-068954] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
611 Hayashi K, Asai S, Umezawa K, Kakizoe H, Miyachi H, Morita M, Akaike T, Kuno H, Komatsu S, Watanabe T, Kawahara T. Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS-CoV-2 as assessed by a plaque assay. J Clin Lab Anal 2021;:e24146. [PMID: 34837712 DOI: 10.1002/jcla.24146] [Reference Citation Analysis]
612 Henao-Kaffure L, Peñaloza G. A critical perspective on pandemics and epidemics: building a bridge between public health and science education. Cult Stud Sci Educ 2021;:1-17. [PMID: 34849176 DOI: 10.1007/s11422-021-10074-4] [Reference Citation Analysis]
613 de O Araújo J, Pinheiro S, Zamora WJ, Alves CN, Lameira J, Lima AH. Structural, energetic and lipophilic analysis of SARS-CoV-2 non-structural protein 9 (NSP9). Sci Rep 2021;11:23003. [PMID: 34837010 DOI: 10.1038/s41598-021-02366-0] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
614 Costa DD, Brites C, Vaz SN, de Santana DS, Dos Santos JN, Cury PR. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial. Oral Dis 2021. [PMID: 34837305 DOI: 10.1111/odi.14086] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
615 Hussein HA, Kandeil A, Gomaa M, Mohamed El Nashar R, El-Sherbiny IM, Hassan RYA. SARS-CoV-2-Impedimetric Biosensor: Virus-Imprinted Chips for Early and Rapid Diagnosis. ACS Sens 2021;6:4098-107. [PMID: 34757734 DOI: 10.1021/acssensors.1c01614] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
616 Rajput R, Sharma J. SARS-CoV-2 in Pregnancy: Fitting Into the Existing Viral Repertoire. Front Glob Womens Health 2021;2:647836. [PMID: 34816202 DOI: 10.3389/fgwh.2021.647836] [Reference Citation Analysis]
617 Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
618 Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, Tivatunsakul N, Luvira V. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. JGH Open 2021;5:1257-65. [PMID: 34816011 DOI: 10.1002/jgh3.12671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
619 Mandal M, Dutta N, Dutta G. Aptamer-based biosensors and their implications in COVID-19 diagnosis. Anal Methods 2021;13:5400-17. [PMID: 34751684 DOI: 10.1039/d1ay01519b] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
620 Hossain MS, Pathan AQMSU, Islam MN, Tonmoy MIQ, Rakib MI, Munim MA, Saha O, Fariha A, Reza HA, Roy M, Bahadur NM, Rahaman MM. Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning. Inform Med Unlocked 2021;27:100798. [PMID: 34812411 DOI: 10.1016/j.imu.2021.100798] [Reference Citation Analysis]
621 Vilibic-Cavlek T, Stevanovic V, Brlek-Gorski D, Ferencak I, Ferenc T, Ujevic-Bosnjak M, Tabain I, Janev-Holcer N, Perkovic I, Anticevic M, Bekavac B, Kaic B, Mrzljak A, Ganjto M, Zmak L, Mauric Maljkovic M, Jelicic P, Bucic L, Barbic L. Emerging Trends in the Epidemiology of COVID-19: The Croatian 'One Health' Perspective. Viruses 2021;13:2354. [PMID: 34960623 DOI: 10.3390/v13122354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
622 Kurtoğlu E, Afsin A, Aktaş İ, Aktürk E, Kutlusoy E, Çağaşar Ö. Altered cardiac autonomic function after recovery from COVID-19. Ann Noninvasive Electrocardiol 2021;:e12916. [PMID: 34817120 DOI: 10.1111/anec.12916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
623 Lian Z, Li Y, Wang W, Ding W, Niu Z, Yang X, Wu C. The Prediction Model of Risk Factors for COVID-19 Developing into Severe Illness Based on 1046 Patients with COVID-19. Emerg Med Int 2021;2021:7711056. [PMID: 34804612 DOI: 10.1155/2021/7711056] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
624 Morales-Núñez JJ, Muñoz-Valle JF, Torres-Hernández PC, Hernández-Bello J. Overview of Neutralizing Antibodies and Their Potential in COVID-19. Vaccines (Basel) 2021;9:1376. [PMID: 34960121 DOI: 10.3390/vaccines9121376] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
625 Shareef RH, Zwain ZD, Mahbuba WA. Superiority of lymphocyte ratio over total leukocyte count in detecting the severity of COVID- 19 pneumonia. Heliyon 2021;7:e08412. [PMID: 34805573 DOI: 10.1016/j.heliyon.2021.e08412] [Reference Citation Analysis]
626 Ferreira BIDS, da Silva-Gomes NL, Coelho WLDCNP, da Costa VD, Carneiro VCS, Kader RL, Amaro MP, Villar LM, Miyajima F, Alves-Leon SV, de Paula VS, Leon LAA, Moreira OC. Validation of a novel molecular assay to the diagnostic of COVID-19 based on real time PCR with high resolution melting. PLoS One 2021;16:e0260087. [PMID: 34807915 DOI: 10.1371/journal.pone.0260087] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
627 Khan H, Winstone H, Jimenez-Guardeño JM, Graham C, Doores KJ, Goujon C, Matthews DA, Davidson AD, Rihn SJ, Palmarini M, Neil SJD, Malim MH. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathog 2021;17:e1009820. [PMID: 34807954 DOI: 10.1371/journal.ppat.1009820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
628 Uğurel OM, Ata O, Turgut-Balik D. Genomic chronicle of SARS-CoV-2: a mutational analysis with over 1 million genome sequences. Turk J Biol 2021;45:425-35. [PMID: 34803444 DOI: 10.3906/biy-2106-8] [Reference Citation Analysis]
629 Banerjee S, Yadav S, Banerjee S, Fakayode SO, Parvathareddy J, Reichard W, Surendranathan S, Mahmud F, Whatcott R, Thammathong J, Meibohm B, Miller DD, Jonsson CB, Dubey KD. Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study. J Chem Inf Model 2021;61:5469-83. [PMID: 34666487 DOI: 10.1021/acs.jcim.1c00524] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
630 Franko N, Teixeira AP, Xue S, Charpin-El Hamri G, Fussenegger M. Design of modular autoproteolytic gene switches responsive to anti-coronavirus drug candidates. Nat Commun 2021;12:6786. [PMID: 34811361 DOI: 10.1038/s41467-021-27072-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
631 Tiwari AK, Mishra A, Pandey G, Gupta MK, Pandey PC. Nanotechnology: A Potential Weapon to Fight against COVID‐19. Part & Part Syst Charact 2022;39:2100159. [DOI: 10.1002/ppsc.202100159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
632 Ramos R, de la Villa S, García-Ramos S, Padilla B, García-Olivares P, Piñero P, Garrido A, Hortal J, Muñoz P, Caamaño E, Benito P, Cedeño J, Garutti I; Marañón Critical COVID-19 Infection Group. COVID-19 associated infections in the ICU setting: A retrospective analysis in a tertiary-care hospital. Enferm Infecc Microbiol Clin 2021. [PMID: 34908639 DOI: 10.1016/j.eimc.2021.10.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
633 Stefanowicz-Bielska A, Słomion M, Stefanowicz J. COVID-19 Pandemic-Knowledge, Attitudes, Behaviours, and Actions among Faculty of Health Sciences Students. Int J Environ Res Public Health 2021;18:12137. [PMID: 34831891 DOI: 10.3390/ijerph182212137] [Reference Citation Analysis]
634 Zhou S, Jin M, Tan R, Shen Z, Yin J, Qiu Z, Chen Z, Shi D, Li H, Yang Z, Wang H, Gao Z, Li J, Yang D. A reduced graphene oxide-Fe3O4 composite functionalized with cetyltrimethylammonium bromide for efficient adsorption of SARS-CoV-2 spike pseudovirus and human enteric viruses. Chemosphere 2021;:132995. [PMID: 34808196 DOI: 10.1016/j.chemosphere.2021.132995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
635 Salasc F, Lahlali T, Laurent E, Rosa-Calatrava M, Pizzorno A. Treatments for COVID-19: Lessons from 2020 and new therapeutic options. Curr Opin Pharmacol 2021;62:43-59. [PMID: 34915400 DOI: 10.1016/j.coph.2021.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
636 Xu F, Gao J, Orgil BO, Bajpai AK, Gu Q, Purevjav E, Davenport AS, Li K, Towbin JA, Black DD, Pierre JF, Lu L. Ace2 and Tmprss2 Expressions Are Regulated by Dhx32 and Influence the Gastrointestinal Symptoms Caused by SARS-CoV-2. J Pers Med 2021;11:1212. [PMID: 34834564 DOI: 10.3390/jpm11111212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
637 Reddy RS, Gautam AP, Tedla JS, Ferreira AS, Reis LFF, Bairapareddy KC, Kakaraparthi VN, Gular K. The Aftermath of the COVID-19 Crisis in Saudi Arabia: Respiratory Rehabilitation Recommendations by Physical Therapists. Healthcare (Basel) 2021;9:1560. [PMID: 34828606 DOI: 10.3390/healthcare9111560] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
638 Li JY, Zhou ZJ, Wang Q, He QN, Zhao MY, Qiu Y, Ge XY. Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2. Front Microbiol 2021;12:770656. [PMID: 34777324 DOI: 10.3389/fmicb.2021.770656] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
639 Pavesi A. Computational methods for inferring location and genealogy of overlapping genes in virus genomes: approaches and applications. Curr Opin Virol 2021;52:1-8. [PMID: 34798370 DOI: 10.1016/j.coviro.2021.10.009] [Reference Citation Analysis]
640 Amato A, Iandolo A, Scelza G, Spirito F, Martina S. COVID-19: The Patients' Perceived Impact on Dental Care. Eur J Dent 2021. [PMID: 34784625 DOI: 10.1055/s-0041-1734470] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
641 Zhou Z, Qiu Y, Ge X. The taxonomy, host range and pathogenicity of coronaviruses and other viruses in the Nidovirales order. Anim Dis 2021;1:5. [PMID: 34778878 DOI: 10.1186/s44149-021-00005-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
642 Kretchy IA, Boadu JA, Kretchy JP, Agyabeng K, Passah AA, Koduah A, Opuni KFM. Utilization of complementary and alternative medicine for the prevention of COVID-19 infection in Ghana: A national cross-sectional online survey. Prev Med Rep 2021;24:101633. [PMID: 34777985 DOI: 10.1016/j.pmedr.2021.101633] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
643 Mahmood MM, Jafarli I, Al-Barazanchi AF, Mosa NM, Al-Ameen ZGY, Alkhanchi T. What you need to know about children's COVID-19: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi 2021;23:1080-90. [PMID: 34753538 DOI: 10.7499/j.issn.1008-8830.2106122] [Reference Citation Analysis]
644 Chowdhury S, Bappy MH, Chowdhury S, Chowdhury MS, Chowdhury NS. COVID-19 Induced Cardiovascular Complications and Recent Therapeutic Advances. EJMED 2021;3:17-22. [DOI: 10.24018/ejmed.2021.3.6.1099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
645 Li D, Fu Z, Xu J. Stacked-autoencoder-based model for COVID-19 diagnosis on CT images. Appl Intell (Dordr) 2021;51:2805-17. [PMID: 34764564 DOI: 10.1007/s10489-020-02002-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
646 Mariotti S, Capocefalo A, Chiantore MV, Iacobino A, Teloni R, De Angelis ML, Gallinaro A, Pirillo MF, Borghi M, Canitano A, Michelini Z, Baggieri M, Marchi A, Bucci P, McKay PF, Acchioni C, Sandini S, Sgarbanti M, Tosini F, Di Virgilio A, Venturi G, Marino F, Esposito V, Di Bonito P, Magurano F, Cara A, Negri D, Nisini R. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency. Front Immunol 2021;12:750386. [PMID: 34764961 DOI: 10.3389/fimmu.2021.750386] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 Bezstarosti K, Lamers MM, Doff WAS, Wever PC, Thai KTD, van Kampen JJA, Haagmans BL, Demmers JAA. Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens. PLoS One 2021;16:e0259165. [PMID: 34762662 DOI: 10.1371/journal.pone.0259165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
648 Zhang L, Tian M, Song Y, Liang W, Li X, Tong Y, Wang H. Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19. Diagnostics (Basel) 2021;11:2089. [PMID: 34829436 DOI: 10.3390/diagnostics11112089] [Reference Citation Analysis]
649 Mamalakis M, Swift AJ, Vorselaars B, Ray S, Weeks S, Ding W, Clayton RH, Mackenzie LS, Banerjee A. DenResCov-19: A deep transfer learning network for robust automatic classification of COVID-19, pneumonia, and tuberculosis from X-rays. Comput Med Imaging Graph 2021;94:102008. [PMID: 34763146 DOI: 10.1016/j.compmedimag.2021.102008] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
650 Ozgocer T, Dagli ŞN, Ceylan MR, Disli F, Ucar C, Yildiz S. Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication. J Med Virol 2021. [PMID: 34766646 DOI: 10.1002/jmv.27452] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
651 Panchamoorthy R, Vel N. Herbal spices-based therapeutics for diabetic patients with COVID-19 infection: A review. NRFHH 2022;2:32-51. [DOI: 10.53365/nrfhh/143758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
652 Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
653 Tepasse PR, Vollenberg R, Nowacki TM. Vaccination against SARS-CoV-2 in Patients with Inflammatory Bowel Diseases: Where Do We Stand? Life (Basel) 2021;11:1220. [PMID: 34833096 DOI: 10.3390/life11111220] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
654 Li H, Zhang Y, Li D, Deng YQ, Xu H, Zhao C, Liu J, Wen D, Zhao J, Li Y, Wu Y, Liu S, Liu J, Hao J, Yuan F, Duo S, Qin CF, Zheng A. Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein. Signal Transduct Target Ther 2021;6:389. [PMID: 34759261 DOI: 10.1038/s41392-021-00797-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
655 Veronin MA, Lang A, Reinert JP. Remdesivir and Coronavirus Disease 2019 (COVID-19): Essential Questions and Answers for Pharmacists and Pharmacy Technicians. J Pharm Technol 2021;37:62-74. [PMID: 34752546 DOI: 10.1177/8755122520967634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
656 Rout RK, Hassan SS, Sheikh S, Umer S, Sahoo KS, Gandomi AH. Feature-extraction and analysis based on spatial distribution of amino acids for SARS-CoV-2 Protein sequences. Comput Biol Med 2021;:105024. [PMID: 34815067 DOI: 10.1016/j.compbiomed.2021.105024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
657 Hu Y, Liu L, Lu X. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Front Endocrinol (Lausanne) 2021;12:725967. [PMID: 34745001 DOI: 10.3389/fendo.2021.725967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
658 Zhou Y, Xu X, Wei H. Complex Pathophysiological Mechanisms and the Propose of the Three-Dimensional Schedule For Future COVID-19 Treatment. Front Immunol 2021;12:716940. [PMID: 34745094 DOI: 10.3389/fimmu.2021.716940] [Reference Citation Analysis]
659 Liu M, Han Y, Sun J, Wei X, Zhao X, Wang B, Zhang Y, Ma X, Gai Z. Comparison of the Epidemiological and Clinical Characteristics of Hospitalized Children With Pneumonia Caused by SARS-CoV-2, Influenza A, and Human Adenoviruses: A Case-Control Study. Clin Pediatr (Phila) 2021;:99228211058601. [PMID: 34753343 DOI: 10.1177/00099228211058601] [Reference Citation Analysis]
660 Agwa SHA, Elghazaly H, Meteini MSE, Shawky SM, Ali M, Abd Elsamee AM, Sayed SM, Sherif N, Sharaf HM, Alhadidy MA, Matboli M. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity. Cells 2021;10:3098. [PMID: 34831321 DOI: 10.3390/cells10113098] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
661 Hadj Hassine I. Covid-19 vaccines and variants of concern: A review. Rev Med Virol 2021;:e2313. [PMID: 34755408 DOI: 10.1002/rmv.2313] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
662 Vlahopoulos S, Wang K, Xue Y, Zheng X, Boldogh I, Pan L. Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections. Cells 2021;10:3067. [PMID: 34831290 DOI: 10.3390/cells10113067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
663 Peker BO, Şener AG, Kaptan Aydoğmuş F. Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis. J Immunol Methods 2021;499:113174. [PMID: 34737165 DOI: 10.1016/j.jim.2021.113174] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
664 Barazorda-Ccahuana HL, Nedyalkova M, Mas F, Madurga S. Unveiling the Effect of Low pH on the SARS-CoV-2 Main Protease by Molecular Dynamics Simulations. Polymers (Basel) 2021;13:3823. [PMID: 34771379 DOI: 10.3390/polym13213823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
665 Baltaziak K, Szpringer A, Czarnek-Chudzik A, Onyszkiewicz M, Toro MD, Pankowska A, Pietura R, Rejdak R, Nowomiejska K. Quadrantanopia as the only symptom of post-COVID stroke in the occipital pole: Case report. Medicine (Baltimore) 2021;100:e27542. [PMID: 34871216 DOI: 10.1097/MD.0000000000027542] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
666 Bagasra O, Pandey P, Sanamandra JR, Houston JM, McLean E, Albrecht H. Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia. Oman Med J 2021;36:e307. [PMID: 34733553 DOI: 10.5001/omj.2021.128] [Reference Citation Analysis]
667 Özdemir İH, Özlek B, Özen MB, Gündüz R, Çetin N, Özlek E, Yıldız BS, Tıkız H. Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study. Anatol J Cardiol 2021;25:811-20. [PMID: 34734815 DOI: 10.5152/AnatolJCardiol.2021.62] [Reference Citation Analysis]
668 Tayara H, Abdelbaky I, To Chong K. Recent omics-based computational methods for COVID-19 drug discovery and repurposing. Brief Bioinform 2021;22:bbab339. [PMID: 34423353 DOI: 10.1093/bib/bbab339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
669 Pal A, Dobhal S, Dey KK, Sharma AK, Savani V, Negi VS. Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein. Comput Biol Chem 2021;95:107594. [PMID: 34736125 DOI: 10.1016/j.compbiolchem.2021.107594] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
670 Tatsi EB, Filippatos F, Michos A. SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence. Epidemiol Infect 2021;149:e237. [PMID: 34732275 DOI: 10.1017/S0950268821002430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
671 Dei Cas M, Ottolenghi S, Morano C, Rinaldo R, Roda G, Chiumello D, Centanni S, Samaja M, Paroni R. Link between serum lipid signature and prognostic factors in COVID-19 patients. Sci Rep 2021;11:21633. [PMID: 34737330 DOI: 10.1038/s41598-021-00755-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
672 Figueroa S, Freire-Paspuel B, Vega-Mariño P, Velez A, Cruz M, Cardenas WB, Garcia-Bereguiain MA. High sensitivity-low cost detection of SARS-CoV-2 by two steps end point RT-PCR with agarose gel electrophoresis visualization. Sci Rep 2021;11:21658. [PMID: 34737323 DOI: 10.1038/s41598-021-00900-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
673 Domokos E, Sebestyén V, Somogyi V, Trájer AJ, Gerencsér-Berta R, Oláhné Horváth B, Tóth EG, Jakab F, Kemenesi G, Abonyi J. Identification of sampling points for the detection of SARS-CoV-2 in the sewage system. Sustain Cities Soc 2022;76:103422. [PMID: 34729296 DOI: 10.1016/j.scs.2021.103422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
674 Al-Daghastani T, Tadros O, Arabiyat S, Jaber D, AlSalamat H. Pharmacists' Perception of the Coronavirus Pandemic (COVID-19) in Jordan: A Cross-Sectional Study. Int J Environ Res Public Health 2021;18:11541. [PMID: 34770055 DOI: 10.3390/ijerph182111541] [Reference Citation Analysis]
675 Zekri AN, Bahnasy AA, Hafez MM, Hassan ZK, Ahmed OS, Soliman HK, El-Sisi ER, Dine MHSE, Solimane MS, Latife LSA, Seadawy MG, Elsafty AS, Abouelhoda M. Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection. Sci Rep 2021;11:21632. [PMID: 34732835 DOI: 10.1038/s41598-021-99014-4] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
676 Lu Y, Liu Q, Yan H, Gao S, Liu T. Job burnout and its impact on work ability in biosafety laboratory staff during the COVID-19 epidemic in Xinjiang. BMC Psychiatry 2021;21:543. [PMID: 34732164 DOI: 10.1186/s12888-021-03555-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
677 Konstantinidis TG, Iliadi V, Martinis G, Panopoulou M. The Usefulness of Rare Blood Group Systems in the Risk Determination for Severe COVID-19. Pathophysiology 2021;28:496-500. [PMID: 35366247 DOI: 10.3390/pathophysiology28040032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
678 Bakhtazad A, Garmabi B, Joghataei MT. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies. J Neurovirol 2021. [PMID: 34727365 DOI: 10.1007/s13365-021-01014-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
679 Ftouh M, Kalboussi N, Abid N, Sfar S, Mignet N, Bahloul B. Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses. PPAR Res 2021;2021:6741290. [PMID: 34721558 DOI: 10.1155/2021/6741290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
680 Khan MA, Alhaisoni M, Tariq U, Hussain N, Majid A, Damaševičius R, Maskeliūnas R. COVID-19 Case Recognition from Chest CT Images by Deep Learning, Entropy-Controlled Firefly Optimization, and Parallel Feature Fusion. Sensors (Basel) 2021;21:7286. [PMID: 34770595 DOI: 10.3390/s21217286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
681 Munis AM, Andersson M, Mobbs A, Hyde SC, Gill DR. Genomic diversity of SARS-CoV-2 in Oxford during United Kingdom's first national lockdown. Sci Rep 2021;11:21484. [PMID: 34728747 DOI: 10.1038/s41598-021-01022-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
682 Liu T, Feng M, Wen Z, He Y, Lin W, Zhang M. Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections. J Inflamm Res 2021;14:5475-87. [PMID: 34720596 DOI: 10.2147/JIR.S329697] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
683 Polese-Bonatto M, Sartor ITS, Varela FH, Giannini GLT, Azevedo TR, Kern LB, Fernandes IR, Zavaglia GO, de David CN, Santos AP, de Almeida WAF, Porto VBG, Scotta MC, Stein RT; COVIDa Study Group. Children Have Similar Reverse Transcription Polymerase Chain Reaction Cycle Threshold for Severe Acute Respiratory Syndrome Coronavirus 2 in Comparison With Adults. Pediatr Infect Dis J 2021;40:e413-7. [PMID: 34596626 DOI: 10.1097/INF.0000000000003300] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
684 Holford P, Carr AC, Zawari M, Vizcaychipi MP. Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence. Life (Basel) 2021;11:1166. [PMID: 34833042 DOI: 10.3390/life11111166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
685 Mac Giolla Phadraig C, van Harten MT, Diniz-Freitas M, Limeres Posse J, Faulks D, Dougall A, Diz Dios P, Daly B. The impact of COVID-19 on access to dental care for people with disabilities: a global survey during the COVID-19 first wave lockdown. Med Oral Patol Oral Cir Bucal 2021;26:e770-7. [PMID: 34414999 DOI: 10.4317/medoral.24742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
686 Qin Z, Dong B, Wang R, Huang D, Wang J, Feng X, Bian J, Li Z. Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning. Acta Pharm Sin B 2021;11:3678-82. [PMID: 34703727 DOI: 10.1016/j.apsb.2021.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
687 Murtuja S, Shilkar D, Sarkar B, Sinha BN, Jayaprakash V. A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases. Bioorg Med Chem 2021;49:116415. [PMID: 34601454 DOI: 10.1016/j.bmc.2021.116415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
688 Munch MW, Meyhoff TS, Helleberg M, Kjaer MN, Granholm A, Hjortsø CJS, Jensen TS, Møller MH, Hjortrup PB, Wetterslev M, Vesterlund GK, Russell L, Jørgensen VL, Kristiansen KT, Benfield T, Ulrik CS, Andreasen AS, Bestle MH, Poulsen LM, Hildebrandt T, Knudsen LS, Møller A, Sølling CG, Brøchner AC, Rasmussen BS, Nielsen H, Christensen S, Strøm T, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Venkatesh B, Hammond N, Jha V, Myatra SN, Jensen MQ, Leistner JW, Mikkelsen VS, Svenningsen JS, Laursen SB, Hatley EV, Kristensen CM, Al-Alak A, Clapp E, Jonassen TB, Bjerregaard CL, Østerby NCH, Jespersen MM, Abou-Kassem D, Lassen ML, Zaabalawi R, Daoud MM, Abdi S, Meier N, la Cour K, Derby CB, Damlund BR, Laigaard J, Andersen LL, Mikkelsen J, Jensen JLS, Rasmussen AH, Arnerlöv E, Lykke M, Holst-Hansen MZB, Tøstesen BW, Schwab J, Madsen EK, Gluud C, Lange T, Perner A. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial. Acta Anaesthesiol Scand 2021;65:1421-30. [PMID: 34138478 DOI: 10.1111/aas.13941] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
689 Vezir E, Hizal M, Cura Yayla B, Aykac K, Yilmaz A, Kaya G, Oygar PD, Ozsurekci Y, Ceyhan M. Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection? Allergy Asthma Proc 2021;42:522-9. [PMID: 34871160 DOI: 10.2500/aap.2021.42.210087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
690 Al Nahid A, Ghosh A. Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh. Infect Genet Evol 2021;95:105057. [PMID: 34481060 DOI: 10.1016/j.meegid.2021.105057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
691 Ha B, Jadhao S, Hussaini L, Gibson T, Stephens K, Salazar L, Ciric C, Taylor M, Rouphael N, Edupuganti S, Rostad CA, Tompkins SM, Anderson EJ, Anderson LJ. Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera. Microbiol Spectr 2021;9:e0045821. [PMID: 34494855 DOI: 10.1128/Spectrum.00458-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
692 Scott SJ, Pfotenhauer B, Weiner JJ, Hilleshiem J, Khubbar M, Bhattacharyya S. Respiratory Pathogen Coinfections in SARS-CoV-2-Positive Patients in Southeastern Wisconsin: A Retrospective Analysis. Microbiol Spectr 2021;9:e0083121. [PMID: 34668725 DOI: 10.1128/Spectrum.00831-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
693 Corchis-Scott R, Geng Q, Seth R, Ray R, Beg M, Biswas N, Charron L, Drouillard KD, D'Souza R, Heath DD, Houser C, Lawal F, McGinlay J, Menard SL, Porter LA, Rawlings D, Scholl ML, Siu KWM, Tong Y, Weisener CG, Wilhelm SW, McKay RML. Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance. Microbiol Spectr 2021;9:e0079221. [PMID: 34612693 DOI: 10.1128/Spectrum.00792-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
694 Zeng X, Jiang X, Yang L, Pan Y, Li Y. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes. J Immunol Res 2021;2021:8669098. [PMID: 34712741 DOI: 10.1155/2021/8669098] [Reference Citation Analysis]
695 Dronina J, Samukaite-Bubniene U, Ramanavicius A. Advances and insights in the diagnosis of viral infections. J Nanobiotechnology 2021;19:348. [PMID: 34717656 DOI: 10.1186/s12951-021-01081-2] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
696 Di Pasquale A, Radomski N, Mangone I, Calistri P, Lorusso A, Cammà C. SARS-CoV-2 surveillance in Italy through phylogenomic inferences based on Hamming distances derived from pan-SNPs, -MNPs and -InDels. BMC Genomics 2021;22:782. [PMID: 34717546 DOI: 10.1186/s12864-021-08112-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
697 An X, Xu X, Xiao M, Min X, Lyu Y, Tian J, Ke J, Lang S, Zhang Q, Fan A, Liu B, Zhang Y, Hu Y, Zhou Y, Shao J, Li X, Lian F, Tong X. Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19: A Randomized Controlled Trial. Front Med (Lausanne) 2021;8:728055. [PMID: 34712679 DOI: 10.3389/fmed.2021.728055] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
698 Wong ACP, Lau SKP, Woo PCY. Interspecies Jumping of Bat Coronaviruses. Viruses 2021;13:2188. [PMID: 34834994 DOI: 10.3390/v13112188] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
699 Altersberger M, Schneider M, Schiller M, Binder-Rodriguez C, Genger M, Khafaga M, Binder T, Prosch H. Point of care echocardiography and lung ultrasound in critically ill patients with COVID-19. Wien Klin Wochenschr 2021. [PMID: 34714384 DOI: 10.1007/s00508-021-01968-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
700 Daverey A, Dutta K, Joshi S, Daverey A. Sophorolipid: A glycolipid biosurfactant as a potential therapeutic agent against COVID-19. Bioengineered 2021. [PMID: 34709115 DOI: 10.1080/21655979.2021.1997261] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
701 Khan KA, Duceppe MO. Cross-reactivity and inclusivity analysis of CRISPR-based diagnostic assays of coronavirus SARS-CoV-2. PeerJ 2021;9:e12050. [PMID: 34703657 DOI: 10.7717/peerj.12050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
702 Azar G, Bonnin S, Vasseur V, Faure C, Salviat F, Clermont CV, Titah C, Farès S, Boulanger E, Derrien S, Couturier A, Duvilliers A, Manassero A, Hage R, Tadayoni R, Behar-Cohen F, Mauget-Faÿsse M. Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? J Clin Med 2021;10:5038. [PMID: 34768555 DOI: 10.3390/jcm10215038] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
703 Peterson SW, Lidder R, Daigle J, Wonitowy Q, Dueck C, Nagasawa A, Mulvey MR, Mangat CS. RT-qPCR detection of SARS-CoV-2 mutations S 69-70 del, S N501Y and N D3L associated with variants of concern in Canadian wastewater samples. Sci Total Environ 2021;:151283. [PMID: 34756912 DOI: 10.1016/j.scitotenv.2021.151283] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
704 Chamata Y, Jackson KG, Watson KA, Jauregi P. Whey-Derived Peptides at the Heart of the COVID-19 Pandemic. Int J Mol Sci 2021;22:11662. [PMID: 34769093 DOI: 10.3390/ijms222111662] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
705 Domingo M, Faraudo J. Interaction between SARS-CoV-2 spike glycoprotein and human skin models: a molecular dynamics study. Soft Matter 2021;17:9457-68. [PMID: 34612290 DOI: 10.1039/d1sm01026c] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
706 Lam JH, Khan AK, Cornell TA, Chia TW, Dress RJ, Yeow WWW, Mohd-Ismail NK, Venkataraman S, Ng KT, Tan YJ, Anderson DE, Ginhoux F, Nallani M. Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine. ACS Nano 2021;15:15754-70. [PMID: 34618423 DOI: 10.1021/acsnano.1c01243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
707 Gutiérrez-Álvarez J, Honrubia JM, Sanz-Bravo A, González-Miranda E, Fernández-Delgado R, Rejas MT, Zúñiga S, Sola I, Enjuanes L. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Proc Natl Acad Sci U S A 2021;118:e2111075118. [PMID: 34686605 DOI: 10.1073/pnas.2111075118] [Reference Citation Analysis]
708 Ye X, Angelo LS, Nicholson EG, Iwuchukwu OP, Cabral de Rezende W, Rajan A, Aideyan LO, McBride TJ, Bond N, Santarcangelo P, Rayford YJ, Ferlic-Stark L, Fragoso S, Momin Z, Liu H, Truong K, Lopez B, Conner ME, Rice AP, Kimata JT, Avadhanula V, Piedra PA. Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2. Front Immunol 2021;12:693462. [PMID: 34691016 DOI: 10.3389/fimmu.2021.693462] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
709 Liu Q, Fung DLX, Lac L, Hu P. A Novel Matrix Profile-Guided Attention LSTM Model for Forecasting COVID-19 Cases in USA. Front Public Health 2021;9:741030. [PMID: 34692627 DOI: 10.3389/fpubh.2021.741030] [Reference Citation Analysis]
710 Qiu C, Song Z, Wang J, Tian C, Liu X, Wu T, Li W, Zhang S, Lu H. Saliva specimen complements anal swab in assessing patients with COVID-19 for discharge from hospital. Emerg Microbes Infect 2021;10:2090-7. [PMID: 34689717 DOI: 10.1080/22221751.2021.1997339] [Reference Citation Analysis]
711 Bukhari SNH, Jain A, Haq E, Mehbodniya A, Webber J. Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets. Diagnostics (Basel) 2021;11:1990. [PMID: 34829338 DOI: 10.3390/diagnostics11111990] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
712 Macip G, Garcia-Segura P, Mestres-Truyol J, Saldivar-Espinoza B, Ojeda-Montes MJ, Gimeno A, Cereto-Massagué A, Garcia-Vallvé S, Pujadas G. Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition. Med Res Rev 2021. [PMID: 34697818 DOI: 10.1002/med.21862] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
713 Zelenova M, Ivanova A, Semyonov S, Gankin Y. Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database. Comput Biol Med 2021;139:104981. [PMID: 34735950 DOI: 10.1016/j.compbiomed.2021.104981] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
714 Nasker SS, Nanda A, Ramadass B, Nayak S. Epidemiological Analysis of SARS-CoV-2 Transmission Dynamics in the State of Odisha, India: A Yearlong Exploratory Data Analysis. Int J Environ Res Public Health 2021;18:11203. [PMID: 34769722 DOI: 10.3390/ijerph182111203] [Reference Citation Analysis]
715 Yamazaki S, Naito E, Sekiya R, Yogi S, Komiyama K, Miyakawa Y, Nagata M. Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine. J Infect Chemother 2021:S1341-321X(21)00291-9. [PMID: 34772624 DOI: 10.1016/j.jiac.2021.10.018] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
716 Jankhonkhan J, Sawangtong W. Model Predictive Control of COVID-19 Pandemic with Social Isolation and Vaccination Policies in Thailand. Axioms 2021;10:274. [DOI: 10.3390/axioms10040274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
717 Martí D, Alsina M, Alemán C, Bertran O, Turon P, Torras J. Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies. Biochimie 2021:S0300-9084(21)00249-2. [PMID: 34710552 DOI: 10.1016/j.biochi.2021.10.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
718 Díaz-Resendiz KJG, Toledo-Ibarra GA, Ruiz-Manzano R, Giron Perez DA, Covantes-Rosales CE, Benitez-Trinidad AB, Ramirez-Ibarra KM, Hermosillo Escobedo AT, González-Navarro I, Ventura-Ramón GH, Romero Castro A, Alam Escamilla D, Bueno-Duran AY, Girón-Pérez MI. Ex vivo treatment with fucoidan of mononuclear cells from SARS-CoV-2 infected patients. Int J Environ Health Res 2021;:1-19. [PMID: 34689674 DOI: 10.1080/09603123.2021.1982875] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
719 Mucino-bermejo M. COVID-19 and the Gastrointestinal Tract. Gastroenterology Insights 2021;12:394-404. [DOI: 10.3390/gastroent12040038] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
720 Pan S, Shu H, Wang Y, Li R, Zhou T, Yu Y, Xu J, Xiong W, Yang X, Zhang J, Yuan Y, Yuan S, Shang Y. The Abnormal Imaging of SARS-CoV-2: A Predictive Measure of Disease Severity. Front Med (Lausanne) 2021;8:694754. [PMID: 34676222 DOI: 10.3389/fmed.2021.694754] [Reference Citation Analysis]
721 Jiao D, Dong X, Yu Y, Wei C. Gene Presence/Absence Variation analysis of coronavirus family displays its pan-genomic diversity. Int J Biol Sci 2021;17:3717-27. [PMID: 34671195 DOI: 10.7150/ijbs.58220] [Reference Citation Analysis]
722 Corrêa RP, Castro HC, Quaresma BMCS, Stephens PRS, Araujo-Jorge TC, Ferreira RR. Perceptions and Feelings of Brazilian Health Care Professionals Regarding the Effects of COVID-19: Cross-sectional Web-Based Survey. JMIR Form Res 2021;5:e28088. [PMID: 34519656 DOI: 10.2196/28088] [Reference Citation Analysis]
723 Swaim CD, Dwivedi V, Perng YC, Zhao X, Canadeo LA, Harastani HH, Darling TL, Boon ACM, Lenschow DJ, Kulkarni V, Huibregtse JM. 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro. iScience 2021;24:103213. [PMID: 34632326 DOI: 10.1016/j.isci.2021.103213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
724 Cox HJ, Sharples GJ, Badyal JPS. Tea–Essential Oil–Metal Hybrid Nanocoatings for Bacterial and Viral Inactivation. ACS Appl Nano Mater 2021;4:12619-28. [DOI: 10.1021/acsanm.1c03151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
725 Sukharani N, Kumar J, Makheja K, Bai P, Sharma S, Subash K, Kamawal Y, Shahid S, Rizwan A. Gastrointestinal Manifestation of COVID-19 in Hospitalized Patients. Cureus 2021;13:e18024. [PMID: 34667695 DOI: 10.7759/cureus.18024] [Reference Citation Analysis]
726 Kamińska D, Augustyniak-Bartosik H, Kościelska-Kasprzak K, Żabińska M, Bartoszek D, Poznański P, Kuriata-Kordek M, Kusztal M, Mazanowska O, Krajewska M. Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients. J Clin Med 2021;10:4833. [PMID: 34768356 DOI: 10.3390/jcm10214833] [Reference Citation Analysis]
727 Mcintyre‐mills JJ. Communication and culture: A multispecies endeavour within a shared habitat. Syst Res Behav Sci 2021;38:671-84. [DOI: 10.1002/sres.2810] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
728 Barghash RF, Fawzy IM, Chandrasekar V, Singh AV, Katha U, Mandour AA. In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19. Coatings 2021;11:1273. [DOI: 10.3390/coatings11111273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
729 Behl T, Kumar S, Sehgal A, Singh S, Sharma N, Chirgurupati S, Aldubayan M, Alhowail A, Bhatia S, Bungau S. Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D. Biochem Biophys Res Commun 2021;583:14-21. [PMID: 34715496 DOI: 10.1016/j.bbrc.2021.10.042] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
730 Bagnato G, La Rosa D, Ioppolo C, De Gaetano A, Chiappalone M, Zirilli N, Viapiana V, Tringali MC, Tomeo S, Aragona CO, Napoli F, Lillo S, Irrera N, Roberts WN, Imbalzano E, Micari A, Ventura Spagnolo E, Squadrito G, Gangemi S, Versace AG. The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study. Front Med (Lausanne) 2021;8:719976. [PMID: 34660631 DOI: 10.3389/fmed.2021.719976] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
731 Yuan S, Balaji S, Lomakin IB, Xiong Y. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition. Front Microbiol 2021;12:752214. [PMID: 34659188 DOI: 10.3389/fmicb.2021.752214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
732 El Khamlichi S, Maurady A, Sedqui A. Comparative study of COVID-19 situation between lower-middle-income countries in the eastern Mediterranean region. J Oral Biol Craniofac Res 2022;12:165-76. [PMID: 34660189 DOI: 10.1016/j.jobcr.2021.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
733 Akter R, Rahman MH, Bhattacharya T, Kaushik D, Mittal V, Parashar J, Kumar K, Kabir MT, Tagde P. Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments. Environ Sci Pollut Res Int 2021. [PMID: 34664166 DOI: 10.1007/s11356-021-16809-8] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
734 Suleman M, Yousafi Q, Ali J, Ali SS, Hussain Z, Ali S, Waseem M, Iqbal A, Ahmad S, Khan A, Wang Y, Wei DQ. Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor. Comput Biol Med 2021;138:104936. [PMID: 34655895 DOI: 10.1016/j.compbiomed.2021.104936] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
735 Malarvili MB, Alexie M, Dahari N, Kamarudin A. On Analyzing Capnogram as a Novel Method for Screening COVID-19: A Review on Assessment Methods for COVID-19. Life (Basel) 2021;11:1101. [PMID: 34685472 DOI: 10.3390/life11101101] [Reference Citation Analysis]
736 Melgoza-González EA, Hinojosa-Trujillo D, Reséndiz-Sandoval M, Mata-Haro V, Hernández-Valenzuela S, García-Vega M, Bravo-Parra M, Arvizu-Flores AA, Valenzuela O, Velázquez E, Soto-Gaxiola A, Gómez-Meza MB, Pérez-Jacobo F, Villela L, Hernández J. Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines. Transbound Emerg Dis 2021. [PMID: 34655457 DOI: 10.1111/tbed.14344] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
737 Jukič M, Janežič D, Bren U. Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations. Int J Mol Sci 2021;22:11143. [PMID: 34681802 DOI: 10.3390/ijms222011143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
738 D'Souza AR, Buckingham AB, Salasc F, Ingemarsdotter CK, Iaconis G, Jarvis I, Groom HCT, Kenyon JC, Lever AML. Duplex formation between the template and the nascent strand in the transcription-regulating sequences is associated with the site of template switching in SARS - CoV-2. RNA Biol 2021;18:148-56. [PMID: 34541994 DOI: 10.1080/15476286.2021.1975388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
739 Chia CSB, Xu W, Shuyi Ng P. A Patent Review on SARS Coronavirus Main Protease (3CLpro ) Inhibitors. ChemMedChem 2021. [PMID: 34651447 DOI: 10.1002/cmdc.202100576] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
740 Forgacs D, Jang H, Abreu RB, Hanley HB, Gattiker JL, Jefferson AM, Ross TM. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Front Immunol 2021;12:728021. [PMID: 34646267 DOI: 10.3389/fimmu.2021.728021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
741 Greger M. Primary Pandemic Prevention. Am J Lifestyle Med 2021;15:498-505. [PMID: 34646097 DOI: 10.1177/15598276211008134] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
742 Cisneros IE, Cunningham KA. Covid-19 interface with drug misuse and substance use disorders. Neuropharmacology 2021;198:108766. [PMID: 34454912 DOI: 10.1016/j.neuropharm.2021.108766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
743 Fontenele RS, Kraberger S, Hadfield J, Driver EM, Bowes D, Holland LA, Faleye TOC, Adhikari S, Kumar R, Inchausti R, Holmes WK, Deitrick S, Brown P, Duty D, Smith T, Bhatnagar A, Yeager RA 2nd, Holm RH, von Reitzenstein NH, Wheeler E, Dixon K, Constantine T, Wilson MA, Lim ES, Jiang X, Halden RU, Scotch M, Varsani A. High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants. Water Res 2021;205:117710. [PMID: 34607084 DOI: 10.1016/j.watres.2021.117710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
744 Alwazeer D, Liu FF, Wu XY, LeBaron TW. Combating Oxidative Stress and Inflammation in COVID-19 by Molecular Hydrogen Therapy: Mechanisms and Perspectives. Oxid Med Cell Longev 2021;2021:5513868. [PMID: 34646423 DOI: 10.1155/2021/5513868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
745 Canh VD, Torii S, Yasui M, Kyuwa S, Katayama H. Capsid integrity RT-qPCR for the selective detection of intact SARS-CoV-2 in wastewater. Sci Total Environ 2021;791:148342. [PMID: 34139497 DOI: 10.1016/j.scitotenv.2021.148342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
746 Xiong J, Xiang Y, Huang Z, Liu X, Wang M, Ge G, Chen H, Xu J, Zheng M, Chen L. Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction. Front Chem 2021;9:740702. [PMID: 34646813 DOI: 10.3389/fchem.2021.740702] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
747 Paulsson-Habegger L, Snabaitis AK, Wren SP. Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection. Bioorg Med Chem 2021;48:116389. [PMID: 34543844 DOI: 10.1016/j.bmc.2021.116389] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
748 Khan J, Asoom LIA, Khan M, Chakrabartty I, Dandoti S, Rudrapal M, Zothantluanga JH. Evolution of RNA viruses from SARS to SARS-CoV-2 and diagnostic techniques for COVID-19: a review. Beni Suef Univ J Basic Appl Sci 2021;10:60. [PMID: 34642633 DOI: 10.1186/s43088-021-00150-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
749 Giampietro BV, Dutra S, Oliveira RVC, Biancardi AL, Veloso V, Curi ALL. Ophthalmological Findings in Patients with SARS-CoV-2 Infection Examined at the National Institute of Infectious Diseases - INI/Fiocruz. Ocul Immunol Inflamm 2021;:1-4. [PMID: 34648392 DOI: 10.1080/09273948.2021.1980812] [Reference Citation Analysis]
750 Mioch D, Kuiper S, van den Bijllaardt W, van Jaarsveld CHM, Kluytmans J, Lodder E, Wissing MD; COco study group. SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: Baseline data from the prospective COco-study. Prev Med Rep 2021;24:101594. [PMID: 34642617 DOI: 10.1016/j.pmedr.2021.101594] [Reference Citation Analysis]
751 Ferreto LED, Bortoloti DS, Fortes PCN, Follador F, Arruda G, Ximenez JP, Wendt GW. Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis. Sao Paulo Med J 2021;139:657-61. [PMID: 34644768 DOI: 10.1590/1516-3180.2021.0120.R1.30062021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
752 Ghosh AK, Raghavaiah J, Shahabi D, Yadav M, Anson BJ, Lendy EK, Hattori SI, Higashi-Kuwata N, Mitsuya H, Mesecar AD. Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies. J Med Chem 2021;64:14702-14. [PMID: 34528437 DOI: 10.1021/acs.jmedchem.1c01214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
753 Shehata MM, Mahmoud SH, Tarek M, Al-Karmalawy AA, Mahmoud A, Mostafa A, M Elhefnawi M, Ali MA. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine. Molecules 2021;26:6182. [PMID: 34684763 DOI: 10.3390/molecules26206182] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
754 Pundir H, Joshi T, Pant M, Bhat S, Pandey J, Chandra S, Tamta S. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches. J Biomol Struct Dyn 2021;:1-12. [PMID: 34637693 DOI: 10.1080/07391102.2021.1987329] [Reference Citation Analysis]
755 Nikolaidis M, Markoulatos P, Van de Peer Y, Oliver SG, Amoutzias GD. The neighborhood of the Spike gene is a hotspot for modular intertypic homologous and non-homologous recombination in Coronavirus genomes. Mol Biol Evol 2021:msab292. [PMID: 34638137 DOI: 10.1093/molbev/msab292] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
756 Vesper N, Ortiz Y, Bartels-Burgahn F, Yang J, de la Rosa K, Tenbusch M, Schulz S, Finzel S, Jäck HM, Eibel H, Voll RE, Reth M. A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants. Front Immunol 2021;12:730766. [PMID: 34630410 DOI: 10.3389/fimmu.2021.730766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
757 Zou J, Jing H, Zhang X, Liu Y, Zhao Z, Duan L, Yuan Y, Chen Z, Gou Q, Xiong Q, Li S, Yang F, Zeng H, Zou Q, Zhang J. α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants. Front Immunol 2021;12:757691. [PMID: 34630436 DOI: 10.3389/fimmu.2021.757691] [Reference Citation Analysis]
758 VanBlargan LA, Adams LJ, Liu Z, Chen RE, Gilchuk P, Raju S, Smith BK, Zhao H, Case JB, Winkler ES, Whitener BM, Droit L, Aziati ID, Bricker TL, Joshi A, Shi PY, Creanga A, Pegu A, Handley SA, Wang D, Boon ACM, Crowe JE Jr, Whelan SPJ, Fremont DH, Diamond MS. A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope. Immunity 2021;54:2399-2416.e6. [PMID: 34481543 DOI: 10.1016/j.immuni.2021.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
759 K D, A S J, Liu Y. A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing. Appl Soft Comput 2021;113:107945. [PMID: 34630000 DOI: 10.1016/j.asoc.2021.107945] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
760 Zahn T, Mhedhbi I, Hein S, Raupach J, Miskey C, Husria Y, Bayanga K, Bartel D, Vieths S, Ivics Z, Oberle D, Keller-Stanislawski B, Herrlein ML, Maier TJ, Hildt E. Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19. Allergy 2021. [PMID: 34637150 DOI: 10.1111/all.15138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
761 Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Peptides and peptidomimetics as therapeutic agents for Covid-19. Pept Sci (Hoboken) 2021;:e24245. [PMID: 34901700 DOI: 10.1002/pep2.24245] [Reference Citation Analysis]
762 Lim HG, Hsiao SH, Lee YG. Orchestrating an Optimized Next-Generation Sequencing-Based Cloud Workflow for Robust Viral Identification during Pandemics. Biology (Basel) 2021;10:1023. [PMID: 34681121 DOI: 10.3390/biology10101023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
763 Liang J, Pitsillou E, Ververis K, Guallar V, Hung A, Karagiannis TC. Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition. J Mol Graph Model 2021;110:108050. [PMID: 34655918 DOI: 10.1016/j.jmgm.2021.108050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
764 Badovinac A, Par M, Plančak L, Balić MD, Vražić D, Božić D, Musić L. The Impact of the COVID-19 Pandemic on Dental Education: An Online Survey of Students' Perceptions and Attitudes. Dent J (Basel) 2021;9:116. [PMID: 34677178 DOI: 10.3390/dj9100116] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
765 Shah JN, Guo GQ, Krishnan A, Ramesh M, Katari NK, Shahbaaz M, Abdellattif MH, Singh SK, Dua K. Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19. Therapie 2021:S0040-5957(21)00204-3. [PMID: 34689960 DOI: 10.1016/j.therap.2021.09.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
766 Asaka MN, Utsumi D, Kamada H, Nagata S, Nakachi Y, Yamaguchi T, Kawaoka Y, Kuba K, Yasutomi Y. Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. JCI Insight 2021;6:e152529. [PMID: 34463644 DOI: 10.1172/jci.insight.152529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
767 Christofferson RC, O'Neal HR, Jagneaux T, O'Neal C, Walsh CS, Mayton EH, Vu LD, Fish AI, Phan A, Stoufflet TE, Schroeder JR, Walker M, Turner EA, Pierce C, Wester KS, DeLeo C, Tenreiro E, Ogden B, Cormier SA. Reduced turnaround times through multi-sectoral community collaboration during the first surge of SARS-CoV-2 and associated effect on patient care and hospital operations. PLoS One 2021;16:e0257302. [PMID: 34618831 DOI: 10.1371/journal.pone.0257302] [Reference Citation Analysis]
768 Ip HS, Griffin KM, Messer JD, Winzeler ME, Shriner SA, Killian ML, K Torchetti M, DeLiberto TJ, Amman BR, Cossaboom CM, Harvey RR, Wendling NM, Rettler H, Taylor D, Towner JS, Barton Behravesh C, Blehert DS. An Opportunistic Survey Reveals an Unexpected Coronavirus Diversity Hotspot in North America. Viruses 2021;13:2016. [PMID: 34696445 DOI: 10.3390/v13102016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
769 Banach BB, Cerutti G, Fahad AS, Shen CH, Oliveira De Souza M, Katsamba PS, Tsybovsky Y, Wang P, Nair MS, Huang Y, Francino-Urdániz IM, Steiner PJ, Gutiérrez-González M, Liu L, López Acevedo SN, Nazzari AF, Wolfe JR, Luo Y, Olia AS, Teng IT, Yu J, Zhou T, Reddem ER, Bimela J, Pan X, Madan B, Laflin AD, Nimrania R, Yuen KY, Whitehead TA, Ho DD, Kwong PD, Shapiro L, DeKosky BJ. Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses. Cell Rep 2021;37:109771. [PMID: 34587480 DOI: 10.1016/j.celrep.2021.109771] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
770 Thom RE, Eastaugh LS, O'Brien LM, Ulaeto DO, Findlay JS, Smither SJ, Phelps AL, Stapleton HL, Hamblin KA, Weller SA. Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms. Front Cell Infect Microbiol 2021;11:716436. [PMID: 34604108 DOI: 10.3389/fcimb.2021.716436] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
771 Jalal Z, Bakour M, Lyoussi B. Medicinal Plants and Zinc: Impact on COVID-19 Pandemic. ScientificWorldJournal 2021;2021:9632034. [PMID: 34602868 DOI: 10.1155/2021/9632034] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
772 Mahmud S, Hasan MR, Biswas S, Paul GK, Afrose S, Mita MA, Sultana Shimu MS, Promi MM, Hani U, Rahamathulla M, Khan MA, Zaman S, Uddin MS, Rahmatullah M, Jahan R, Alqahtani AM, Saleh MA, Emran TB. Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach. Front Bioinform 2021;1:717141. [DOI: 10.3389/fbinf.2021.717141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
773 Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res 2021:cvab315. [PMID: 34609508 DOI: 10.1093/cvr/cvab315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
774 Aladag E, Tas Z, Ozdemir BS, Akbaba TH, Akpınar MG, Goker H, Unalan-Altintop T, Inkaya AC, Alp A, Metan G, Haznedaroglu IC, Balci-Peynircioglu B, Sayinalp N. Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19. J Renin Angiotensin Aldosterone Syst 2021;2021:5509280. [PMID: 34603503 DOI: 10.1155/2021/5509280] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
775 Tsai SJ, Atai NA, Cacciottolo M, Nice J, Salehi A, Guo C, Sedgwick A, Kanagavelu S, Gould SJ. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity. J Biol Chem 2021;297:101266. [PMID: 34600888 DOI: 10.1016/j.jbc.2021.101266] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
776 Yin X, Chen L, Yuan S, Liu L, Gao Z. A robust high-throughput fluorescent polarization assay for the evaluation and screening of SARS-CoV-2 fusion inhibitors. Bioorg Chem 2021;116:105362. [PMID: 34598089 DOI: 10.1016/j.bioorg.2021.105362] [Reference Citation Analysis]
777 Rana R, Tripathi A, Kumar N, Ganguly NK. A Comprehensive Overview on COVID-19: Future Perspectives. Front Cell Infect Microbiol 2021;11:744903. [PMID: 34595136 DOI: 10.3389/fcimb.2021.744903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
778 Lin B, Zhong G, Liang Z, Huang J, Wang X, Lin Y. Perceived-stigma level of COVID-19 patients in China in the early stage of the epidemic: A cross-sectional research. PLoS One 2021;16:e0258042. [PMID: 34597354 DOI: 10.1371/journal.pone.0258042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
779 Cherkaoui D, Huang D, Miller BS, Turbé V, McKendry RA. Harnessing recombinase polymerase amplification for rapid multi-gene detection of SARS-CoV-2 in resource-limited settings. Biosens Bioelectron 2021;189:113328. [PMID: 34051382 DOI: 10.1016/j.bios.2021.113328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
780 Han T, Cong H, Shen Y, Yu B. Recent advances in detection technologies for COVID-19. Talanta 2021;233:122609. [PMID: 34215093 DOI: 10.1016/j.talanta.2021.122609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
781 Forrestall KL, Burley DE, Cash MK, Pottie IR, Darvesh S. Phenothiazines as dual inhibitors of SARS-CoV-2 main protease and COVID-19 inflammation. Can J Chem 2021;99:801-11. [DOI: 10.1139/cjc-2021-0139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
782 Gomes Noll JC, do Nascimento GM, Diel DG. Natural Transmission and Experimental Models of SARS CoV-2 Infection in Animals. Comp Med 2021;71:369-82. [PMID: 34702427 DOI: 10.30802/AALAS-CM-21-000046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
783 Natarajan A, Han A, Zlitni S, Brooks EF, Vance SE, Wolfe M, Singh U, Jagannathan P, Pinsky BA, Boehm A, Bhatt AS. Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA. Nat Commun 2021;12:5753. [PMID: 34599164 DOI: 10.1038/s41467-021-25576-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
784 Choudhary S, Sharma K, Singh PK. Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19. Chem Biol Interact 2021;348:109657. [PMID: 34516971 DOI: 10.1016/j.cbi.2021.109657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
785 McArdle A, Washington KE, Chazarin Orgel B, Binek A, Manalo DM, Rivas A, Ayres M, Pandey R, Phebus C, Raedschelders K, Fert-Bober J, Van Eyk JE. Discovery Proteomics for COVID-19: Where We Are Now. J Proteome Res 2021;20:4627-39. [PMID: 34550702 DOI: 10.1021/acs.jproteome.1c00475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
786 Trichel AM. Overview of Nonhuman Primate Models of SARS-CoV-2 Infection. Comp Med 2021;71:411-32. [PMID: 34548126 DOI: 10.30802/AALAS-CM-20-000119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
787 Sehgal T, Gupta N, Kohli S, Khurana A, Dass J, Diwan S, A J M, Khan M, Aggarwal M, Subramanian A. A Prospective Study of Specialized Coagulation Parameters in Admitted COVID-19 Patients and Their Correlation With Acute Respiratory Distress Syndrome and Outcome. Cureus 2021;13:e17463. [PMID: 34589359 DOI: 10.7759/cureus.17463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
788 Mamun AA, Akter F, Khan M, Ahmed SS, Uddin MG, Tasfia NT, Efaz FM, Ali MA, Sultana MUC, Halim MA. Identification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2. J Biomol Struct Dyn 2021;:1-13. [PMID: 34590967 DOI: 10.1080/07391102.2021.1980109] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
789 Tu J, Mo X, Zhang X, Xun J, Chen X, Liu Y, Jing W, Xie T. Effects of different corticosteroid therapy on severe COVID-19 patients: a meta-analysis of randomized controlled trials. Expert Rev Respir Med 2021;:1-11. [PMID: 34541972 DOI: 10.1080/17476348.2021.1983429] [Reference Citation Analysis]
790 Han Y, Yuan K, Wang Z, Liu WJ, Lu ZA, Liu L, Shi L, Yan W, Yuan JL, Li JL, Shi J, Liu ZC, Wang GH, Kosten T, Bao YP, Lu L. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl Psychiatry 2021;11:499. [PMID: 34593760 DOI: 10.1038/s41398-021-01629-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
791 Gupta RK, Nwachuku EL, Zusman BE, Jha RM, Puccio AM. Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium. PLoS One 2021;16:e0257784. [PMID: 34582497 DOI: 10.1371/journal.pone.0257784] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
792 Mollentze N, Babayan SA, Streicker DG. Identifying and prioritizing potential human-infecting viruses from their genome sequences. PLoS Biol 2021;19:e3001390. [PMID: 34582436 DOI: 10.1371/journal.pbio.3001390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
793 Kukla M, Menżyk T, Dembiński M, Winiarski M, Garlicki A, Bociąga-Jasik M, Skonieczna M, Hudy D, Maziarz B, Kuśnierz-Cabala B, Kapusta M, Skladany L, Grgurevic I, Mikolasevic I, Filipec-Kanizaj T, Wójcik-Bugajska M, Grodzicki T, Rogula T, Stygar D. Fetuin-A Deficiency but Not Pentraxin 3, FGF-21, or Irisin, Predisposes to More Serious COVID-19 Course. Biomolecules 2021;11:1422. [PMID: 34680053 DOI: 10.3390/biom11101422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
794 Kim DM, Seo JW, Kim Y, Park U, Ha NY, Park H, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Kim YS, Cho NH. Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients. Korean J Intern Med 2022;37:201-9. [PMID: 34565131 DOI: 10.3904/kjim.2021.093] [Reference Citation Analysis]
795 Ozimek N, Velez K, Anvari H, Butler L, Goldman KN, Woitowich NC. Impact of Stress on Menstrual Cyclicity During the Covid-19 Pandemic: A Survey Study. J Womens Health (Larchmt) 2021. [PMID: 34582731 DOI: 10.1089/jwh.2021.0158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
796 Khan WH, Hashmi Z, Goel A, Ahmad R, Gupta K, Khan N, Alam I, Ahmed F, Ansari MA. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions. Front Cell Infect Microbiol 2021;11:690621. [PMID: 34568087 DOI: 10.3389/fcimb.2021.690621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
797 Sultan A, Ali R, Ishrat R, Ali S. Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 Mpro for the treatment of COVID-19. J Biomol Struct Dyn 2021;:1-15. [PMID: 34569411 DOI: 10.1080/07391102.2021.1979097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
798 Quan S, Guo Y, Zhou J, Zhang G, Xing K, Mei H, Li J. Orthodontic emergencies and mental state of Chinese orthodontic patients during the COVID-19 pandemic. BMC Oral Health 2021;21:477. [PMID: 34579698 DOI: 10.1186/s12903-021-01834-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
799 Khan A, Khan T, Ali S, Aftab S, Wang Y, Qiankun W, Khan M, Suleman M, Ali S, Heng W, Ali SS, Wei DQ, Mohammad A. SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines. Biomed Pharmacother 2021;143:112176. [PMID: 34562770 DOI: 10.1016/j.biopha.2021.112176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
800 Carvalho-Correia E, Calçada C, Branca F, Estévez-Gómez N, De Chiara L, Varela N, Gallego-García P, Posada D, Sousa H, Sousa J, Veiga MI, Osório NS. OmniSARS2: A Highly Sensitive and Specific RT-qPCR-Based COVID-19 Diagnostic Method Designed to Withstand SARS-CoV-2 Lineage Evolution. Biomedicines 2021;9:1314. [PMID: 34680431 DOI: 10.3390/biomedicines9101314] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
801 Abdali S, Yu J. Occupational Dermatoses Related to Personal Protective Equipment Used During the COVID-19 Pandemic. Dermatol Clin 2021;39:555-68. [PMID: 34556245 DOI: 10.1016/j.det.2021.05.009] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
802 Sauleda S, Palacios L, Brès V, Piñana M, Alonso-Hernandez L, Bes M, Piron M, Entrena E, Minguez-Micolau AM, Marimón JM, Gurrola A, Soria G, Puig L, Antón A, Pumarola T, Linnen JM. Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system. Diagn Microbiol Infect Dis 2021;102:115560. [PMID: 34688036 DOI: 10.1016/j.diagmicrobio.2021.115560] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
803 Abdrabbo M, Birch CM, Brandt M, Cicigoi KA, Coffey SJ, Dolan CC, Dvorak H, Gehrke AC, Gerzema AEL, Hansen A, Henseler EJ, Huelsbeck AC, LaBerge B, Leavens CM, Le CN, Lindquist AC, Ludwig RK, Reynolds JH, Severson NJ, Sherman BA, Sillman HW, Smith MA, Smith MA, Snortheim MJ, Svaren LM, Vanderpas EC, Wackett MJ, Wozney AJ, Bhattacharyya S, Hati S. Vitamin D and COVID-19: A review on the role of vitamin D in preventing and reducing the severity of COVID-19 infection. Protein Sci 2021;30:2206-20. [PMID: 34558135 DOI: 10.1002/pro.4190] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
804 Herr C, Mang S, Mozafari B, Guenther K, Speer T, Seibert M, Srikakulam SK, Beisswenger C, Ritzmann F, Keller A, Mueller R, Smola S, Eisinger D, Zemlin M, Danziger G, Volk T, Hoersch S, Krawczyk M, Lammert F, Adams T, Wagenpfeil G, Kindermann M, Marcu C, Ataya ZWD, Mittag M, Schwarzkopf K, Custodis F, Grandt D, Schaefer H, Eltges K, Lepper PM, Bals R; CORSAAR Study Group. Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19. J Inflamm Res 2021;14:4651-67. [PMID: 34552347 DOI: 10.2147/JIR.S320685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
805 Collins DP, Osborn MJ, Steer CJ. Differentiation of immortalized human multi-lineage progenitor to alveolar type 2-like cells: angiotensin-converting enzyme 2 expression and binding of severe acute respiratory syndrome coronavirus 2 spike and spike 1 proteins. Cytotherapy 2021;23:1064-73. [PMID: 34551876 DOI: 10.1016/j.jcyt.2021.07.017] [Reference Citation Analysis]
806 Lakhera S, Devlal K, Ghosh A, Rana M. In Silico Investigation of Phytoconstituents of Medicinal Herb 'Piper Longum' Against SARS-CoV-2 by Molecular Docking and Molecular Dynamics Analysis. Results Chem 2021;:100199. [PMID: 34603947 DOI: 10.1016/j.rechem.2021.100199] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
807 Hsieh WY, Lin CH, Lin TC, Lin CH, Chang HF, Tsai CH, Wu HT, Lin CS. Development and Efficacy of Lateral Flow Point-of-Care Testing Devices for Rapid and Mass COVID-19 Diagnosis by the Detections of SARS-CoV-2 Antigen and Anti-SARS-CoV-2 Antibodies. Diagnostics (Basel) 2021;11:1760. [PMID: 34679458 DOI: 10.3390/diagnostics11101760] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
808 Islam A, Ferdous J, Islam S, Sayeed MA, Dutta Choudhury S, Saha O, Hassan MM, Shirin T. Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife. Viruses 2021;13:1908. [PMID: 34696338 DOI: 10.3390/v13101908] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
809 Kaziz S, Saad Y, Bouzid M, Selmi M, Belmabrouk H. Enhancement of COVID-19 detection time by means of electrothermal force. Microfluid Nanofluidics 2021;25:86. [PMID: 34548854 DOI: 10.1007/s10404-021-02490-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
810 Sun L, Yi B, Pan X, Wu L, Shang Z, Jia Y, Tao X, Zhao F, Xie W, Sun Z, Bai Y, Liu W. PTSD Symptoms and Sleep Quality of COVID-19 Patients During Hospitalization: An Observational Study from Two Centers. Nat Sci Sleep 2021;13:1519-31. [PMID: 34548832 DOI: 10.2147/NSS.S317618] [Reference Citation Analysis]
811 Spampinato MD, Sposato A, Migliano MT, Gordini G, Bua V, Sofia S. Lung Ultrasound Severity Index: Development and Usefulness in Patients with Suspected SARS-Cov-2 Pneumonia-A Prospective Study. Ultrasound Med Biol 2021;47:3333-42. [PMID: 34548188 DOI: 10.1016/j.ultrasmedbio.2021.08.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
812 Kumar R, Christensen ND, Kaddis Maldonado RJ, Bewley MC, Ostman A, Sudol M, Chen EC, Buchkovich NW, Gontu A, Surendran Nair M, Nissly RH, Minns AM, Kapur V, Rossi R, Kuchipudi SV, Lindner SE, Parent LJ, Flanagan JM, Buchkovich NJ. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses. Viruses 2021;13:1899. [PMID: 34696329 DOI: 10.3390/v13101899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
813 Mesquita JR, Barradas P, Gomes da Silva P, Ferreira AS, Silva E, Matas IM, Thomson G, Amorim I, Duarte R, Gomes HC, Monteiro Á, Nascimento MSJ. SARS-CoV-2 and blood donations in Portugal, June-July 2020. J Med Virol 2022;94:42-3. [PMID: 34546586 DOI: 10.1002/jmv.27353] [Reference Citation Analysis]
814 Zandi M, Farahani A, Zakeri A, Akhavan Rezayat S, Mohammadi R, Das U, Dimmock JR, Afzali S, Nakhaei MA, Doroudi A, Erfani Y, Soltani S. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic COVID-19 Patients: A Systematic Literature Review. Int J Microbiol 2021;2021:5528786. [PMID: 34545287 DOI: 10.1155/2021/5528786] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
815 Obande GA, Bagudo AI, Mohamad S, Deris ZZ, Harun A, Yean CY, Aziah I, Banga Singh KK. Current State of COVID-19 Pandemic in Africa: Lessons for Today and the Future. Int J Environ Res Public Health 2021;18:9968. [PMID: 34639270 DOI: 10.3390/ijerph18199968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
816 Das P, Dudley JP. How Viruses Use the VCP/p97 ATPase Molecular Machine. Viruses 2021;13:1881. [PMID: 34578461 DOI: 10.3390/v13091881] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
817 Muto Y, Awano N, Inomata M, Kuse N, Tone M, Takada K, Fujimoto K, Ueda A, Hayashi M, Izumo T. Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan. Respir Investig 2021;59:804-9. [PMID: 34538593 DOI: 10.1016/j.resinv.2021.08.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
818 Abe T, Furukawa R, Iwasaki Y, Ikemura T. Time-Series Trend of Pandemic SARS-CoV-2 Variants Visualized Using Batch-Learning Self-Organizing Map for Oligonucleotide Compositions. CODATA 2021;20:29. [DOI: 10.5334/dsj-2021-029] [Reference Citation Analysis]
819 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
820 Deng H, Yan X, Yuan L. Human genetic basis of coronavirus disease 2019. Signal Transduct Target Ther 2021;6:344. [PMID: 34545062 DOI: 10.1038/s41392-021-00736-8] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
821 Shaban MS, Müller C, Mayr-Buro C, Weiser H, Meier-Soelch J, Albert BV, Weber A, Linne U, Hain T, Babayev I, Karl N, Hofmann N, Becker S, Herold S, Schmitz ML, Ziebuhr J, Kracht M. Multi-level inhibition of coronavirus replication by chemical ER stress. Nat Commun 2021;12:5536. [PMID: 34545074 DOI: 10.1038/s41467-021-25551-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
822 Aiello F, Ciotti M, Gallo Afflitto G, Rapanotti MC, Caggiano B, Treglia M, Grelli S, Bernardini S, Mauriello S, Nucci C, Marsella LT, Mancino R. Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients' Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs. J Clin Med 2021;10:4256. [PMID: 34575369 DOI: 10.3390/jcm10184256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
823 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
824 Sharma HN, Latimore COD, Matthews QL. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens 2021;10:1218. [PMID: 34578250 DOI: 10.3390/pathogens10091218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
825 Dong H, Zhou M, Che D, Zhang H, Bodomo A. Analysis of COVID-19 Name Varieties in Chinese Mass and Social Media. Int J Environ Res Public Health 2021;18:9850. [PMID: 34574774 DOI: 10.3390/ijerph18189850] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
826 Elli S, Bojkova D, Bechtel M, Vial T, Boltz D, Muzzio M, Peng X, Sala F, Cosentino C, Goy A, Guerrini M, Müller L, Cinatl J, Margitich V, Te Velthuis AJW. Enisamium Inhibits SARS-CoV-2 RNA Synthesis. Biomedicines 2021;9:1254. [PMID: 34572438 DOI: 10.3390/biomedicines9091254] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
827 Mateus D, Sebastião AI, Carrascal MA, Carmo AD, Matos AM, Cruz MT. Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection. Rev Med Virol 2021;:e2290. [PMID: 34534372 DOI: 10.1002/rmv.2290] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
828 Miller AK, Mifsud JCO, Costa VA, Grimwood RM, Kitson J, Baker C, Brosnahan CL, Pande A, Holmes EC, Gemmell NJ, Geoghegan JL. Slippery when wet: cross-species transmission of divergent coronaviruses in bony and jawless fish and the evolutionary history of the Coronaviridae. Virus Evol 2021;7:veab050. [PMID: 34527280 DOI: 10.1093/ve/veab050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
829 Made F, Utembe W, Wilson K, Naicker N, Tlotleng N, Mdleleni S, Mazibuko L, Ntlebi